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Abstract
Kalirin-7 (Kal7) is a Rho-guanine nucleotide exchange factor localized to the post-synaptic
density (PSD) of neurons in the forebrain. For several years, Kal7 has been known to be an
important regulator of dendritic spine formation and stabilization in cultured neurons. However,
the functional consequences of these morphological changes remained largely unexplored. A
transgenic mouse with a constitutive genetic deletion of Kal7 (Kal7KO) was developed and
characterized. Initial studies on this mouse showed that Kal7 was essential for normal dendritic
spine formation in the hippocampus and hippocampal long-term potentiation. Additionally,
Kal7KO mice displayed decreased anxiety-like behavior and fear conditioning, while exhibiting
normal behavior in other hippocampal-dependent learning tasks. Biochemical characterization
of these mice showed that Kal7KO caused a compensatory increase in other splice variants of
Kalirin, and decreased PSD levels of the NR2B subunit of the NMDA receptor. Following this
initial characterization, Kal7KO mice were examined in models of cocaine addiction. Kal7KO mice
exhibited increased locomotor sensitivity to cocaine, but showed decreased preference for
cocaine in a conditioned place preference assay. While wild-type mice exhibited an increase in
dendritic spine density in the nucleus accumbens following cocaine treatments, Kal7KO mice did
not. Hence, we looked more closely at the decrease in NR2B levels in Kal7KO mice. We saw
specific decreases in NR2B currents and cell surface localization in the Kal7KO. Biochemical
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studies revealed a direct interaction between Kal7 and NR2B. Inhibition of NR2B currents prior
to fear or cocaine conditioning caused wild-type mice to phenocopy Kal7KO mice, while leaving
the Kal7KO unaffected. This suggests that decreases in NR2B mediated currents account for
behavioral abnormalities seen in Kal7KO mice. Finally, we used mass spectrometry to identify
>30 sites of phosphorylation in Kal7 isolated from mouse brain and transfected cells.
Phosphorylation sites for a number of kinases known to be crucial for normal synaptic plasticity
were identified. These studies identify Kal7 as a critical component of morphological response
and NMDA receptor function in dendritic spines, consistent with its essential role in normal
behavioral adaptations.
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Chapter 1: Introduction
Drug addiction is an insidious condition characterized by a long period of
escalating drug intake, intermingled with cycles of abstinence and relapse.
Eventually, the addict comes to forsake all else in life, even that which was once
precious, in order to find and take drugs. The hallmark symptom of addiction is the
persistence of drug seeking and taking, despite numerous and profound negative
consequences. Addicts lose their jobs and homes and families, they lie and steal and
end up in jail – and yet addiction persists1. For years, addiction was viewed as moral
turpitude; addicts simply chose to engage in self-destructive behaviors that they could
readily stop2. However, an abundance of research over the past several decades has
demonstrated that the repeated pharmacological insult of drugs of abuse produces
pathological changes to the circuits that control behavioral response to external
stimuli3,4. On the path from casual user to addict, there is a fundamental change that
takes place in the brain that removes all volitional control from the addict and
replaces it with an insatiable need for drugs5,6. Most vexing about the changes that
take place in the brain of an addict is that they are essentially permanent; despite
extensive therapy and abstinence, relapse to drug taking is the rule rather than the
exception3. For years, the acute pharmacological actions of addictive drugs have
been well characterized7. Unfortunately, despite extensive research in the field, the
nature of the long-term changes that lead to addiction remain elusive.
Drug abuse takes a huge toll both on the lives of users, and on society as a
whole. The most recent results from the National Survey of Drug Use and Health, the
most comprehensive analysis of drug use in the United States, paints a grim picture8.
In 2008, there were over 9,000,000 people in the U.S. who met the criteria for
dependence on an illicit drug (these figures do not include legal but addictive
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substances such as nicotine or alcohol). Of these 9 million, 1.76 million were
dependent on cocaine or other similar stimulant drugs (e.g. methamphetamine). Most
troubling about these statistics is the age distribution of the drug abusing population.
Of the 700,000 first-time users of cocaine in the year of the study, the mean age was
~20; while not all of these people will become drug dependent, this highlights the
young age at which drug use begins. Addiction is a lifelong disease that strikes
people down in the prime of their lives. Not only is this tragic because of the
unfortunate toll these users take on themselves and their families, but it represents a
tremendous financial strain on society in the form of hospital bills, arrests,
incarcerations and rehabilitation8. Clearly addiction is an issue that affects us all.
One of the revelations that has transformed the field of addiction research is
the concept that development of addiction is likely accomplished via the same
mechanisms as other learned behaviors9,10. For example, in the animal kingdom the
seeking out of food and mating opportunities is essential for survival and propagation.
When these goals are achieved, the person or animal feels a sense of “reward”, a
positive reinforcement that leads to these behaviors becoming ingrained. These
behaviors are driven both by internal motivation (e.g. feelings of hunger) and by
external cues (e.g. the smell of food). A similar pattern is seen in the development of
addiction11. The initial taking of drugs typically produces a positive sensation of
reward – often described as a near euphoric feeling. As with naturally rewarding
stimuli, the taking of drugs becomes driven by both internal (craving) and external
(drug paraphernalia, drug dealer’s house) cues. Unfortunately, however, the surge of
neurotransmitters associated with drugs of abuse is supraphysiological compared to
that seen with natural rewards, and thus works as a stronger positive reinforcer12-14.
As the addiction progresses, the addict comes only to act upon cues associated with
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drugs, and to feel rewarded only when taking drugs. This shift in reward priorities
drives the addict to seek and take drugs obsessively and compulsively.

Cocaine mechanism of action and the circuitry underlying addiction
While there are commonalities in the neuronal changes that underlie addiction
to various drugs of abuse7, I will focus on what has been learned by modeling cocaine
abuse in animals. Cocaine is the third most commonly abused illicit drug in the United
States, and its use has profoundly negative effects on abusers’ lives8. Extensive
study in animal models of cocaine abuse has generated a set of well characterized
molecular and morphological changes that have begun to provide clues to the
underlying pathophysiology of addiction – though much remains to be determined.

Mechanism of cocaine action
Cocaine is a crystalline alkaloid that is derived from the leaves of the coca
plant (Erythroxylon coca)15. In human users, it is typically consumed via nasal
inhalation and absorbed into the circulation via the nasal capillary beds1 or via
smoking the free base form of cocaine, referred to as “crack”16. In animal models of
addiction, cocaine is commonly injected into the peritoneal cavity (I.P.) or
administered through a catheter in the external jugular vein. In either case, cocaine
rapidly crosses the blood brain barrier and in the central nervous system binds to and
inhibits the transporters of dopamine, serotonin and norepinephrine, thereby
decreasing synaptic clearance of these neurotransmitters. Despite the fact that
cocaine binds to all of these transporters with high affinity, a preponderance of
research suggests that the ability of cocaine to increase synaptic levels of dopamine
is primary to its rewarding/addictive properties9,10,13,17-21.
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Circuitry of addiction
As mentioned, addiction is believed to be a corruption of the normal reward
learning and memory circuits in the brain which leads the addict to place undue
emphasis on the finding and taking of drugs. A simplified diagram of this reward
circuitry appears in Figure 1-1A. When an animal encounters a rewarding stimulus
such as finding or ingesting palatable food, the dopaminergic neurons from the
ventral tegmental area (VTA) exhibit an increase in firing rate, which results in an
increase in dopamine release from nerve terminals in the prefrontal cortex (PFC),
nucleus accumbens (NAc – also referred to as the ventral striatum) and dorsal
striatum (Stri)22. Dopamine has long been linked to feelings of pleasure and the firing
of these dopaminergic neurons is considered crucial to the learning of positively
reinforcing (rewarding) behaviors9. Simultaneously, projection neurons from the
prefrontal cortex release glutamate into the NAc and the dorsal striatum. The
prefrontal cortex is known to be key in the planning of complex tasks and in the
suppression of inappropriate behavior; it is often referred to as exerting “executive
control” over behavior23-25. From the NAc and striatum, signals are relayed through
the ventral pallidum (VP – a subregion of the globus pallidus) and thalamus and back
to motor and prefrontal cortices, completing the circuit26. The circuits involved in
regulating both reward learning and addiction are far more complex than those shown
in Figure 1-1, and are discussed in exquisite detail in a number of excellent
reviews23,26-28. However, for the purposes of this review, I will maintain focus on
connections between the VTA or PFC and the NAc, as these pathways have been
the primary focus of much addiction research.
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Figure 1-1. Neuronal signaling pathways critical to the development of
addiction.
A. Neuronal reward circuitry at baseline. Dopaminergic projections from the VTA to
the NAc, Stri and PFC help to indicate the salience of a rewarding stimulus.
Glutamatergic projections from the PFC to the NAc/Stri help in the planning of
complex behaviors. B. With acute administration of cocaine, levels of dopamine in the
VTA  NAc/Stri and VTA  PFC rise dramatically, producing feelings of euphoria.
With repeated drug treatment, signaling from the PFC  NAc increases. C. During
periods of withdrawal, dopaminergic and glutamatergic signaling in these pathways is
decreased (indicated by dotted line). Subjects report feelings of anhedonia and
lethargy. D. During periods of drug craving or drug seeking, signaling from the PFC to
the NAc increases dramatically. Dopaminergic activity in the NAc also increases,
adding to the pleasurable feeling of drug taking.
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Effects of acute cocaine treatment
With acute drug treatment, the primary neurochemical effect of inhibiting
dopamine uptake is a spike to supraphysiological levels of dopamine in the NAc, Stri
and PFC (Fig. 1-1B). During this time, a robust increase in locomotor activity is seen
as a result of hyperactivity of the striatal motor pathways29, and humans taking an
acute dose of cocaine report feelings of great pleasure12. One of the important
features that makes drug taking different from natural rewards is that with drugs, this
surge of dopamine is seen each time the drug is taken. In natural reward learning,
salient stimuli are associated with a modest surge of dopamine, and this increase in
dopamine is believed to be important for the reward driven learning13. In particular,
dopamine seems to modulate what is typically referred to as “incentive salience”; in
lay terms this is defined as the “wanting” to obtain a particular reward rather than the
actual “liking” of said reward30. However, in learning to seek natural rewards, the
dopamine surge diminishes as the behavior becomes well rehearsed and habitual9.
With repeated cocaine dosing, there is a supraphysiologic surge of dopamine which
does not attenuate with repeated dosage; this may contribute to drug-related cues
and memories having such high salience and being so difficult to extinguish10,27.
Interestingly, although an acute dose of cocaine does not dramatically alter PFC
signaling to the striatum, extended treatment with cocaine increases PFC  NAc/Stri
signaling via metabotropic mechanisms6,31.
Dopaminergic signaling in the striatum
Within the nucleus accumbens and the dorsal striatum approximately 90-95%
of all neurons are GABAergic projection neurons known as medium spiny neurons
(MSNs)26. While all of these neurons express dopamine receptors, the cells are
roughly evenly divided in the types of dopamine receptors that they express.
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Approximately half of the MSNs express D1-type dopamine receptors32, which are Gs
coupled and activate the adenylate cyclase  cAMP  PKA pathway20. These D1expressing neurons are a key component of the striatonigral or direct motor pathway
in the basal ganglia33. The other half of the MSNs express D2-type dopamine
receptors, which are Gi coupled and suppress activation of the adenylate cyclase 
cAMP  PKA pathway20. These D2-expressing neurons are a key component of the
striatopallidal or indirect motor pathway of the basal ganglia33. While some MSNs
express both D1 and D2 dopamine receptors, this population accounts for less than
10% of the MSNs32.
Despite the difference in dopamine receptor expression, these cells display no
gross morphological differences and have no specific anatomic distribution within the
striatum, making their identification difficult. As a result, nearly all biochemical and
morphological studies on the striatum following cocaine treatment have looked at
MSNs without distinguishing between D1-expressing and D2-expressing cells. The
development of transgenic mice that express GFP specifically in one population of
cells34,35 has facilitated research into the different roles that these two cell types may
play in addiction. Morphological analysis of the NAc showed that D1-expressing
neurons exhibit longer lasting increases in dendritic spine density than D2-expressing
neurons (discussed in detail below)36. Another study showed that D1-expressing
neurons were more responsive to cocaine following withdrawal from chronic
treatment37. A study in which striatopallidal neurons were specifically ablated
demonstrated that mice lacking D2-expressing neurons showed increased preference
for cocaine38, suggesting that the striatopallidal pathway plays an inhibitory role in
drug seeking. This finding complements data indicating that in human addicts there
are decreased levels of D2 receptors in the striatum13,14,39. The ability to distinguish
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between changes in D1 and D2-expressing neurons should increase our ability to
understand how cocaine alters function.

Reward circuitry signaling during withdrawal and craving
Neuroimaging studies have revealed that signaling patterns in the brains of
addicted patients are quite different when they are undergoing prolonged withdrawal
or when they have been given a cue that elicits drug craving. During periods of
enforced abstinence that are not associated with drug craving, metabolic studies
show decreased activity of dopaminergic neurons as well as prefrontal cortex
neurons13 (Fig. 1-1C). During this withdrawal period, addicts will typically report
feeling anhedonic, showing little or no interest in non-drug rewarding stimuli12. When
addicts are presented with a small dose of drug, drug related cues, or report feelings
of drug craving, a large increase is seen in the activity of the prefrontal cortex13,40-43 as
well as increases in dopaminergic activity6,13,14 (Fig. 1-1D). An increasingly large
literature has shown that in animal models of drug seeking after cocaine selfadministration (described below), glutamatergic transmission from the PFC to the
NAc is critical for the reinstatement of drug seeking behaviors6,24,27,44. These findings
have lead to the hypothesis that while dopamine likely plays the largest role in the
early stages of addiction, cortical  striatal glutamatergic transmission likely plays a
key role in the persistence of addiction behaviors.

Nucleus Accumbens
Within the reward circuitry of the brain, the nucleus accumbens plays a unique
and important role. By receiving heavy dopaminergic innervation from the VTA, the
NAc can acutely modulate behavioral response to salient/rewarding stimuli.
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Additionally, the glutamatergic signals from the PFC to the NAc are important for the
planning of complex actions and executive control over behavior. As a result of these
concomitant innervations, the NAc is crucial for exerting control over rewarding
behaviors (Fig. 1-2). As such, it has been the most extensively studied brain nucleus
in the field of addiction. Interestingly, the dorsal striatum receives similar
dopaminergic and glutamatergic inputs but seems not to be critical for the rewarding
properties of drugs during the development of addiction, but does seem to play a
larger role in the later stages of addiction when behaviors have become
habitual14,23,45.
Within the NAc, dopaminergic and glutamatergic inputs converge on the same
neurons, and even onto the same dendritic spines. Histochemical studies have
shown that glutamatergic synapses terminate on the head of the spine while
dopaminergic terminals synapse on the neck of the same spine46,47 (Fig. 1-2). This is
particularly interesting as this co-transmission has repeatedly been shown to be
facilitative in the NAc with D1 dopamine receptor stimulation potentiating NMDA
receptor currents48 and vice versa49,50. Additionally, synergistic transmission by
glutamate and dopamine terminals in the NAc is critical for potentiation of NAc
synapses51 and for the acquisition of instrumental learning behaviors wherein a
particular action is linked to the acquisition of a reward52,53. Indeed, numerous studies
in NAc neurons support a direct physical interaction between dopamine receptors,
which are G protein coupled, and glutamate receptors of the NMDA subtype, which
are ligand gated ion channels54,55. By physically and functionally linking transmission
by these two systems, both of which are critical for control over rewarding behaviors,
the NAc plays a critical role in the development and maintenance of addictive
behaviors.
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Figure 1-2. The nucleus accumbens serves as an integrator of key signals in
addiction
Ultrastructural studies have shown that medium spiny neurons of the nucleus
accumbens receive projections from the VTA and PFC that synapse not only onto the
same neuron, but even onto the same dendritic spine. By integrating the
dopaminergic “reward” signals from the VTA and the glutamatergic “control” signals
from the PFC, the NAc is at the center of transmission that drives the formation and
persistence of addiction.
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Modeling cocaine addiction in animals
For years, numerous labs have tried to identify pathological changes that
occur in the brain during the transition to addiction. Given that the background of
human addicts is, almost by definition, poorly controlled, progress in this area has
required the development of animal models of drug addiction. Modeling complex
behavioral responses in animals is an inherently difficult task, as one cannot simply
ask an animal about the subjective rewarding value of a particular stimulus. Thus, any
animal model necessarily contains some amount of interpretation and
anthropomorphizing. However, a number of reliable addiction models have been
developed, each with its own unique set of advantages and drawbacks. In order to
further later discussion, I will review the three most commonly used animal models of
addiction.

Locomotor Sensitization
One of the first and most widely used behavioral models is locomotor
sensitization29. In this paradigm an animal is given repeated doses of cocaine over a
period of days and its locomotor response is monitored daily. With repeated doses,
animals display an increase in locomotor activity in response to the same dose of
drug; this is referred to as a sensitized response to the drug3. This is a phenomenon
that is common to almost all addictive drugs, and is not unique to cocaine29. Many
consider this to be a good model of addiction for two main reasons. First, locomotor
sensitization represents gradually escalating response to drug, as is seen in human
addicts56. Secondly, locomotor sensitization is a persistent phenotype, with rodents
displaying a “sensitized” response to drug for up to a year after cessation of
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injections57. One year is the longest withdrawal period tested in rodents, and likely the
longest that can reasonably be tested before old age becomes a confounding
variable. Like addiction, locomotor sensitization is a lifelong change. Studies utilizing
locomotor sensitization as a model have helped to clarify the brain circuitry and
neurotransmitters involved in the development of addiction, revealing an important
role for both glutamatergic and dopaminergic neurotransmission in these behaviors
as levels of these neurotransmitters increase in key brain regions during the
development of sensitization3,27,29,58(Fig. 1-1B).

Conditioned place preference (CPP)
Another commonly used animal model of addiction is conditioned place
preference (CPP)59. This model is a more direct measure of the rewarding value of a
drug to an animal60. In this procedure, an animal is placed into a two-chambered box,
wherein each chamber represents a unique context; each animal is first tested to
determine whether it has a preference for one side over the other. A door is then
used to separate the two chambers; for conditioning, the animal is given an injection
of cocaine and confined to one chamber, and later given an injection of saline and
confined to the other chamber. This process is repeated over the course of several
days. On the final day, the animal is allowed to ambulate freely between chambers,
with the amount of time spent on the drug paired side versus the amount spent on the
saline paired side taken as a measure of preference for the drug60,61. This test has
relevance to human addicts, in that relapsing addicts often start by seeking out the
places in which they used to buy or take drugs, and these contextual cues are often
important triggers of relapse11. While the CPP test is not a direct measure of drug
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seeking per se, it does measure an animal’s willingness to seek out cues associated
with drug treatment.

Self-Administration
Perhaps the best animal model of drug addiction is cocaine selfadministration, which is more easily extrapolated to the human condition. In this
paradigm, an animal has a catheter placed into its external jugular vein and is then
trained to press a lever in order to administer drug directly into the circulation62.
Clearly, this model is more technically challenging than either locomotor sensitization
or CPP, but the data that it produces are invaluable. Studies in self-administration
have determined dose-response curves for cocaine and other drugs of abuse.
Additionally, in a model known as reinstatement, drug seeking behavior can be
induced by drugs or drug cues in animals that were previously extinguished from drug
seeking24,27,28,61,63,64. In particular, these self-administration studies have been
instrumental in identifying glutamatergic signaling from the PFC to the NAc as critical
in reinstatement of drug seeking (Fig. 1-1D)27. It is now widely believed that these
glutamatergic changes may underlie the persistence of addiction65. While the self
administration/relapse models are not without their flaws63, these are the best models
for examining true drug seeking behavior in an animal. For many years there were
very few self-administration experiments performed on mice due to the technical
challenges of the procedure62. This has meant that genetically altered mice, which are
excellent models for looking at the behavioral effects of changes in gene expression,
have largely not been studied in the self administration model. While new surgical
techniques have made these experiments more feasible in mice66, most modeling of
addiction in mice has used either locomotor sensitization or CPP.
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Synaptic changes in addiction
While much has been done to clarify the changes that occur at the level of
circuits during the development of addiction, a good deal of research has also
focused on looking at changes that occur at the level of the synapse, particularly in
the NAc. Given that synapses onto NAc medium spiny neurons are responsible for
integrating both glutamatergic and dopaminergic inputs from the PFC and VTA,
changes in synaptic strength in these neurons may be a critical feature in the
development of addiction.

Postsynaptic Densities
Situated atop all mature dendritic spines is a heavily interconnected network
of proteins that forms an intricate one gigadalton molecular machine67 known as the
postsynaptic density (PSD)68. Contained within each PSD are hundreds of proteins
including ion channels, kinases, phosphatases, guanine nucleotide exchange factors
(GEFs), GTPases, scaffolding proteins, and receptors68-71. A simplified model of one
of these structures is presented in Figure 1-3. The constituents of this complex and
their interactions are of crucial importance for rapid synaptic responses to stimuli and
for triggering long-term responses in downstream signaling pathways. Previous
studies have shown that stimulation of slices with different receptor agonists can
rapidly lead to greater than five hundred distinct phosphorylation events within the
PSD72; imaging of single spines has shown that synaptic stimulation can lead to
changes in spine size on a time scale of seconds to minutes73. Given that cocaine
produces dramatic but transient changes in neurotransmitter concentrations in the
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Figure 1-3. A simplified diagram of the post-synaptic density
The PSD is a complex, interconnected network of receptors, scaffolds and signaling
proteins. Interactions and communication between constituents of the PSD is critical
for normal neuronal function. Note that AMPA and NMDA receptors have many
proteins bound to their intracellular tails forming localized signaling complexes.
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synapse27, the function of proteins in the PSD is critical for the behavioral
response to cocaine.
A number of studies have examined the behavioral effects of inhibiting or
knocking out proteins that are important to the synaptic response to cocaine. There
are over fifty kinases and phosphatases localized to the PSD that are critical for
normal synaptic function72,74. Behavioral studies have been performed on mice with
genetic deletions of various kinase and phosphatase modulators including Darpp-32
(an inhibitor of protein phosphatase 175), Erk1 (a kinase known to be important in the
development of LTP76), and Arg2 (a tyrosine kinase important in regulation of GTPase
function77). Interestingly, knockout of each of these kinases resulted in increased
locomotor sensitization (Table 1-1), while the effects on CPP were mixed. Similar
behavioral tests have been performed on scaffolding molecules in the PSD. Knockout
of Spinophilin, Neurabin or Homer1/2 resulted in increases in locomotor sensitization,
and Spinophilin and Homer knockouts showed at least modest increases in CPP
(Table 1-1). These experiments suggest that some proteins play a more important
role in the motor response or in the reward response to cocaine; both are critical
aspects of developing addiction. Future studies utilizing self-administration and
knockout of proteins in specific brain regions will go a long way toward clarifying the
role of these proteins and identifying those that might provide useful therapeutic
targets.

Changes in glutamate receptor signaling
Given the critical role that PFCNAc glutamate transmission plays in the
development and persistence of addiction27 a great deal of attention in recent years

17

has been paid to changes in ionotropic glutamate receptor signaling in animal models
of addiction. The three main types of ionotropic glutamate receptors in the brain are
AMPA, NMDA and kainate receptors78,79. Despite the presence of all three glutamate
receptor subtypes in the NAc, within the addiction literature, the primary focus has
been on the function of AMPA and NMDA receptors. These receptors have very
different behaviors and function at the synapse, and some of these differences seem
to be important in the development of addiction.

AMPA and NMDA receptors
NMDA and AMPA receptors play very different roles in intracellular signaling
and alterations in synaptic strength. For many years, NMDA receptors have been
considered the gatekeepers of synaptic plasticity, with their signaling being essential
for the most heavily studied forms of synaptic modification: long-term potentiation
(LTP) and long-term depression (LTD)80,81. NMDA receptors have the unique property
of only being activated when they are bound by ligand and the cell is depolarized –
which allows them to pass current only when a neuron is multiply stimulated78,82.
NMDA receptors are tetramers composed of two NR1 subunits and two NR2
subunits, with NR2A and NR2B being the most highly expressed in the mammalian
forebrain82. Particularly in the striatum, NR2A and NR2B are expressed at high levels
in adult rat and human samples83. This heterogeneity is important because the two
NR2 subunits convey different channel properties, have different intracellular binding
partners, and play different roles in plasticity induction84. Additionally, the extracellular
domains of the receptors are different enough that specific inhibitors of NR2A
containing receptors or NR2B containing receptors have been developed, allowing
examination of these currents in neuronal function85,86. For years, the role of the two
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NR2 subunits in different forms of plasticity has been controversial87-90; a good deal of
recent evidence suggests that NR2B subunits are critical for potentiation of synapses
whereas NR2A is likely a hallmark of already potentiated or stable synapses87,91-93. As
a correlate to this, silent synapses and those spines that undergo greater potentiation
tend to have a greater NR2B than NR2A component94-97.
In addition to strengthening existing synapses, it seems that stimulation of
NMDA receptors is a critical feature in the development and maintenance of new
dendritic spines. A number of studies have shown that specific stimulation of NMDA
receptors leads to the formation of new dendritic spines98-100. Conversely, inhibition of
NMDA receptors during stimulation protocols that would normally induce new spine
formation blocks the formation of new spines101,102. It is widely believed that many of
these newly formed spines form only so-called silent synapses – synapses that
express NMDA receptors, but not AMPA receptors81,103. While these silent synapses
do not pass any current at baseline, they are considered to be key markers of
potential plasticity81. Interestingly, many of the new synapses formed in the NAc in
response to cocaine are believed to be silent synapses104, which will be discussed in
more detail below.
When NMDA receptors in silent synapses are stimulated in the context of
depolarization, they allow calcium and sodium entry into the cell, activating various
intracellular signaling cascades. During LTP, one of the most important
consequences is the trafficking of AMPA receptors to the synapse105. Unlike NMDA
receptors, AMPA receptors open in response to glutamate binding alone. As a result,
they are responsible for the majority of excitatory transmission in the central nervous
system79. The trafficking of AMPA receptors to synapses results in increases synaptic
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strength, and actually leads to increases in spine size100 and greater spine
stability103,106.
Alterations of AMPA and NMDA receptors in animal models of addiction
A recent study demonstrated that chronic treatment with cocaine resulted in
the formation of new synapses in the NAc, and that most of these synapses were
silent synapses dependent on NR2B107. Interestingly, other groups have reported a
decreased AMPA/NMDA ratio after similar drug treatment and withdrawal108. This
finding was originally thought to represent a decrease in synaptic AMPA receptors,
however biochemical measurements of cell-surface receptors suggest that there is no
change in surface AMPA receptors after only short withdrawal from cocaine109. These
studies then begin to paint a picture of newly formed spines (discussed below) in the
NAc that contain NR2B but not AMPA receptors, and have a high probability of future
potentiation (Figure 1-4). These findings are also interesting because activity of
NR2B receptors has been shown to be critical for the development of locomotor
sensitization110 and conditioned place preference for cocaine111, and for conditioned
place preference for morphine112.
Several studies have shown an increase in trafficking of AMPA receptors,
particularly GluR1-containing AMPA receptors, to NAc synapses - particularly after
long (≥ 1 week) periods of withdrawal108,113. This increase in cell-surface AMPA
receptors is dependent on the development of locomotor sensitization, and is not
seen in those animals that do not sensitize109. This increase in surface receptors is
quite long lasting, remaining detectable even after 45 days of withdrawal114. The fact
that the AMPA receptors sent to synapses tend to contain the GluR1 subunit is
important because these receptors are typically only driven into synapses after long-

20

Figure 1-4. Spine and glutamate receptor changes in the NAc during addiction
A. Baseline: Medium spiny neurons in the accumbens have a number of dendritic
spines containing AMPA and NMDA receptors. B. Short-term withdrawal from
chronic cocaine: The neurons of the NAc have increased their dendritic spine
density with many of the new spines being NR2B-containing “silent synapses”. The
AMPA/NMDA ratio is decreased as the number of synaptic NMDA receptors has
increased with no increase in synaptic AMPA receptors. C. Long-term withdrawal
from chronic cocaine: The increase in dendritic spines persists, but now the
synapses have been strengthened by the addition of calcium-permeable AMPA
receptors. This increased synaptic strength is a sustained change that helps to fuel
the behaviors of drug seeking and taking. The model presented here is similar to one
proposed in104.
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term potentiation79,115,116. In contrast, AMPA receptors containing GluR2/3 subunits
are constitutively cycled into and out of synapses. GluR1-containing, GluR2-lacking
AMPA receptors are also important because they are permeable to calcium as well
as sodium, and are more potent activators of intracellular signaling cascades65,117. It
is possible that the newly formed NR2B-containing synapses in the NAc are subject
to potentiation and lead to trafficking of GluR1 to the cell surface, resulting in
stabilization of those synapses and perhaps persistence of addictive behaviors (Fig.
1-4). While increases in surface NR2B are noted after short periods of withdrawal107,
they are not seen with extended periods of withdrawal118. This suggests the possibility
that these receptors are trafficked out of the synapse as the synapses mature104.
Dendritic Spines
In the mammalian forebrain, the vast majority of excitatory synapses terminate
on dendritic spines68,119. One of the most interesting features of dendritic spines is
their ability to change in size, shape and number in response to extracellular
stimuli73,103,120. These morphological alterations are highly correlated with synaptic
strength, with larger spines passing larger amounts of current and being more
stable103,121-125. Slices or neuronal cultures that are stimulated to produce long term
potentiation (LTP), widely believed to be the cellular correlate of learning and
memory80,81, exhibit an increase in both dendritic spine size and number122,124,126. In
addition to these ex vivo preparations, behavioral conditioning of animals is also
associated with increases in spine size and number in the areas most important to
the behavior127-130.

Regulation of dendritic spine morphology
At the core of each dendritic spine is the actin cytoskeleton, which is essential
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for the stabilization of the spine as well as for its rapid changes in morphology. A
critical class of mediators of rearrangements of the actin cytoskeleton is the RhoGTPase family; in dendritic spines, the three GTPases that have received the most
focus are: Rac, RhoA and Cdc42131. Under basal conditions the Rho-GTPases exist
in their inactive, GDP bound state; they are activated by guanine nucleotide
exchange factors (Rho-GEFs), which facilitate dissociation of GDP and allow biding of
GTP. GTPase activating proteins (Rho-GAPs), speed up the inherently slow GTPase
activity of the Rho GTPases, yielding inactive Rho-GDP. A basic diagram of this cycle
is pictured in Figure 1-5A. Activated Rho GTPases bind multiple effector proteins,
which participate in a complex signaling network that leads to changes in the
structure of the actin cytoskeleton, changes in membrane trafficking and changes in
gene expression132 (effects on actin diagrammed in Fig. 1-5B). Rearrangements of
the actin cytoskeleton are not solely mediated by changes in the Rho-GTPases and
their downstream targets; membrane phospholipids and a large number of actin
binding proteins are also contributors133-136. However, in the PSD the function of the
Rho-GTPases and their response to external stimuli has been the best characterized
and will be the focus of the remainder of this discussion131,137. Increases in activated
Rho-GTPases are seen within time periods as short as ten seconds after a number of
extracellular stimulations131,137. Most pertinent to this discussion, activation of NMDA
receptors and the subsequent influx of calcium seems to be critical for activation of
Rac, RhoA and Cdc4273,138. Rearrangements of actin following stimulation is critical
for the enhancement of synaptic strength and for the development of LTP70,139-143.
Controlling the activation of Rho GTPases at the synapse are approximately a dozen
Rho-GEFs that are localized to the postsynaptic density70. Interestingly, a number of
these Rho-GEFs have been shown to have connections with NMDA receptors either
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Figure 1-5. Regulation of the actin cytoskeleton by Rho-GEFs and Rho GTPases
A. Rho GTPases are activated by Rho-GEFs, which catalyze the exchange of GDP
for GTP, which activates the Rho protein. Rho proteins are subsequently inactivated
by GAP proteins, which enhance their GTPase activity, speeding their return to the
inactive, GDP bound state. B. Signaling networks downstream of Rho GTPases.
When activated, the Rho GTPases activate a complex network of downstream
signaling proteins that exert control over actin polymerization, depolymerization and
branching. These pathway diagrams are adapted from previous reviews119,131,137,147.
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directly or as part of NMDA receptor complexes74,144-146, further strengthening the link
between NMDA receptor activity and GEFGTPase function. Dysregulation of RhoGTPases and Rho-GEFs has been linked to a variety of psychiatric/neurological
conditions involving altered dendritic plasticity: mental retardation, schizophrenia and
Alzheimer’s disease148-153. Given that addiction is widely believed to be a corruption of
normal synaptic plasticity, the role of Rho-GEFs and Rho GTPases in addiction is
potentially critical.

The Actin Cytoskeleton in Addiction
Several studies have been performed examining the role of actin
rearrangements following cocaine treatment. Inhibition of actin polymerization by
administration of latrunculin-A, which inhibits polymerization of globular actin, into the
NAc led to a decrease in spine density following cocaine treatment, and to a reduced
percentage of spines with large heads154. These studies follow previous reports which
showed a persistent increase in filamentous actin in the NAc following withdrawal
from chronic cocaine administration155. Behavioral experiments looking at inhibition
of actin polymerization during cocaine treatment showed that infusion of latrunculin-A
prior to a challenge dose of cocaine blocked the sensitized locomotor response154
and that a similar treatment greatly enhanced cocaine-induced reinstatement of drug
seeking155. These reports are the only ones that have directly looked at changes in
the state of actin following chronic cocaine administration.

Dendritic Spines and Addiction
Changes in dendritic spines in the NAc in response to drugs of abuse were
first noted in 1997, when it was shown that after five weeks of twice daily
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amphetamine injections, rats showed increased NAc spine density and dendritic
complexity156. Importantly, these changes were noted to last for up to one month
following cessation of drug treatment. This made dendritic spine morphological
changes equal in duration to the longest lasting biochemical changes reported in the
literature for animal models of addiction4. The finding of increased spine density in the
NAc after amphetamine was replicated with cocaine – these two psychostimulants
operate via similar mechanisms157. Interestingly, the extent of the increase in dendritic
spine density was directly correlated with the degree of behavioral sensitization158 –
rats that did not sensitize to the drug did not exhibit increases in spine formation. This
was the first study to suggest a linkage between increased dendritic spine density
and development of an addiction-like phenotype. Additionally, it was demonstrated
that chronic injections of cocaine decreased the ability of dendritic spines to adapt
their morphology in response to other rewarding stimuli such as exposure to an
enriched environment159. These observations present clear parallels to the inability of
drug addicts to experience pleasure in response to previously rewarding stimuli. One
study using similar methods reported that after prolonged withdrawal from cocaine (3
weeks), dendritic spine density in the NAc was not altered, but dendritic spine size
and response to a challenge dose of cocaine were significantly altered160. In either
case, dendritic spine plasticity is altered for long periods following cocaine withdrawal.
As mentioned previously, MSNs in the NAc can be almost equally split into
D1-expressing and D2-expressing categories. All of the previously mentioned
morphological experiments examined changes in dendritic spine density without
regard for dopamine receptor expression. Recent studies using BAC-transgenic mice
expressing GFP in D1- or D2-expressing neurons have made some interesting
findings about morphological differences between these two cell types. An initial set
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of experiments showed that both cell types exhibited increases in spine density, but
that only D1-expressing cells exhibited a prolonged increase in spine density36. More
recent studies have shown that even at short withdrawal times, spine density is
increased only in D1-expressing cells161,162. Consistent with this, mice constitutively
lacking D1 receptors did not show increases in spine density in the NAc in response
to cocaine163. Taken together, these studies suggest that the phenomenon of
increased NAc spine density after cocaine may be specific to D1-expressing cells. In
addition to an abnormal morphological profile, D1RKO mice exhibit aberrant behavioral
responses to cocaine. While these mice exhibit no locomotor sensitization, they
exhibit normal place preference for cocaine164-166. However, when placed in a selfadministration paradigm, D1RKO mice would not self-administer cocaine despite
normal responding for a food reward167. While these results highlight the importance
of D1R signaling in the cocaine behavioral response, they also serve to highlight the
complexity of the circuitry and signaling underlying these behaviors and difficulties in
interpreting these behavioral tests.
Initial experiments with psychostimulant drugs were performed using
experimenter-administered drug. In rats trained to self-administer cocaine, increases
in spine density in the NAc were also seen, with greater increases noted in the NAc of
animals given longer periods of access to cocaine168,169. When layer V pyramidal
neurons in the prefrontal cortex were examined, similar long-lasting increases in
dendritic spine density were reported156,157. Clearly, this increase in dendritic spines is
a lasting change that is seen in areas of the brain that are highly relevant to the
development of addiction, and is correlated with the development of addiction-like
behaviors. Despite the repeated findings of increased dendritic spine density
following cocaine treatment, the causes and consequences of these changes are still
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not fully clear. Over the past several years, several specific proteins have been found
to alter the dendritic spine response to chronic cocaine treatment.

Transcription Factors and Spine Changes
Much research in drug addiction has focused on the role played by activation
or suppression of transcription factors7,10. With the ability to alter transcript levels of
multiple genes, these proteins can clearly exert a powerful role in the development of
synaptic plasticity170. Only recently has the role of transcription factors in the
morphological changes following treatment with drugs of abuse been examined.
In 2008 it was discovered that inhibitory phosphorylation of the transcription
factor myocyte enhancing factor 2 (MEF-2) was increased following chronic cocaine
treatment171. Consistent with this, knockdown of MEF-2 increased spine density in the
nucleus accumbens at baseline, and constitutively active MEF-2 blocked the ability of
cocaine to increase spine density following cocaine treatment171. These
morphological changes were accompanied by aberrant behavioral responses to
cocaine. Animals expressing constitutively active MEF-2 exhibited a very modest
increase in locomotor sensitization to cocaine, and a more pronounced increase in
conditioned place preference for the drug171.
Nuclear factor κB (NFκB), well known for its roles in cell growth, apoptosis
and the inflammatory response172, demonstrated a stimulatory role in cocaineinduced morphological changes. Initial experiments showed that NFκB activity was
increased in the NAc following chronic cocaine treatment173. NFκB was inactivated by
viral injection of a dominant negative NFκB activator (IKK)172 into the NAc. This
decrease in NFκB activity decreases baseline spine density, while injection of a
constitutively active form of the NFκB activator increases baseline spine density. In
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chronic cocaine experiments, inactive NFκB blocked the ability of cocaine to increase
spine density in the NAc173. These morphological findings were accompanied by a
behavioral phenotype. Animals expressing inactive NFκB exhibited a significant
decrease in their conditioned place preference response for cocaine173.
The transcription factor ΔFosB has been the subject of extensive study in
addiction over the past 15 years. It has been repeatedly reported that this
transcription factor is robustly and stably (up to 1 month) upregulated following
cocaine treatment, and that this change is essential for the behavioral response to
cocaine170,174-176. Until recently, however, the effect of ΔFosB on morphology had not
been examined. Overexpression of ΔFosB in the NAc of mice treated with either
saline or cocaine increased baseline spine density and produced a further increase in
dendritic spines in mice treated with chronic cocaine177.

Epigenetic Factors and Spine Changes
Epigenetic modifications are modifications of chromatin structure brought
about via methylation of DNA or post-translational modifications (PTMs) of
histones178. These changes are known to play a role in development of psychiatric
diseases, including addiction179. Histone methylation can serve as either a
transcriptional activator or repressor178, these modifications are catalyzed by a series
of proteins known as histone methyltransferases180. The expression of one specific
histone methyltransferase known as G9a falls in response to chronic cocaine,
decreasing inhibitory histone methylation177. Overexpression of G9a in the NAc
abolished the ability of cocaine to upregulate dendritic spine number in the NAc. As
for inactive NFκB, the G9a-mediated decrease in spine number was accompanied by
a decrease in conditioned place preference behavior for cocaine177.
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Methylation of cytosine residues on DNA is a widely accepted means of
transcriptional inhibition. DNA methylation is particularly interesting as these
modifications are potentially more stable than histone methylation178,180 and may
represent one of the long-lasting biochemical modifications that lead to addiction.
After the cessation of chronic cocaine, DNA (cytosine-5)-methyltransferase 3A
(Dnmt3a) mRNA showed an increase at 4 hours and then a decrease to baseline by
24 hours. Interestingly, however, Dnmt3a mRNA was significantly upregulated in the
NAc 28 days after cessation of chronic experimenter or self-administered cocaine181,
which places Dnmt3a as a possible regulator of the long-term behavioral changes
seen following cocaine treatment. Following pharmacologic Dnmt3a inhibition by
constant infusion of a Dnmt3a specific inhibitor in the NAc, cocaine was no longer
able to upregulate spine density in the NAc. Inhibition of Dnmt3a activity resulted in
an increase in preference for cocaine; in agreement, overexpression of active
Dnmt3a caused a marked decrease in cocaine preference181. As with MEF-2
modifications, a change that lead to decreased spine density after cocaine lead to an
increase in conditioned place preference (Table 1-1).
Methyl CpG binding protein 2 (Rett syndrome) (MeCP2) acts as a
transcriptional inhibitor by binding to methylated cytosine residues179. A recent study
examined mutant mice that express a truncated form of the protein that has
significantly lower binding activity than the full-length form182. Mice with this
inactivating mutation of MeCP2 exhibited increased place preference and locomotor
sensitization to repeated injections of amphetamine182. Morphological examination of
mice expressing the truncated protein showed no increase in dendritic spine density
after chronic amphetamine treatment182. While this study examined morphology and
behavior after amphetamine rather than cocaine, these two drugs act via similar
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mechanisms and produce similar morphological and behavioral responses156,157,159.
Consistent with this, MeCP2 knockdown in the NAc resulted in dramatically increased
cocaine self-administration183.

Synaptic Proteins Influencing Dendritic Spine Morphology
The majority of proteins known to alter dendritic spine morphology following
cocaine treatment are transcription factors or epigenetic modifiers thought to affect
the expression of numerous gene products in the nervous system. Other than actin,
the only synaptically localized protein known to alter dendritic spine morphology
following cocaine is cyclin-dependent kinase 5 (Cdk5), a proline directed kinase that
has a myriad of functions in the developing and adult nervous systems184. Chronic
treatment with cocaine upregulated Cdk5 levels and activity, and inhibition of its
catalytic activity increased the development of locomotor sensitization to cocaine185.
When animals were given chronic injections of cocaine while simultaneously having a
Cdk5 inhibitor infused into the NAc, cocaine-mediated increases in dendritic spine
density were blocked186. Additionally, mice with a conditional postnatal knockout of
Cdk5 exhibit enhanced locomotor sensitization to cocaine and increased place
preference for low doses of cocaine187.

Spine Summary
From these mouse studies, a complex picture of the role of changes in spine
morphology in addiction begins to emerge. The behavioral effects of proteins (listed in
bold) that alter dendritic spine morphology in response to cocaine are catalogued in
Table 1-1. From these experiments, it is clear that alterations of NAc spine number
and/or morphology are not simply related to changes in locomotor sensitization or
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CPP. There are several possible reasons for the lack of consistency seen with
changes in spine density and the behavioral response to cocaine. As mentioned
previously, D1 and D2-expressing neurons in the striatum play different roles in the
behavioral response to cocaine37,38 and exhibit different morphological responses to
chronic cocaine treatment36,161,188. For most of the studies catalogued in Table 1-1, no
distinction between D1 and D2-expressing neurons was made. It is possible that
some of these mutations/alterations more specifically affect spine function in one type
of cell or the other. Changes that were more prominent in D1 or D2-expressing cells
might cause differential effects on behavior.
A more mundane possible reason for the discrepancy between spine changes
and behavior is the simple fact that these experiments were all carried out in different
labs all using different drug doses, behavioral training paradigms, and withdrawal
times. Dendritic spines are highly dynamic, exhibiting dramatic changes in size and
shape over a span of seconds to minutes73, and spines seem to become even more
dynamic following chronic cocaine treatment160. Given the relatively small percentage
increase in spine density that is seen after cocaine treatment189, it is possible that
alterations at any stage of the experiment may result in a different picture of the
morphological changes seen. Conversely, given the exquisitely sensitive nature of
mice to variations in environment, any changes in conditioning paradigms between
groups could lead to inconsistent findings.
Despite the lack of a clear answer for the role of dendritic spine changes in
these models of addiction, there is one important conclusion that can be drawn: in all
of the animal models where NAc dendritic spines were altered, the behavioral
response to cocaine was also altered. While we still may not know the final
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conclusion, all indications are that these morphological changes are playing a key
role in the regulation of cocaine related behaviors.

Kalirin-7
Kalirin-7 (Kal7) is a Rho-GEF specific for Rac and RhoG190, localized to the
postsynaptic density191. It has been shown to be capable of modulating dendritic
spine formation and stabilization in numerous in vitro studies over the past ten
years192-194. This large (~190kDa) protein has multiple functional domains in addition
to the catalytic GEF domain, including: an N-terminal Sec14p domain which can bind
phosphatidyinositides195; nine spectrin-like repeat domains which interact with several
other proteins196-200; a pleckstrin homology domain which binds the TrkA receptor201;
and a C-terminal PDZ binding motif which interacts with PSD-95, AF-6 and numerous
other PDZ domain containing proteins194,202.
Given the potentially critical role of dendritic spine formation in both learning
and addiction, we wanted to examine the role that Kal7 might play in regulating these
behaviors. Recent development of a constitutive Kal7 knockout mouse (Kal7KO) in our
laboratory made this feasible. In the first set of experiments (Chapter 2), we
characterized the effect of Kal7 knockout on dendritic spines, synaptic plasticity and
learning behaviors. Following completion of these studies, we examined the
morphological and behavioral responses of the Kal7KO mice to repeated cocaine
exposures (Chapter 3). In our initial characterization of the Kal7KO mouse, we noted a
specific decrease in levels of the NR2B NMDA receptor subunit. In following up on
this, we found a specific and direct interaction between Kal7 and NR2B, and
demonstrated that many of the behavioral phenotypes in the Kal7KO mouse reflected
loss of the NR2B Kal7 interaction (Chapter 4). Finally, regulation of proteins in the
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PSD by phosphorylation is critical for normal synaptic function. To determine how
Kal7 might be affected by phosphorylation we identified over thirty phosphorylation
sites in Kal7, including sites phosphorylated by kinases known to play important roles
in synaptic plasticity and addiction (Chapter 5). These studies have made important
progress in determining the role that Kal7 plays at the synapse in regulating spine
morphology, receptor function and behavioral activity.
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Protein Alteration
Kinase/Phosphatase
DARPP-32 (KO)
Cdk5 (fKO)
Erk1 (KO)
Arg2 (KO)
Receptor
GluR1 (KO)
D1R (KO)
Transcription Factor
MEF-2 (CA)
NFκB (Inh)
ΔFosB (KO)
Epigenetic Factor
G9a (OE)
Dnmt3a (Inh)
MECP-2 (KD)
Scaffolding Protein
Spinophilin (KO)
Neurabin (KO)
Homer 1/2 (KO)

Locomotor
Sensitization

CPP

References

↑
↑

↓

203,204

↑ (at low dose)

187,205

↑

206

↑
↑

N.D.

207

NL/↑

↓↓/NL

208,209

↓↓

NL

164-166

Slight ↑
N.D.

↑
↓
↑

171

↑
N.D.
Slight ↑

↑
↑
↑
↑

↓
↑
↑
↑ at low dose
NL

↑

173
175,176

177
181
182,183

17
17
210

Table 1-1. Knockout or alteration of protein function affects behavioral
responses to cocaine.
While not a comprehensive list, this table summarizes the behavioral effects of
knocking out some of the proteins thought to be critical in cocaine-mediated plasticity.
Abbreviations: KO knockout; fKO focal knockout; CA constitutively active; Inh
inhibition; OE overexpression; KD knockdown; N.D. not done; NL normal. Proteins
listed in bold are those that have been shown to alter dendritic spine morphology in
response to cocaine.

Chapter 2: Kalirin-7 is required for synaptic structure and
function
This chapter is a duplicate version of a published manuscript: Ma X.M.**, Kiraly
D.D.**, Gaier E.D., Wang Y., Kim E.J., Levine E.S., Eipper B.A., Mains R.E. (2008)
Kalirin-7 is required for synaptic structure and function. J. Neurosci. 28(47):12368-82.
** These authors contributed equally to this work

Abstract
Rho GTPases activated by GDP/GTP exchange factors (GEFs) play key roles
in the developing and adult nervous system. Kalirin-7 (Kal7), the predominant adult
splice form of the multifunctional Kalirin RhoGEF, includes a PDZ binding domain and
localizes to the postsynaptic side of excitatory synapses. In vitro studies
demonstrated that overexpression of Kal7 increased dendritic spine density whereas
reduced expression of endogenous Kal7 decreased spine density. To evaluate the
role of Kal7 in vivo, mice lacking the terminal exon unique to Kal7 were created. Mice
lacking both copies of the Kal7 exon (Kal7KO) grew and reproduced normally. Golgi
impregnation and electron microscopy revealed decreased hippocampal spine
density in Kal7KO mice. Behaviorally, Kal7KO mice showed decreased anxiety-like
behavior in the elevated zero maze and impaired acquisition of a passive avoidance
task, but normal behavior in open field, object recognition and radial arm maze tasks.
Kal7KO mice were deficient in hippocampal long-term potentiation. Western blot
analysis confirmed the absence of Kal7 and revealed compensatory increases in
larger Kalirin isoforms. PSDs purified from the cortices of Kal7KO mice showed a
deficit in Cdk5, a kinase known to phosphorylate Kal7 and play an essential role in
synaptic function. The early stages of excitatory synaptic development proceeded
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normally in cortical neurons prepared from Kal7KO mice, with decreased excitatory
synapses apparent only after 21 days in vitro. Expression of exogenous Kal7 in
Kal7KO neurons rescued this deficit. Kal7 plays an essential role in synaptic structure
and function, affecting a subset of cognitive processes.
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Introduction
Alterations in the placement, prevalence and structure of dendritic spines, the
site of most glutamatergic, excitatory endings in the brain, play a critical role in the
synaptic plasticity underlying learning and memory140,211-217. Spines change in
response to stimuli producing long term potentiation or long term depression218,219. In
vivo, learning tasks, memory tasks, electroconvulsive shock and exposure to
hormones, cocaine or ethanol alter spine morphology and
function158,168,186,212,217,220,221. Inherited conditions associated with mental retardation
and neurologic/psychiatric abnormalities are often associated with spine
abnormalities and have revealed key roles for small GTP binding proteins of the Rho
family222-226.
Variations in spine size and shape affect signal transmission by AMPA and
NMDA receptors localized to the post-synaptic density (PSD). The PSD is a complex,
1.1 gigadalton molecular machine, with its many components arrayed in a tightly
controlled but dynamic manner; proteomic approaches68,74,227,228 reveal the presence
of 300 copies of PSD-95 and 15 to 20 tetrameric NMDA and AMPA receptors in the
typical cortical PSD. Kalirin-7(Kal7) is the only Rho GDP/GTP exchange factor
(RhoGEF) identified in purified PSDs68,74,194. Cyclin dependent kinase 5 (Cdk5), a
Ser/Thr kinase localized to the PSD and known to phosphorylate several proteins
critical to synaptic function229-231, also phosphorylates Kal7, altering its effects on
spine morphology232.
Kal7 is co-localized with PSD-95, AMPA and NMDA receptors at excitatory
synapses on the dendritic spines of CA1 hippocampal pyramidal neurons and the
dendritic shafts of hippocampal GABAergic interneurons193. Expression of Kal7
increases during the time of maximal synaptogenesis in the hippocampus192,193. In
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vitro studies point to an important role for Kal7 in synaptic function. Exogenous Kal7
caused spine formation in aspiny GABAergic interneurons while decreased
expression of endogenous Kal7 caused the loss of excitatory synapses193. The
interactions of Kal7 with PDZ domain proteins such as AF-6202 and PSD-95194,
coupled with the actions of the Sec14p, spectrin-like and GEF domains it shares with
the larger isoforms of Kalirin195,198, all contribute to its actions.
Since in vitro studies do not always accurately indicate in vivo
function226,233,234, we engineered a mouse lacking the unique exon that defines Kal7.
Despite the existence of 69 RhoGEFs147, lack of this isoform of Kalirin results in a
decreased number of dendritic spines and excitatory synapses. In addition to
morphological changes, mice lacking Kal7 and ∆Kal7 (Fig. 2-1A) exhibit decreased
anxiety-like behavior, deficits in hippocampal-dependent learning and diminished long
term potentiation. The decreased levels of Cdk5 found in PSDs purified from Kal7KO
mice may contribute to many of these deficits.
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Materials and Methods
Creation of the Kal7 conditional and total null mice.
The basic strategy for creation of the conditional knockout is diagramed in Fig.
2-1B. The Kal7 exon, which encodes the 20 amino acids unique to Kal7 and ∆Kal7, is
0.9 kb in length and is flanked by introns which are 18 kb (upstream) and 36 kb
(downstream). Lox-p sites were introduced 1.7 kb upstream (nt 34155267, mm9, July
2007) and 2.0 kb downstream of the Kal7 exon (924 nt) (nt 34150670). The neomycin
resistance cassette was used in cell selection and was removed by passage through
flipper female mice235. The conditional knockout (Kal7CKO/+) was bred for 10
generations into C57Bl/6 females from Jackson Labs. To remove the Kal7 exon,
Kal7CKO/+ males were bred with Hprt-Cre females (Jackson # 004302) and the
progeny were then bred into the C57Bl/6 background; these mice lack 4.6 kb of
chromosome 16 and retain the lox-p sequence
(ATAACTTCGTATAATGTATGCTATACGAAGTTAT; Fig. 2-1C). Experiments
reported here used mice back-crossed into C57Bl/6 for three to seven generations;
Kal7KO/+ and Kal7KO mice were compared to littermate controls. Screening of genomic
DNA prepared from tail snips utilized primers A
(AATAAAATTACTCAAGCCACTTCCAGTC), B
(GGACATTTGCATGACATTGAGTCTAAAG) and E
(TGTTCATACAGCTGTCTGGGG) (Fig. 2-1B,C). PCR conditions: 94°C, 2.5 min;
55°C,1 min; 72°C, 32 sec; 40 cycles. Products encompassing the lox-p sites and the
products of Flp and Cre recombinase were of the predicted sizes; DNA sequence
analysis of excised bands confirmed their identities. The Kal7CKO mice were created in
the University of Connecticut Gene Targeting and Transgenic Facility.
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Antibodies used in these studies
Antisera described previously include polyclonal antisera to the Kalirin spectrin
domain (JH2582), Kal7 COOH-terminal end (affinity-purified JH2958; JH2959;
specific for the COOH-terminal portion of the 20 amino acid residues unique to
Kal7193), Kal12 COOH-terminal end (JH3225) and monoclonal antibodies to the Kal7
COOH-terminal end (20D8; specific for the NH2-terminal portion of the 20 amino acid
residues unique to Kal7), PSD-95, and myc193, and a polyclonal to Trio (CT233)236.
Commercial antibodies to bassoon, Vglut1, GluR1, GluR2, NR1, GAD65, GAD65/67,
VGAT, MAP2, and GFP were as described193. The following commercial antibodies
were also used: synaptophysin (Clone svp-38), β-catenin (C2989) and actin (A2066)
(Sigma, St. Louis, MO), NR2B (clone N59/20, NeuroMab, Davis, CA), Shank3
(cloneN69/46, NeuroMab), neuroligins-1 and -2 (Synaptic Systems, Gottingen,
Germany), βIII-tubulin (Covance, Berkeley, CA), GFAP, CaMKIIα (MAB3119) and
Cre-recombinase (Chemicon, Temecula, CA), α-adaptin, dynamin and clathrin (BD
Transduction Labs, San Jose, CA), BiP (Affinity BioReagents, Golden, CO), Rac1
(23A8, Millipore, Temecula CA), Cdk5 and PP1 (Santa Cruz, Santa Cruz CA).

Western blot analyses and Rac activation assays
For analysis of total protein, freshly dissected tissue or cells were sonicated in
SDS lysis buffer and heated for 5 min at 95ºC193. Subcellular fractionation was used
to prepare samples enriched in ER/Golgi, cytosol, synaptosomal membranes,
synaptic vesicles and synaptosomal cytosol237. Purified PSDs were prepared using a
modification of published procedures238. PSDs removed from the interface of the
1.0/1.2 M sucrose layers of an equilibrium gradient were pelleted and then solubilized
by incubation for 30 min at 4oC with 0.5% TX-100, 10 mM Hepes, pH 7.4. The identity
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of various Kalirin proteins was established using differential antibody reactivity plus
comigration with recombinant ∆Kal7, Kal7, Kal9, and Kal12 (produced in pEAK-Rapid
cells;195). ∆Kal7 expressed in insect cells using the Baculovirus expression system
was purified using Talon resin195. Protein concentrations were determined using
bicinchoninic acid (Pierce) with bovine serum albumin as the standard.
For measurement of activated Rac, cerebral cortex (50 mg wet weight) was
homogenized in 10 volumes 10 mM HEPES, 320 mM sucrose, 10 mM MgCl2, 1 mM
EDTA, 1 mM NaF, pH 7.4 containing 10 µg/ml GST-Pak-CRIB and protease inhibitor
mix. Following removal of debris (1000 x g for 5 min), Rac activation in the total lysate
was assessed by adding ¼ vol 5X MLB195 and allowing each sample to tumble with
15 µl glutathione Sepharose 4B resin for 1 h at 4oC. Beads were washed twice with
1XMLB containing 8% glycerol and bound proteins were eluted with boiling Laemmli
sample buffer. Rac was visualized using monoclonal antibody from Upstate. Crude
synaptosomes were prepared by differential centrifugation238; P2 was resuspended in
1XMLB containing 10 µg/ml GST-Pak-CRIB and allowed to tumble at 4oC for 20 min
before centrifugation at 100,000xg for 15 min; this supernatant was bound to
glutathione Sepharose 4B resin and washed as described above. Positive and
negative controls were prepared as described232.

Immunocytochemistry
Dissociated neurons
Immunocytochemical staining of neuronal cultures was performed as
described192,193. Neurons were generally fixed for 20 min in 4% paraformaldehyde in
PBS or with anhydrous methanol (-20oC). For visualization of synaptic proteins
including PSD-95, NR1, Vglut1, GluR1, VGAT, and Kal7, cells were fixed with
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methanol for 12 min at -20°C, except where indicated. Primary antibodies were
visualized with appropriate secondary antibodies as described193.
Tissue sections
Immunohistochemical staining of tissue sections from perfusion-fixed mice
has been described239,240. Briefly, animals were perfused transcardially with 4%
formaldehyde/ 0.1 M Na phosphate buffer , pH 7.4, under deep anesthesia with
Ketamine. Following fixation, brains were postfixed in 4% paraformaldehyde for 6
hours. Sections (10 µm) through dorsal hippocampus were cut using a cryostat and
immunostained with appropriate antibodies as described239.

Golgi staining
Animals were perfused transcardially with 2% formaldehyde/1%
glutaraldehyde (in 0.1 M Na phosphate buffer, pH 7.4) under deep anesthesia with
Ketamine (n=4, Wt; n=4, Kal7KO). Following fixation, brains were removed and half
brains were placed in 4% paraformaldehyde overnight. Brains were then sectioned
through dorsal hippocampus at 100 µm on a vibratome and prepared for Golgi
impregnation as described223. The other halves of the brains were processed for
electron microscopy as described below.

Electron microscopy
Half brains prepared as described above were postfixed in 2% glutaraldehyde
for 2 hours. Brains were then sectioned at 50 µm on a vibratome and the sections
were embedded in Polybed epoxy resin (Polysciences, Warrington, PA). Ultrathin
sections (50 nm) from hippocampal CA1 stratum radiatum were cut with a Reichert
Ultracut E ultramicrotome and collected on copper grids and counterstained with
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uranyl acetate and lead citrate. Sections were examined in a JEOL 100CX
transmission electron microscope at 80 kV accelerating voltage. For quantification of
PSDs, images were taken at 8,000x magnification. All measurements were performed
independently by two researchers who were blind to the genotype of the animals.

Behavioral and physiological testing
Initial Behavioral data
Animals were group housed in the UCHC animal facility with a 12 hour
light/dark cycle (lights on 0700 – 1900). All behavior experiments were done in
accordance with UCHC IACUC and NIH procedures for animal care. Simple
physiological observations were performed on all mice, including body weight over
time and general observations such as lack of obvious tremor, normal gait and ability
to navigate/climb in the home cage. For behavioral studies, male littermates between
2 and 4 months of age were tested during the light phase. All animals were handled
daily for at least five days before behavioral testing to minimize experimenter-induced
stress during testing. With the exception of passive avoidance testing, all behavioral
tests were carried out in dim lighting in the Scoville Neurobehavioral Suite at UCHC.
For all experiments, animals were allowed to habituate to the room for one hour
before testing. Some animals were re-used for behavioral tests, but great care was
taken to ensure that the less stressful tests preceded those that were more stressful
(Elevated zero  Open Field  Object recognition  Radial arm  Passive
avoidance). Statistical analysis was performed using SPSS software (SPSS Inc.,
Chicago, IL) with one-way ANOVA or repeated measures ANOVA to assess
differences between groups.
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Open Field
Spontaneous locomotor activity was measured using a PAS Open Field
system (San Diego Instruments, San Diego, CA). Briefly, animals were placed in the
center of a 15” x 15” plexiglas chamber and their horizontal ambulatory activity was
recorded by photocell beam breaks. Animals were allowed to move freely about the
chamber for an hour for a single testing session.
Elevated Zero Maze
The zero maze (San Diego Instruments) was made of white plastic with two
“closed” quadrants consisting of 6” tall walls on either side and two “open” quadrants
with ¼” walls. At the beginning of testing, each animal was placed in a closed
quadrant facing it. Behavior was monitored by a blinded experienced scorer for the
next five minutes. Time spent in the open, open entries (all four paws entering the
open arm), stretch attends (stretching of forepaws into the open arm before retraction
into the closed arm) and head dips (dipping the head over the open arm to the crux of
the mandible) were scored for each animal. Entry into a new quadrant was scored
only when all four paws of the animal left the previous quadrant.
Passive Avoidance
Mice were tested using a two compartment box with footshock grid (San
Diego Instruments). On the training day, each animal was placed in the box with
lights off and the interchamber door closed. After a five second habituation, the house
lights were turned on only in the side where the mouse had been placed and the door
was opened. When the mouse crossed to the darkened side, the door was closed
and a 0.3 mA x 2 sec scrambled footshock was delivered. Mice were left in the
shocked environment for 30 sec before being returned to their homecage. For the test
trial, animals were brought back to the room after the appropriate interval and run
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through the same protocol, but without footshock. For both training and testing, the
latency to cross to the dark was measured using photocells in the boxes. Shock
sensitivity was assessed214 with cohorts of previously shocked and naïve animals.
Animals were placed in the box and given 2 sec shocks ranging from 0.05-0.5mA. A
blinded scorer examined videotape and recorded the lowest shock that elicited
vocalization, flinching and jumping.
Radial Arm Maze
The radial arm maze was used to test both working and reference memory.
The maze (San Diego Instruments) consisted of a 5.25” central platform with eight
arms (2” wide x 6” high) radiating from the platform. Extensive intramaze (distinct
geometric shapes on walls) and extramaze (objects of varying shape and size
present over arms) cues were provided throughout the testing procedures. Animals
were food deprived for 5 days prior to the start of the experiment and were
maintained at 85% of their free-feeding weight throughout training. Mice were first
group habituated (3-4 mice at a time) to the maze, where reward pellets (small pieces
of Cocoa Puffs cereal, General Mills Inc, Golden Valley, Minnesota) were scattered
throughout. The mice were then given an individual habituation session with similarly
scattered rewards. During testing, the animals were placed in the maze and confined
to the center platform using a white cylinder for 15 sec. After the 15 sec acclimation,
the cylinder was removed and the animals were given free run of the maze.
Throughout the training period, two arms separated by 135° were baited with a
hidden food pellet. The baited arms were varied between animals but remained
consistent for each subject. Mice were allowed to explore the maze freely for four
minutes or until both rewards were obtained. A blinded observer watched and scored
throughout each session. Reference memory errors were scored when an animal
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entered an unbaited arm or when a baited arm was entered but the reward was not
obtained. Working memory errors were re-entries into arms within a trial. Two cohorts
of animals were used for this experiment. In the first (4 Wt, 6 KO), animals were given
one trial per day for the first seven days and then three trials per day for the
remaining days. Animals in the second cohort (5 Wt, 7 KO) were given two trials on
the first day and three trials on each successive day. These differences in training
procedure produced no difference in acquisition curves, so data were combined for
the purpose of analysis.
Object Recognition
Testing was performed in a large, clean cage normally used for housing rats.
At the start of the training day, each mouse was placed into this novel environment,
which contained no objects other than bedding, and allowed to habituate for five
minutes. After habituation, the animals were briefly placed in a holding cage while two
identical objects were placed at either end of the cage (50 ml Falcon tubes or small
Leggo objects). Mice were allowed three minutes to explore the two objects before
being returned to their home cages. Twenty four hours later, the animals were again
habituated to the empty cage for five minutes. When they were returned to the cage
for the test, one of the objects was the same as the previous day (Object A) and the
other was a novel object (Object B – the object not used previously). Animals were
again allowed three minutes to explore the cage and objects. Both sessions were
videotaped and scored by an experienced blinded observer. Object exploration was
strictly defined as direct nasal contact with the object.
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Cell culture
Hippocampal or cortical cultures from genotyped newborn mice (P1) were
prepared as described193; PCR genotyping allows same day culturing of Wt and KO
neurons from Kal7KO/+ x Kal7KO/+ matings. Briefly, hippocampi or cortices were
digested with 0.25% trypsin for 25 min at 37°C. Dissociated cells were plated in
Neurobasal A medium containing 7% heat-inactivated horse serum, maintained at
37°C in 5% CO2. Three hours later, plating medium was replaced with fresh medium
containing only 3% horse serum (heat inactivated), 2% B27 supplement, 0.5mM
glutamine, 25 µM glutamate, 25 units/ml penicillin, 25 µg/ml streptomycin. Three days
after plating, the culture medium was exchanged with maintenance medium
[Neurobasal A medium containing 2% B27 supplement, 0.5mM glutamine, 25 units/ml
penicillin, 25 µg/ml streptomycin]. Thereafter, half of the medium was replaced twice
a week for up to 4 weeks. Nucleofection of freshly dissociated neurons was
performed at P1 as described193. Adenovirus encoding Cre recombinase (Iowa Gene
Transfer Vector Core (http://www.uiowa.edu/~gene/) was used where indicated.

Electrophysiological analysis of Kal7 null mice
Slice Preparation
Mice of 4-5 weeks of age were sacrificed by decapitation and their brains
quickly removed in ice-cold artificial cerebral spinal fluid solution (ACSF; in mM): 125
NaCl, 26 NaHCO3, 10 glucose, 2.3 KCl, 2 CaCl2, 2 MgSO4, 1.26 KH2PO4 (aerated
with 95% O2 and 5%CO2; pH=7.3; 310 mOsm/kg)126. Coronal slices, 300 µm thick,
were allowed to incubate at room temperature for at least 1 hour before recordings.
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Whole Cell Recordings
Slices were transferred to a recording chamber heated to 32°C and perfused
with aerated ACSF with the addition of 50 µM Picrotoxin (PTX; Sigma-Aldrich) to
isolate excitatory neurotransmission. Recording pipettes with 3-5 MΩ tips were filled
with internal solution containing (in mM): 135 KGluconate, 10 HEPES, 10 PCreatine,
3 Na2ATP, 2 MgCl2, 0.3 Na2GTP (pH=7.3; 285 mOsm/kg)126. Cells were patched
under visual guidance using infrared differential interference contrast optics. Data
were collected using a Multiclamp 700B amplifier (Axon Instruments/Molecular
Devices Sunnyvale, CA) and recorded/analyzed using pClamp 9.2 software (Axon
Instruments).
Intrinsic Membrane Properties
Integrity of each patch was assessed through a series of negative and positive
steps in current clamp mode (20 x 100 pA steps, -600 pA to +1300 pA; 100 msec
steps). The three initial negative steps were used to calculate membrane resistance;
single exponential curve fits yielded tau (t) and capacitance. Action potential
threshold was defined as the point of voltage inflection for the first spike fired in the
lowest current step. Inter-spike interval (ISI) was assessed in steps eliciting 3 or more
spikes and defined as time between peaks of the last two spikes within a step.
Spontaneous Glutamatergic Activity
We recorded spontaneous Excitatory Post Synaptic Currents (EPSCs) while
voltage clamped at -70 mV for 1 minute for each cell. Events observed in the full
minute were analyzed using MiniAnalysis (Synaptosoft Inc, Chapel Hill, NC). Two
outlier cells from each group were excluded from statistical analysis; their event
frequency values were far greater than 2 standard deviations above their group
mean.
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Long Term Potentiation
Bipolar tungsten electrodes (World Precision Instruments, Sarasota, FL) were
placed in the stratum radiatum to stimulate Schaffer collateral axons. EPSCs were
recorded in voltage clamp mode at -70 mV, with stimulation strength adjusted to
obtain 20-50 pA EPSCs at baseline. Test pulses were applied at 0.1 Hz to establish
averaged baseline (10-25 pulses) and post-LTP induction EPSC values (25-50
pulses, recorded within 15 min after LTP induction). EPSC amplitudes were
measured as the absolute difference between baseline and peak inward current
within 50 ms after the stimulus artifact. A small subset of cells was recorded in the
absence of PTX, and included in the analysis because their electrophysiological
measures were consistent. LTP induction was initiated using Theta Burst Pairing in
voltage clamp mode and always within 15 minutes after achieving whole cell
configuration. LTP induction consisted of 15 4-pulse bursts at 100 Hz separated by
200 ms intervals, and each burst was paired with a 50 msec depolarizing voltage step
to 0 mV. Cells that required greater than 200 µA of stimulation or showed LTP smaller
than 120% were excluded from analyses28. Statistical comparisons were made using
Student’s T-test.

Image analysis and quantification
Images captured using a Zeiss LSM510 Meta confocal microscope were
analyzed as described192,193. For quantification of spine density and synaptic clusters,
a stack of images (Z step, 0.2 µm) was acquired using a 63X objective (3.0 digital
zoom factor) and dendrites were visualized in 3-dimensions. For analysis of synaptic
marker colocalization, single plane images through the brightest point were used. For
analysis of Golgi staining, a stack of images (Z step, 0.2 µm) was acquired using a
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Nikon TE 300 microscope with a 100X objective and a Hamamatsu camera; dendrites
were visualized in 3-dimensions using Open Lab and Volocity software (Improvision,
Waltham, MA). For each experiment, all images were taken with identical settings
under the same conditions. Spine density and synaptic clusters were counted after
images were calibrated and thresholds were set to ensure that all interesting
structures were included in the analysis. Quantifications were performed using
Metamorph (Universal Imaging, West Chester, PA) and were limited to dendrites
within 100 µm of the soma in culture, or 100-150 µm in tissue slices. Data are
presented as average + SEM. Statistical analyses were performed with JMP6
software (SAS Institute, Cary NC) using one way analysis of variance (ANOVA)
followed by Dunnett’s test or Student’s T-test to assess statistical significance
between groups; *p < 0.05 or **p<0.01 was considered statistically significant. All
quantifications were performed independently by two investigators blind to genotype.
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Results
Design and characterization of Kal7 null (Kal7KO) mice
The targeting scheme shown in Fig. 2-1 was used to establish two
independent lines of mice with lox-p sequences flanking the single exon unique to
Kal7 and ∆Kal7. The polymerase chain reaction (PCR) schemes for screening mouse
genomic DNA before and after Cre-recombinase mediated excision of the Kal7 exon
are outlined in Fig. 2-1B-E. Sequence analysis of the lox-p PCR product (primers
A+B) and the knockout allele PCR product (primers A+E) confirmed that lox-p
insertion and DNA excision occurred as expected (not shown). Neuronal cultures
prepared from conditional null mice (Kal7CKO/CKO) were infected with adenovirus
encoding Cre-recombinase or GFP in order to verify successful excision of the Kal7
exon (Fig. 2-1D). Male Kal7+/CKO mice were mated with female mice expressing Crerecombinase, producing Kal7+/KO heterozygote mice, with a normal Kal7 allele from
the mother and a null allele from the father (Fig. 2-1E). After several back-crosses
into the C57Bl/6 background, Kal7+/KO heterozygote matings yielded wildtype, Kal7+/KO
and Kal7KO mice in the expected Mendelian ratio with no differences in survival (Fig.
2-1F). Western analysis of cortical extracts from Kal7KO mice demonstrated complete
loss of Kal7 and ∆Kal7 (Fig. 2-1G). Growth curves for wildtype and Kal7KO mice were
identical (Fig. 2-1H).

52

Figure 2-1. Design and Charachterization of Kal7KO mice
A. The major isoforms of Kalirin are shown; alternative splicing of three different 3’untranslated regions generates Kal7, Kal8 and Kal9. Use of a promoter located in the
intron preceding exon 11 (which encodes spectrin repeat 5) yields ΔKal7. Sec14p,
homologous to yeast Sec14p; SH3, Src homology 3 domain; DH, Dbl homology
domain; Kin, Ser/Thr protein kinase domain. B. The gene targeting approach used to
eliminate the Kal7 exon, a 0.9 kb 3’-terminal exon situated between exons 33 and 34,
is shown (not to scale); lox-p, neomycin-resistance, frt sites and primers are
indicated. Product A/B had the expected sequence. C. The genomic product created
by the action of FRT (frt) and Cre (lox-p) recombinase is shown; PCR primers used to
detect excision are shown; product A/E exhibited the correct sequence. D. PCR
genotyping of progeny from a Kal7+/CKO cross with C57BL/6 mouse (CKO mice) and
from a Kal7+/CKO cross with a female expressing Cre recombinase in the germ cells
(KO mice). E. PCR genotyping of pups from a Kal7+/KO x Kal7+/KO mating; under the
conditions used, primer pair A/E only yielded product from the knockout allele;
controls are shown to right of molecular weight ladder. F. Kal7+/KO and Kal7KO mice
were born in the expected Mendelian ratio when Kal7+/KO mice were mated (N=377
animals). G. Western blot analysis of cerebral cortex from wildtype and Kal7KO adult
mice. SDS lysates (30 µg protein) were analyzed using Kal7-specific antibody
(JH2959), with tubulin and synaptophysin as loading controls. H. Growth curve for
male Kal7KO mice and wildtype littermate controls (n=7-15 at each timepoint).
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Hippocampal histology and spine density in adult wildtype and Kal7KO mice
In Wt mice, Kal7 is at the postsynaptic side of virtually all excitatory synapses
in the cortex and hippocampus (Fig. 2-11). Low resolution images of the brain were
obtained using cresyl violet stained sections from wildtype and Kal7KO mice (Fig. 212). The gross anatomy of the hippocampus and cortex, regions rich in Kal7/∆Kal7,
and the cerebellum, a region with very little Kal7/∆Kal7 (not shown), did not differ
between wildtype and Kal7KO mice. To compare spine density and morphology, Golgi
impregnation techniques were utilized, revealing a deficit in spine density along the
apical dendrites of CA1 pyramidal neurons in Kal7KO mice (Fig. 2-2A,B). In the Kal7KO
mice, linear spine density dropped to 85% of wildtype values (Fig. 2-2C); spines in
the knockout animals were smaller than those from wildtype animals (not shown).
Tissue sections from the hippocampus of wildtype and Kal7KO mice of the same age
were also examined immunocytochemically. Consistent with the decrease in spine
density seen with the Golgi method, Kal7KO tissue showed a slight decrease in Vglut1
(excitatory presynaptic marker) and PSD-95 (postsynaptic marker) staining in the
neuropil, with no change in GAD65 (inhibitory presynaptic markers) staining (not
shown).

Normal Gross Development and Physiology in Kal7KO Mice
From the time of birth, Kal7KO mice exhibited no gross developmental or
physiological deficits. Kal7KO animals bred successfully with other Kal7KO animals,
with no difference in average litter size when compared to Wt pairs, and Kal7KO pups
suckled normally. Adult Kal7KO animals had a normal gait, lacked any sign of tremor,
had a normal righting reflex, had normal leg splay when lifted by the tail and
displayed normal climbing behavior in the home cage. In a wire hang test to measure

54

Figure 2-2. Kal7KO neuronal architecture
A-C. Golgi staining showed a decrease in spine density in apical dendrites of CA1
pyramidal neurons from 6-7 week old Kal7KO mice; Wt, n=4 mice; Kal7KO, n=4 mice.
Three sections (100 µm) through the dorsal hippocampus were used per animal and
at least two neurons were analyzed for each section. Spines on apical dendrites in
the stratum radiatum (SR), 100-150 µm from the soma, were counted; SO, stratum
oriens. At least 500 spines were counted for each neuron.
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grip strength, both wildtype and Kal7KO animals hung suspended from a wire for three
minutes without failure. To measure their spontaneous locomotor activity, Wt, Kal7KO/+
and Kal7KO mice were monitored for 60 minutes in an open field chamber. Genotype
had no effect on total locomotor activity (Fig. 2-13). Additionally, mice of all three
genotypes exhibited a similar decrease in locomotor activity across the 60 minute
session (data not shown).

Decreased anxiety-like behaviors in Kal7KO mice
Given the apparent deficits in synaptic connectivity in Kal7KO mice, baseline
anxiety-like behavior was assessed to determine if the morphological changes
observed lead to behavioral changes241. Wildtype and Kal7KO mice underwent a one
time elevated zero maze test. When compared to wildtype mice, Kal7KO mice spent
significantly longer in the open arm of the elevated zero maze (Fig. 2-3A left).
Additionally, Kal7KO exhibited fewer stretch attend postures as they extended from the
closed into the open area (Fig. 2-3A right) and a greater number of open arm entries
(not shown). Data from the open field test (Fig. 2-13) demonstrated that these effects
were not simply due to hyperactivity in response to a novel environment. Stretch
attend postures are generally thought to represent hesitation as the mouse tries to
avoid any unseen threat in the exposed area. The fact that the Kal7KO mice made
more open entries with fewer stretch attend postures indicates less anxiety about
entering a potentially threatening area. Given the greater time spent in the open arms
and the decreased hesitation to enter the open areas, it is clear that Kal7KO mice have
a significantly decreased level of anxiety-like behavior at baseline.
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Figure 2-3. Behavioral deficits in Kal7KO mice
A. In the elevated zero maze, Kal7KO mice spent more time in the open arm (left,
p=0.003; ANOVA) and displayed fewer stretch attend postures (right, p=0.011;
ANOVA) [N=14Wt; 9KO] than Wt mice. B. In a passive avoidance task, Kal7KO and
Wt mice exhibited no differences in training times (p=0.895; ANOVA); compared to
Wt mice, Kal7KO mice showed decreased latency to enter the dark, shock-paired side
at 1 (p=0.03; ANOVA), 24 (p=0.006; ANOVA) and 72 (p=0.02; ANOVA) hr after the
training session. C. In a radial arm maze acquisition task, both Wt (N=9) and Kal7KO
(N=13) animals made an equal number of reference and working errors initially and
throughout the learning sessions: Left, reference errors, F(1,20)=0.02; p = 0.888,
repeated measures two-way ANOVA; Right, working errors, F(1,20)=0.54; p = 0.469,
repeated measures two-way ANOVA. D. Both Wt (N=11) and Kal7KO (N=7) mice
spent an equal amount of time exploring a novel object in an object recognition task
(p=0.364; Fisher’s LSD).
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Impaired contextual fear learning in Kal7KO mice
Passive avoidance conditioning was used to determine if Kal7KO mice
exhibited altered abilities in a hippocampus-dependent learning task; in this
paradigm, lasting context-fear association can be imparted with a single training
session242. During the training session, wildtype and Kal7KO animals showed the
same latency to cross to the dark side of the chamber (Fig. 2-3B), whereupon they
received a single footshock. When animals were tested one hour after conditioning,
Kal7KO animals exhibited a significantly decreased latency to cross to the footshockpaired side. This decrease in latency was also seen in animals that were tested 24
hours and 72 hours after conditioning. This pattern of behavior indicates that Kal7KO
animals had difficulty with the initial learning of the association rather than a simple
deficit in long term consolidation of the association. To ensure that the shock was
being interpreted similarly by Kal7KO and wildtype mice, a shock sensitivity test was
performed. Both Wt and Kal7KO mice showed identical thresholds to vocalize, flinch
and jump in response to a scrambled footshock (Fig. 2-13). Taken together, these
experiments indicate that Kal7 is necessary for contextual fear memory, which is
dependent on both the hippocampus and amygdala243.

Kal7KO mice exhibit normal learning in a radial arm maze task as well as normal
object recognition
From the passive avoidance experiments, it was clear that Kal7KO mice were
deficient in learning in response to an aversive stimulus. We next examined their
ability to acquire a repeated-trial appetitively motivated task that was also dependent
on the hippocampus. For this task, Kal7KO and wildtype mice were food deprived to
85% of their free-feeding body weight and trained to locate food rewards in a radial
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arm maze. By baiting only two arms, we were able to examine both long term
(reference) memory and short term (working) memory. Each mouse received 23 trials
in the maze and all mice decreased the number of reference and working memory
errors made over the course of the training (Effect of Day F(1,20)=13.65; p=0.001,
repeated measures two-way ANOVA). The Kal7KO mice made the same number of
reference (Fig. 2-3C left) and working (Fig. 2-3C right) errors as the wildtype
controls. Our experimental design allowed the animals free reign of the maze, likely
leading to more exploratory reference errors, causing the number of errors to plateau
at a higher level than reported with some other experimental designs244,245.
Regardless of this, animals of both genotypes showed significant improvement
across days, with similar learning curves and similar final levels of responding. These
data indicate that Kal7 is not necessary for this type of appetitive repeated-trial
hippocampal conditioning.
To further test the ability of Kal7KO animals to learn hippocampal dependent
tasks, an object recognition test was performed (Fig. 2-3D). There was no difference
between genotypes in level of object exploration on the training day. Animals of each
genotype showed significantly increased exploration of the novel object on day 2, and
there was no significant difference between genotypes. These data indicate that
Kal7KO mice are able to form a stable contextual hippocampal dependent memory in a
non-aversive context.

Electrophysiological analysis of Kal7KO mice
In order to assess the functional consequences of Kal7 knockout, we
performed electrophysiological recordings from acute slice preparations. First we
evaluated passive membrane properties. Capacitance is a measure of cell surface
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area and dendritic spines contribute 40-70% of the total surface area of hippocampal
CA1 pyramidal cells246-248. Given the reduction in spine density observed in the CA1
pyramidal neurons of Kal7KO mice (Fig. 2-2), we expected to see slightly reduced
capacitance values for Kal7KO vs. Wt neurons. Hyperpolarizing and depolarizing
current steps were applied to patched CA1 hippocampal neurons to provide
measures of membrane resistance and tau so that capacitance could be calculated
(Fig. 2-4A). On average, Kal7KO neurons had higher input resistance (Wt: 0.12±0.007
MΩ, Kal7KO: 0.15±0.0052 MΩ; p=0.008; 32 Wt neurons and 29 KO neurons) and
lower membrane capacitance (Wt: 66±3.2 pF, Kal7KO: 57±2.4 pF; p=0.028); time
constants did not differ (Wt: 7.6 ± 0.27 ms; KO: 8.1 ± 0.27 ms; p=0.19). The resting
potential and action potential threshold for knockout and Wt pyramidal neurons were
identical (Fig. 2-14A). In knockout neurons, the number of action potentials fired
during weak depolarizing current steps was slightly increased (Fig. 2-14B) while
latency to fire the first action potential following step initiation was decreased (Fig. 214C); both results are consistent with the decreased membrane capacitance
(decreased surface area) observed in Kal7KO neurons. There was no significant
difference in interspike interval between the two groups. Since the CA1 pyramidal
neurons of Kal7KO mice have fewer dendritic spines, we assessed spontaneous
excitatory post-synaptic currents (EPSCs) (Fig. 2-4B left); as predicted, spontaneous
EPSC frequency was significantly decreased in Kal7KO neurons. No difference was
observed in amplitude (Fig. 2-14D).
We went on to compare plastic properties of Wt and Kal7KO synapses.
EPSCs, evoked via Schaffer collateral stimulation, were of similar amplitude and
required similar stimulation strengths in Wt and Kal7KO neurons (Fig. 2-14E,F). Taken
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Figure 2-4. Kal7KO Electrophysiological Deficits
A. Representative traces from Wt and Kal7KO CA1 pyramidal neurons of membrane
responses to positive and negative 200 pA somatic current injections. B. Composite
spontaneous EPSC frequency (N= 24 Wt, 18 KO neurons; p=0.023; left) and LTP (N=
7 Wt, 13 KO neurons; p=0.0079; right) data. C. Averaged traces of EPSCs recorded
from single CA1 pyramidal neurons from Wt and Kal7KO mice before and within 15
minutes following theta burst pairing.
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with the lack of difference in spontaneous EPSC amplitude, these data suggest
normal strength of basal synaptic transmission in Kal7KO neurons. In order to
measure Long Term Potentiation (LTP), EPSCs were examined before and after
applying a Theta Burst Pairing paradigm (TBP). A single TBP trial resulted in
significant LTP that was maintained for at least 1 hour in both Wt and Kal7KO slices
(Fig. 2-4C). LTP was quantified by comparing EPSC amplitudes within 15 min after
the TBP trial to averaged baseline EPSC amplitudes. In comparison to Wt neurons,
Kal7KO neurons showed markedly blunted LTP (Fig. 2-4B right). This deficiency in
LTP may correlate with the decreased ability to retain behavioral training (Fig. 2-3),
as LTP is typically considered to be one cellular correlate of learning.

Kal7 and ΔKal7 are halved in Kal7+/KO mice and eliminated in Kal7KO mice
Antisera specific for the sequence encoded by the Kal7 exon were used to
evaluate the success of the targeting strategy (Fig. 2-5A). In both cortex and
hippocampus, levels of Kal7 and ∆Kal7 were reduced to approximately 50% of Wt
levels in Kal7+/KO mice (Fig. 2-5B); no compensatory increase in Kal7 expression was
observed. In the Kal7KO mice, cross-reactive material the size of Kal7 and ∆Kal7 was
eliminated (Fig. 2-5A). Differential centrifugation was used to prepare fractions
enriched in synaptsomal membranes (LP1), synaptic vesicles (LP2), synaptosomal
cytosol (LS2), endoplasmic reticulum/Golgi (P3) and cytosol (S3). Two independent
polyclonal antisera specific for the C-terminus of Kal7/ΔKal7 confirmed its elimination
in the Kal7KO mice (Fig. 2-5C; one shown).
Transcripts encoding Kal9 and Kal12 are generated by splicing Kalirin exon 33
to exon 34, eliminating the exon that encodes the unique COOH-terminus and 3’untranslated region of Kal7249 (Fig. 2-5D). The genomic
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Figure 2-5. Biochemical verification of Kal7KO
A. Total SDS lysates (20 µg protein) prepared from the parietal cortices and
hippocampi of Wt, Het, and Kal7KO mice were analyzed for Kal7 and βIII-tubulin. B.
Levels of Kal7 and ΔKal7 in Kal7+/KO mice were compared with levels in Wt mice. C.
Parietal cortices from Wt and Kal7KO mice were separated into crude subcellular
fractions. Equal amounts of protein (5 µg) from each fraction were analyzed using
Kal7-specific antibody (JH2959); similar results were obtained with affinity-purified
Kal7-specific antibody (JH2958). The success of the fractionation was verified by
visualizing synaptophysin and PSD-95. D. The splicing pattern for the region around
the Kal7-specific exon is depicted; introns are not drawn to scale. Kal8 transcripts
retain part of the adjacent intron (hatched), including a small protein coding region
(gray) followed by a poly(A) addition signal and a poly(A) tract250. E. SDS lysates (20
µg) prepared from parietal cortices of Wt and Kal7KO mice were visualized with a panKalirin antibody, JH2582; the asterisk indicates a nonspecific band. F. Scans of gels
were aligned, revealing the presence of Kal8 in Kal7KO lysates; the asterisk indicates
a nonspecific band. G. Levels of Kal12 and Kal9 in Het and KO mice were compared
with Wt mice (n = 7). Error bars indicate SEM.
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region excised in the Kal7KO mouse included the polyA addition site249. To explore the
possibility that transcripts that would normally encode Kal7 generated Kal8, Kal9 and
Kal12 in Kal7KO mice, we used pan-Kalirin antibodies to visualize these isoforms (Fig.
2-5E). Levels of Kal7 and ΔKal7 were not detectable as expected in Kal7KO mice, but
levels of Kal9 and Kal12 increased. Scans of these gels confirmed the appearance of
a protein the size of Kal8 (Fig. 2-5F) and quantification revealed an increase of about
50% in levels of Kal9 and Kal12 in both Kal7+/KO and Kal7KO mouse cortex (Fig. 25G). Although Kal7/∆Kal7 account for about 75% of the pan-Kalirin signal in wildtype
samples, the increased levels of Kal8, Kal9 and Kal12 in Kal7KO cortex mean that
pan-Kalirin levels normalized to tubulin dropped by only about 25% in the knockouts
(to 74 ± 5% of wildtype; N=7).

Biochemical analysis of Kal7KO mice
We first examined levels of cell-type specific markers in SDS lysates prepared
from cerebral cortex. Neuron-specific bIII-tubulin, glutamic acid decarboxylase (GAD;
a marker for inhibitory neurons) and glial fibrillary acidic protein (GFAP; a marker for
astrocytes) were unaltered (Fig. 2-6A). Proteins abundant in presynaptic terminals
(synaptophysin, α-adaptin and clathrin) were unchanged, as was BiP, a major
endoplasmic reticulum marker common to all cells. Levels of known Kalirin interactors
were then assessed (Fig. 2-6B); levels of PSD-95, a Kal7/∆Kal7 specific interactor194
and Rac1, a Kal7 substrate, were unaltered. Cdk5, which phosphorylates Thr1590 in
Kal7/∆Kal7, and PP1, which reverses this modification232, were unaltered. Levels of
dynamin, an interactor with the IgFnIII domain of Kalirin (Xin et al, submitted) were
unaltered. Levels of several postsynaptic proteins, AMPA receptor subunits GluR1
and GluR2, and NMDA receptor subunits
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Figure 2-6. Western blots of Kal7KO lysates
Parietal cortex SDS lysates were analyzed (5, 10 or 20 µg protein). A. Levels of the
indicated cell type, presynaptic and subcellular organelle markers were quantified
after normalization to βIII tubulin and setting the average Wt intensity to 1.0.
Representative gels are shown. The graphs show the average ± standard error of the
mean for at least 6 independent pairs of wildtype and Kal7KO mice. B. Levels of
known Kalirin interactors were tested in the same manner. C. Glutamate receptor
subunits and neuroligin-1 (NL1) were tested as in A.
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NR1, NR2B were unaltered in Kal7KO mice (Fig. 2-6C); levels of neuroligin-1, another
component of the PSD, were unaltered. Finding normal levels of these markers in
tissue lysates is consistent with the limited deficits observed. The significant
alterations observed in Golgi impregnation profiles (Fig. 2-2), behavioral parameters
(Fig. 2-3) and electrophysiological properties (Fig. 2-4) led us to focus on the
ultrastructure of synapses in Kal7KO vs. Wt mice.

Hippocampal ultrastructure in adult male Wt and Kal7KO mice
Synapses on the apical dendrites of CA1 hippocampal pyramidal neurons in
Wt and Kal7KO neurons were compared (Fig. 2-7A,B). Despite the total absence of
Kal7, synaptic structures of normal appearance were plentiful in Kal7KO tissue.
Postsynaptic densities aligned with presynaptic endings full of small synaptic vesicles
were prevalent in Wt and Kal7KO tissue. The formation of spines is clearly possible in
the total absence of Kal7. The length and thickness of the PSD were measured in
wildtype and Kal7KO neurons. Compared to wildtype mice, there was a small, but
significant decrease in both the length and thickness of the PSD in Kal7KO mice (Fig.
2-7C,D; p<0.005, Kolmogorov-Smirnov, 800+ PSDs measured for each plot). Even a
change of this magnitude can be of significance in synaptic transmission244,247. The
synapses present in micrographs from the CA1 region of wildtype and Kal7KO tissue
were counted (arrows in Fig. 7A,B). The number of synapses (defined as a PSD with
apposed presynaptic ending containing vesicles) in Kal7KO mice dropped by about a
third compared to wildtype mice (from 0.53 + 0.02 / µm2 to 0.31 + 0.02 / µm2;
synapses in 100 µm2 were quantified for 5 images of each genotype; p<0.005,
Student’s T-test). Although larger in magnitude, the change in ultrastructurally
identified synapse number is consistent with the
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Figure 2-7. Decreased PSD size in Kal7KO mice
A. Representative electron micrographs of hippocampal CA1 striatum radiatum
synapses from adult Wt and Kal7KO mice. Complete synapses (PSDs apposed to
presynaptic endings with vesicles) were readily identified in Kal7KO tissue. PSD length
and thickness were measured. Cumulative frequency distributions of PSD length (C)
and thickness (D) from Wt (solid line) and Kal7KO (dashed line) mice are shown. Both
PSD length (C) and thickness (D) were decreased in Kal7KO mice. At least 800
randomly selected synapses from each of four Wt and four Kal7KO mice were
measured by observers blind to genotype. Differences are significant by KolmogorovSmirnov, p<0.005.
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decrease in linear spine density observed using Golgi impregnation (Fig. 2-2). Our
cell culture studies demonstrated that Kal7 shRNA and antisense treatments
produced spine-like structures lacking presynaptic terminals; if a similar phenomenon
occurs in vivo, synapse number as measured by EM would decrease more than spine
number as measured by Golgi staining192,193.

Biochemical characterization of purified PSDs from Kal7KO mice
While the GEF domain of Kal7 clearly has a catalytic role, its spectrin-repeat
region suggests that Kalirin might serve a structural role similar to that of spectrin
itself195. To evaluate this possibility, we determined the average number of Kal7
molecules present per PSD (Fig. 2-8A). The PSD purification protocol optimized for
wildtype mouse cortex and hippocampus worked well for tissue from Kal7KO mice
(Fig. 2-15). Using purified ∆Kal7 as a standard, we determined that the average
cortical or hippocampal PSD contained only 9 -12 molecules of Kal7. With hundreds
of copies of PSD-95, Shank and Homer per PSD, a structural role for Kal7 seems
unlikely67,68,74,227,228,251, and instead suggests a role as an organizing molecule.
A pan-Kalirin antibody was used to compare the Kalirin content of PSDs
purified from wildtype and Kal7KO animals (Fig. 2-8B). Although Kal7 was absent, the
amount in Kal7KO PSDs increased compared to Wt for both Kal9 (50 + 22% over
wildtype; N=3) and Kal12 (79 + 21% over wildtype), indicating that the PDZ binding
motif at the COOH-terminus of Kal7 is not the only means of localizing Kalirin to the
PSD. In non-neuronal cells, both Sec14p mediated interactions with
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Figure 2-8. PSD preparations from Kal7KO mice
A. Purified ΔKal7 was used to quantify the amount of Kal7 in the average 1.1
gigadalton PSD68,74. Recombinant purified ΔKal7 was quantified by making a dilution
series and comparing Coomassie Blue staining to a bovine serum albumin standard
of known concentration. Western blot signals, using affinity-purified Kal7 antibody, for
the ΔKal7 standard were used to construct a standard curve to quantify Kal7 in the
PSD samples. B. Use of the pan-Kalirin antibody revealed that PSDs (5 µg protein)
prepared from Kal7KO mice had increased levels of Kal9 and Kal12 compared to
PSDs prepared from Wt mice. C. Left. PSDs (5 µg protein) purified from the cortices
of 2 sets of Wt and Kal7KO mice were blotted for AMPA and NMDA receptor subunits,
neuroligins 1 and 2, δ-catenin and for the Kal7 interactors PSD-95, Rac1, and PP1.
Right. Both the Triton-soluble (S) and insoluble PSD (P) fractions were blotted for
NR2B and Cdk5. D. Data from 3 sets of Wt and Kal7KO PSDs were averaged (n = 2
for Cdk5 TX S); *, p<0.05; **, p<0.01.
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phosphatidylinositides and the spectrin-repeat region contribute to the association of
Kal7 with membranes195. To determine whether the absence of Kal7 diminished Rac
activation, we assayed crude tissue homogenates and the synaptosomal fraction (P2)
for Rac1-GTP using the Pak-CRIB pulldown assay195. No difference in Rac1
activation was detected in either fraction under baseline conditions (Fig. 2-15C).
Investigation of specific signaling pathways may be required to reveal the effect of a
lack of Kal7 on Rac activation.
Since Kal7KO neurons were deficient in LTP, we examined levels of AMPA
receptor subunits GluR1 and GluR2 and NMDA receptor subunits NR1 and NR2B in
purified cortical PSDs (Fig. 2-8C). A significant decrease in the level of NR2B was
observed (Fig. 2-8C,D), with no significant change in GluR1, GluR2 or NR1. Levels of
neuroligin-2, which is associated with inhibitory synapses233,234 and d-catenin, a
neuron-specific catenin which brings PDZ domain proteins such as AMPA receptors
to the PSD252,253, were unchanged. Further studies will be required to determine
whether surface levels of AMPA and NMDA receptors and receptor trafficking are
altered.
We next looked at levels of several Kal7 interactors. Neither levels of
CaMKIIα, which has been reported to phosphorylate Kalirin254, nor actin were
changed (Fig. 2-8C). Levels of PSD-95, which binds the COOH-terminus of Kal7, and
Rac1, a Kalirin substrate, were unaltered (Fig. 2-8C). The most striking change
observed was a decrease in the level of Cdk5 (Fig. 2-8C,D), which phosphorylates
Kal7 at Thr1590232. Since Cdk5 associates with membranes via its interactions with p35
and p39, we examined Cdk5 levels in the TX-100 wash used to prepare PSDs; levels
of Cdk5 were also reduced in this fraction (Fig. 2-8C,D). Cdk5 regulates the actions
of a wide variety of post-synaptic proteins214,229,230 and its loss may contribute to the
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phenotype observed in Kal7KO mice. Levels of PP1, which dephosphorylates P-Thr1590
of Kal7232 were unchanged.

The late stages of synaptogenesis are deficient in Kal7KO neurons in culture
We next asked whether the differences in spine density seen in Kal7KO mice in
vivo could be reproduced in vitro. Dissociated cortical neurons prepared from P1
wildtype and Kal7KO littermates were examined after 7, 14, 21 or 28 days in vitro (DIV)
(Fig. 2-9 and Fig. 2-16). At each time point, replicate cultures were stained for MAP2,
a dendritic marker, and Vglut1; one culture was stained for Kal7 and the other for
PSD-95. Images from DIV21 are shown in Fig. 2-9 and images from DIV7 and DIV14
are shown in Fig. 2-16. The MAP2 staining patterns were similar in wildtype and
Kal7KO neurons at all time points, but dendritic morphology has not yet been
quantified. As expected, Kal7KO cultures lacked any detectable staining for Kal7 at all
time points. At DIV28, Vglut1 staining along wildtype dendrites was almost perfectly
aligned with Kal7 staining (Fig. 2-9A). Vglut1 positive clusters still abutted the
dendritic shafts of Kal7KO neurons (Fig. 2-9B,C). Quantification revealed a decrease
of 28% in the density of Vglut1 positive clusters along the dendrites of DIV28 Kal7KO
neurons (Fig. 2-9G,H). Vglut1 staining was paired with PSD-95 in order to determine
whether glutamatergic presynaptic endings were contacting dendritic spines (Fig.29D-F). In DIV28 wildtype neurons, almost every Vglut1 cluster was apposed to a
PSD-95-positive cluster. The number of Vglut1-PSD-95 clusters along the dendrites
of Kal7KO neurons dropped by 39% and Vglut1 clusters not apposed to PSD-95
clusters became apparent (Fig. 2-9E,F,H; 0.99 Vglut alone/10µm in Kal7KO; p=0.003
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Figure 2-9. Decreased synapses in the mature Kal7KO neurons in culture
Cortical cultures were prepared from P1 littermate wildtype and Kal7KO mice. Replicate
cultures were fixed at DIV7 (Fig. 2-16A), DIV14 (Fig. 2-16B), DIV21 (images not shown) and
DIV28 (A–F). One set of cultures was visualized with antibodies specific to Vglut1, MAP2 and
Kal7 (A–C); the other set was visualized with antibodies to Vglut1, MAP2 and PSD-95 (D–F).
Clusters of Vglut1, Kal7 and PSD-95 staining were quantified by observers blinded to
genotype. Differences in number of Vglut1-only clusters (excitatory presynaptic terminals;
green stars) or number of excitatory synapses (Vglut1-PSD-95 clusters; red circles) between
wildtype and Kal7KO mice were only detected at DIV28 (G–H); n=9–12 for Wt, n=10–12 for
KO. Scale bar, 5 µm.
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vs. Wt; green stars). These data are in remarkably good agreement with the decrease
in the number of synapses in vivo in the ultrastructural analyses (Fig. 2-7).
Younger cultures were examined to determine when these differences
between Kal7KO and wildtype neurons became apparent (Fig. 2-16). Similar numbers
of Vglut1-PSD-95 clusters were found along the dendrites of wildtype and Kal7KO
neurons at DIV7; Kal7 was not yet detectable in wildtype neurons (Fig. 2-16A). For
both wildtype and Kal7KO neurons, the number of dendritic Vglut1 clusters increased
substantially by DIV14 (Fig. 2-16B,C). In wildtype neurons, Kal7 staining localized to
the postsynaptic side of a few Vglut1 positive synapses. As at DIV7, neither the
number of Vglut1 clusters nor the number of Vglut1-PSD-95 clusters was altered in
Kal7KO neurons (Fig. 2-16C). At DIV21, Kal7 was detected in most excitatory
synapses in wildtype cultures. However, Kal7KO neurons and wildtype neurons still
had the same number of Vglut1 clusters and Vglut1-PSD-95 synapses (Fig. 2-16C).
The linear density of Vglut1 clusters along the dendrites of Kal7KO neurons did not
increase after DIV14 (Fig. 2-9G), while wildtype neurons formed more synapses
between DIV14 and DIV28 (p=0.032, Wt vs. KO at DIV28).

Rescue of Kal7KO neurons
We next asked whether the deficit in dendritic spines observed in Kal7KO
neurons could be reversed by introduction of exogenous Kal7. DIV1 cortical neurons
from Kal7KO mice were transfected with two different amounts of vector encoding
Kal7; control neurons were not transfected (Fig. 2-10). At DIV28, expression of Kal7
caused a DNA dose-dependent increase in the number of Vglut1 positive clusters
along the dendrites of Kal7KO neurons (Fig. 2-10B-D). The presynaptic Vglut1
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terminals were closely aligned with postsynaptic clusters of Kal7 (Fig. 2-10B,C). The
Vglut1 clusters were aligned with PSD-95, NR1 and GluR1 positive clusters (not
shown).
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Figure 2-10. Exogenous Kal7 restores synapse number in Kal7KO neurons
At the time of plating, cortical neurons from Kal7KO mice were transfected by
nucleofection with a vector encoding Kal7; control cells were not transfected. At
DIV28, Kal7 (red), Vglut1 (green) and MAP2 (blue) were visualized as in Fig. 2-9. A.
Kal7-staining was absent from control neurons; Vglut1 clusters were apparent along
MAP2 positive dendrites. In Kal7KO neurons transfected with 3 (B) or 6 (C) µg of Kal7
vector, Vglut1 clusters were often apposed to clusters of Kal7. The reduced number
of excitatory presynaptic Vglut1 terminals in KO mice was rescued with exogenous
Kal7 in a DNA concentration-dependent manner (D). N=11 Wt, n=10–12 for Kal7KO.
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Discussion
Kal7 plays an essential role in neuronal function in vivo
A series of in vitro studies demonstrated that Kal7 is necessary for the
formation and maintenance of dendritic spines192,193. We show here that mice lacking
Kal7 have deficits severe enough to affect synaptic transmission and specific
behaviors. Shank1 and Kal7 are essential for dendritic spine formation in vivo and in
culture, but Kal7KO produces a more severe drop in hippocampal spine density than
Shank1 (15% vs. 6%)244, making Kal7 an important model for human disease. Mental
retardation syndromes are often associated with dysregulation of dendritic
spines148,255. For example, Patau Syndrome (trisomy 13), Down Syndrome (trisomy
21) and Fragile X all have alterations in the number and shape of dendritic spines256258

. Understanding why a subset of behaviors is affected by loss of Kal7 while several

other learning tasks are not affected should provide new insights into signaling.

Comparing in vitro and in vivo phenotypes
As observed for other PSD protein knockout mice227,234,259, the phenotype of
the Kal7KO mouse is less severe than would have been predicted from in vitro studies.
Several factors may contribute to this difference. Most importantly, alternative splicing
allows the larger isoforms of Kalirin to accumulate in Kal7KO neurons. Lacking the
Kal7 exon, the splicing machinery associated with Kalirin transcripts would be
expected to splice exon 33 to exon 34, creating the increased levels of Kal8, Kal9 and
Kal12 in total homogenates (Fig. 2-5 E-H). The other targeting strategy considered,
insertion of a stop codon within the Kal7 exon preceding the PDZ binding motif, would
have generated a truncated product, complicating analysis in a different manner.
Since the Sec14p and spectrin-like repeats target Kalirin to membranes, the 9 copies
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of Kal7 present at the “typical” synapse in wildtype mice may be replaced by 6 copies
of these larger Kalirin isoforms, which could help preserve excitatory synapses and
alter synaptic function in a region- and context-specific manner.
Recent studies assigning an essential role for Kal7 in the activity-dependent
activation of Rac and the N-cadherin/afadin pathway utilized an shRNA directed
against the spectrin repeat region (nt 1229-1250; spectrins 2-3)202,254, reducing
expression of all major forms of Kalirin, not just Kal7. Although this approach led to
the conclusion that Kal7 regulates the GluR1 content of pyramidal neuron dendritic
spines and AMPA receptor mediated synaptic transmission254, it is clear that the
GluR1 content of PSDs purified from Kal7KO neurons is indistinguishable from
wildtype. Selective elimination of Kal7 using antisense or shRNA targeted to its
unique 3’-untranslated region193 produced a more profound decrease in spine density
(~ 2-fold) than observed in cultures prepared from Kal7KO mice. A Kal7-specific
shRNA would not be expected to increase levels of the larger kalirin isoforms; in
addition, breakdown products generated from Kal7 transcripts targeted by the shRNA
could contribute to the effects observed260.

Spine and Plasticity Analysis
Ultrastructural analyses demonstrated a substantial decrease in the number of
synapses (PSD with presynaptic terminal) in CA1 hippocampal neurons from Kal7KO
mice. Our cell culture data showed a similar decline in synapses assessed as
VGlut1/PSD-95 clusters (Fig. 2-9). Golgi staining revealed a less dramatic decrease
in linear spine density. While Vglut1-positive terminals in wildtype neurons usually
align with PSD-95 clusters, this strict association is lost in Kal7KO neurons (Fig. 2-9H).
Neither unpaired spine-like structures nor unpaired presynaptic endings would be
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counted in the EM analysis. The PSDs in Kal7KO mice were narrower and thinner than
in wildtype mice. These changes in PSD dimensions were consistent and comparable
to changes seen in Shank1KO mice244.
Tracking the development of synapses in cortical cultures prepared from
Kal7KO mice was revealing. Both in vivo and in culture, synapses begin to form before
Kal7 expression is detectable. Synaptic development proceeded normally for 21 days
in the absence of Kal7; VGlut1 positive presynaptic endings contacted dendritic
shafts aligned with PSD-95 clusters. While spine density increased between DIV21
and DIV28 in wildtype neurons, no increase was observed in Kal7KO neurons. Kal7 is
detected at virtually every excitatory synapse in mature wildtype mice; it is not clear
what distinguishes the spines formed between P21 and P28. Kal7 may play an
essential role in the maturation and/or maintenance of dendritic spines, as proposed
for the neuroligins234. Consistent with the conclusion that Kal7 has a role late in
synaptic development, no differences in LTP were apparent when slices from P21
and younger mice were examined. When synaptic plasticity was tested in Kal7KO mice
older than P28, deficits were apparent (Fig. 2-4).
Although PSD length and width were reduced in Kal7KO mice, the effect was
small, consistent with our inability to see dramatic changes in PSD content of a
number of proteins. Indeed, similar results have been seen with other PSD-protein
knockouts. Ablation of PSD-95 caused no change in spine volume, but made spines
longer and thinner and decreased the number of AMPA receptors227,228. Knockout of
Shank1, which caused a decrease in spine number and PSD size, decreased levels
of GKAP and Homer and weakened basal synaptic transmission, leaving synaptic
plasticity unaltered244.
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Potential Mechanisms
Determining how the absence of Kal7 causes these changes in spine number
and synaptic function will require detailed analysis of the deficits. Kal7KO PSDs
contained less Cdk5 and less NR2B than wildtype PSDs. Cdk5 plays a complex and
important role in postsynaptic signaling and architecture231,261 and the decrease in
Cdk5 may contribute to many of the changes observed. For example, the GEF
activity of Kal7 is increased following Cdk5-catalyzed phosphorylation of Thr1590232.
Although Kal7 with either a T1590A or T1590D mutation caused spine formation when
expressed in rat cortical neurons232, spine morphologies differed232. Based on the fact
that dominant negative Cdk5 blocked the ability of Kal7 to affect PC12 cell
morphology, this interaction appears to play a critical role in Kalirin function.
Like Kal7, the Cdk5/p35 complex affects Rac/Pak signaling262, which alters
cytoskeletal dynamics in dendritic spines263. Through its effects on ephrins, the
decreased Cdk5 in Kal7KO PSDs may contribute to the dearth of dendritic spines.
Cdk5 plays a role in EphA-dependent spine retraction264 while Kal7 plays a role in
EphB-dependent spine maturation265. Cdk5 phosphorylates PSD-95, regulating its
clustering230, which might contribute to the changes in PSD size and shape seen in
Kal7KO mice. Importantly, Cdk5 plays a role in the phosphorylation of NR2B, resulting
in its stabilization in the membrane229. The decreased levels of Cdk5 in Kal7KO PSDs
may cause the decreased levels of NR2B. Further studies are underway to determine
how Kal7 and Cdk5 interact to contribute to the changes observed in Kal7KO mice.

Kal7 is essential for specific memory processes
Given the spine changes seen in mental retardation and the role of dendritic
spines in memory formation148, it is not surprising that Kal7KO animals exhibit learning
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deficits. While numerous knockout mice have demonstrated deficits in hippocampal
learning processes, few have revealed disparities in appetitive spatial and aversive
contextual hippocampal-dependent learning paradigms244,266. It has been posited that
different mechanisms underlie single-trial versus more gradual repetitively learned
tasks244,266. The Kal7KO mice were normal in non-aversive tests of learning and
memory (object recognition, radial arm maze), but abnormal in tests of anxiety and
fear learning (elevated zero maze, passive avoidance). Perhaps specific proteins or
signaling pathways are essential for the formation/function of synapses necessary for
particular types of learning (e.g. fear learning) but not others (e.g. spatial learning).
The hypothesis that specific synapses or molecular pathways underlie different forms
of hippocampal memory was put forth previously266, but has received little further
investigation. Future behavioral and neurochemical mapping studies of Kal7KO and
Kal7CKO mice will help to clarify the role of different spine proteins in different types of
learning.

Kal7 plays a key role in synaptic plasticity and in human psychiatric conditions
Kal7 is the only RhoGEF specifically trafficked to the PSD68 and the only
RhoGEF identified in the complex of NR2B associated proteins74. Decreased levels of
Kal7 were observed in postmortem cortices from schizophrenics and Alzheimer
Disease patients153,200,225. In addition to the present findings, preliminary studies with
Kal7KO mice revealed aberrant responses to drugs of abuse267 and additional deficits
in synaptic plasticity and cognitive function (Kiraly and Gaier, unpublished). Kal7KO
mice have now emerged as a valuable model for understanding synaptic
malfunctions and human psychiatric disorders.
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Figure 2-11. Kal7 is post-synaptically localized
Kal7 is localized to the postsynaptic side of excitatory synapses in mouse
hippocampal neurons. Hippocampal cultures prepared from postnatal day 1 (P1) mice
were examined at DIV28. Cultures fixed with cold methanol were visualized with
antibodies specific to Kal7 (red), Map2 (blue) and Vglut1 (green), a maker for
excitatory presynaptic terminals. The merged image is shown; scale bar= 5 µm.
Vglut1-positive clusters on dendritic spines (arrows) and on the dendritic shaft (lines)
are apposed to Kal7-positive clusters.
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Figure 2-12. Hippocampal cellular histology of Wt and Kal7KO mice
Wildtype (A-C) and Kal7KO (D-F) mice (90 days old) were perfused transcardially with
4% paraformaldehyde. Sections (10 µm) through the dorsal hippocampus were
stained with cresyl violet. B and E are high power images from boxed areas of cortex
from A and D, respectively. C and F are high power images form boxed areas of CA1
from A and D, respectively. Cortical and hippocampal structures were not altered,
and no cell loss was observed in these areas in Kal7KO mice.
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Figure 2-13. Normal ambulatory activity and shock sensitivity in Kal7KO mice
A. Kal7KO (KO), Kal7+/KO (Het) and Wt mice were observed in the open field apparatus
for 60 min (N= 9 Wt; 7 Het; 6 KO). Genotype had no effect on total locomotor activity
(ambulatory counts) (p=0.577; ANOVA). B. The sensitivity of the mice to a graded
series of footshocks was determined by monitoring vocalization (Vocal.), flinching and
jumping in response to increasing shock intensity. No differences related to genotype
were observed. N=8 Wt; 7 KO.
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Figure 2-14. Membrane properties of Wt and Kal7KO mice
A. Resting membrane potential and action potential threshold were similar in Wt and
KO cells. B-C. For the 100 pA, 200 pA and 300 pA injections, average values for the
number of action potentials in the 100 msec step (B) and latency to fire the first spike
(C) are plotted. KO cells only fired significantly more action potentials in the 100 pA
step (p=0.0499). KO cells fired the first spike significantly sooner in the 200 pA and
300 pA steps (p=0.0021 and p=0.0045, respectively). D. There was no significant
difference in spontaneous EPSC amplitude. E. There was no difference in the
amplitude of evoked EPSCs recorded for baseline values in LTP experiments. F.
There was no difference in the stimulation strengths used to elicit those responses.
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Figure 2-15. PSD preparation protocol and Rac activity assays
The protocol used to prepare PSDs from wildtype and Kal7KO mice is illustrated. Two
independent preparations of PSDs from both cortex (n=3) and hippocampus (n=2) of
wildtype and Kal7KO mice were examined. Tissue from wildtype and Kal7KO mice
fractionated in an indistinguishable manner. B. Equal amounts of protein (5 µg) from
P3 (ER/Golgi), LP2 (synaptic vesicles, SVs), TX-100 solubilized PSD proteins (TX
Sol) and TX-100 insoluble PSD proteins (TX InSol) were resolved on 4-15% Criterion
gradient gels (BioRad Laboratories, Hercules CA). NR2B, 166 kDa; GluR1, 100 kDa;
PSD-95, 95 kDa; Synaptophysin, 38 kDa; Rac1, 21 kDa. C. Levels of Rac-GTP were
assessed in lysates (“Tissue”) and crude synaptosomes prepared from parietal
cortex of Wt and Kal7KO mice (n=3 each) using GST-Pak-CRIB as described in
Methods.
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Figure 2-16. Kal7KO does not affect morphology of immature neuronal cultures
Cortical cultures prepared from P1 Wt and KO mice were examined at DIV7 (A),
DIV14 (B) and DIV21 (not shown). After methanol fixation, antibodies specific to
Map2 (Blue), Vglut1 (Green) and either Kal7 (red; left side) or PSD-95 (red; right
side) were applied simultaneously. At DIV7 (A), Kal7 was not detected in the
dendrites of Wt or Kal7KO mice, and Vglut1 positive excitatory presynaptic terminals
were present in similar numbers in both. Similar numbers of Vglut1-PSD-95 positive
synapses were observed in the dendrites of Wt and Kal7KO mice at DIV7 (A, right
side). At DIV14 (B), low levels of Kal7 were detected in some Wt synapses; the
dendrites of Kal7KO neurons were devoid of staining. A similar number of Vglut1
positive presynaptic terminals were apposed to the dendrites of DIV14 Wt and Kal7KO
neurons (B, left side). By DIV14, both Wt and Kal7KO neurons had acquired more
PSD-95/Vglut1 positive clusters than present at DIV7 (B, right side). In both Wt and
Kal7KO neurons, PSD-95 clusters were almost always aligned with Vglut1 clusters,
marking excitatory synapses. C. Vglut1 clusters, PSD-95-Vglut1 clusters and Vglut1
clusters lacking PSD-95 were quantified at DIV14 (C1, C2) and DIV21 (C3, C4) in Wt
and Kal7KO neurons; no significant differences were apparent at either time.
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Chapter 3: Behavioral and morphological responses to
cocaine require Kalirin-7
This chapter is a duplicate version of a published manuscript: Kiraly D.D., Ma X.-M.,
Xin X., Mains R.E., Eipper B.A. (2010). Behavioral and morphological responses to
cocaine require Kalirin-7. Biol. Psychiatry. 68(3), 249-55.

Abstract
Long-lasting increases in dendritic spine density and gene expression in the
nucleus accumbens and in the ambulatory response to cocaine occur following
chronic cocaine treatment. Despite numerous reports of these findings, the molecular
mechanisms leading to these morphological, biochemical and behavioral changes
remain unclear. We used mice genetically lacking Kalirin-7 (Kal7KO), a Rho-GEF
which regulates dendritic spine formation and function. Both wildtype (Wt) and Kal7KO
mice were given high dose cocaine (20 mg/kg) for four or eight consecutive days.
Locomotor sensitization and conditioned place preference elicited by cocaine were
evaluated. The nucleus accumbens core was diolistically labeled and spine density
and morphology were quantified using confocal microscopy. Cocaine increased
Kalirin7 mRNA and protein expression in the nucleus accumbens of Wt mice. Kal7KO
animals showed greater locomotor sensitization to cocaine than Wt mice. In contrast,
Kal7KO mice exhibited decreased place preference for cocaine, despite displaying a
normal place preference for food. While Wt mice showed a robust increase in
dendritic spine density after four and eight days of cocaine treatment, dendritic spine
density failed to increase in cocaine-exposed Kal7KO mice. Wt mice treated with
cocaine for eight days exhibited larger dendritic spines than cocaine-treated Kal7KO
mice. Kalirin7 is an essential determinant of dendritic spine formation following
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cocaine treatment. The absence of this single isoform of one of the many Rho-GEFs
expressed in the nucleus accumbens results in enhanced locomotor sensitization and
diminished place preference in response to cocaine.
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Introduction
Drug addiction is a recalcitrant condition affecting millions of families
worldwide. Drugs of abuse are thought to co-opt normal learning and plasticity
mechanisms and permanently alter the structure and function of the brain10. Over the
past two decades a number of candidate pathways have emerged that may support
these lasting changes. The transcription factor ΔFosB remains elevated at least one
month following cocaine treatment in rodents, and levels of ΔFosB dictate behavioral
responses to cocaine176. Similarly, recent work has shown that GluR1-containing
AMPA receptors are trafficked to synapses throughout extended withdrawal periods
and that this membrane trafficking has effects on the behavioral response to
cocaine114. One of the most consistently reported and longest-lasting changes in
animal models of drug addiction is an increase in dendritic spine density in the
nucleus accumbens (NAc)189. In rats these increases in spine number persist up to
3.5 months following drug administration159. A recent study by Shen and colleagues
found that, while cocaine withdrawal itself did not alter spine density, the increase in
spine density in response to a cocaine injection was more rapid in cocaine withdrawn
rats, compared to saline-treated rats160. Despite repeated findings of alterations in
NAc spine number and morphology, the molecular mechanisms underlying the
morphological changes and their physiological significance remain elusive.
Rho-GDP/GTP exchange factors (Rho-GEFs) are known to play critical roles
in spine morphogenesis131,268. Kalirin is one of 31 Rho-GEFs expressed at significant
levels in the NAc of the adult mouse and one of 10 Rho-GEFs localized to the PSD70.
Kalirin7 (Kal7), the Kalirin splice variant most prevalent at the PSD, regulates
dendritic spine morphogenesis in vitro193,202 and in vivo260 (Figure 3-1A). Examination
of the CA1 region of the hippocampus in Kal7 knockout mice (Kal7KO) revealed a
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decrease in linear spine density260. These mice exhibited abnormal fear learning as
well as decreased anxiety-like behavior, yet maintained normal radial arm maze and
object recognition learning260. The deficit in hippocampal dendritic spine density in
these animals resulted in specific losses of function. Given the role that dendritic
spine alterations may play in cocaine-mediated behaviors, we explored the possibility
that chronic cocaine treatment would affect spine morphology differently in Wt and
Kal7KO animals. If so, this would provide a model system to begin to explore both the
molecular mechanisms underlying the morphological changes observed in cocaine
addiction and their functional consequences.
In this study we probed the morphological and behavioral responses of Wt
and Kal7KO animals to chronic cocaine treatment. Unlike Wt mice, Kal7KO animals
showed no increase in spine density following either a four or eight day course of
cocaine administration. Additionally, Kal7KO animals exhibited abnormal spine
morphology after the longer cocaine treatment. Behaviorally, the Kal7KO animals
were hypersensitive to the locomotor sensitizing effects of cocaine but showed a
decrease in conditioned place preference for cocaine, despite their normal place
preference for food.
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Materials and Methods
Animals
For these experiments, all Kal7KO mice had been back-crossed into C57BL/6J
(Jackson Labs) for at least four generations260; further breeding to greater than 10
generations into BL6 has not altered biochemical or behavioral outcomes. As with all
back-crossed knockout lines, fragments of 129 genome remain in these largely
C57BL/6J mice269. Since the deleted Kal7 exon is 507 kb and 193 kb distant from the
immediately adjacent genes, the possibility that a polymorphism at a locus near the
Kal7 exon accounts for our results is slight269. All animals were housed in the UCHC
animal facility on a 12 hour light/dark cycle with food and water ad lib except as
noted. All procedures were in accord with the guidelines of the UCHC IACUC.

Behavioral Experiments
Animals were allowed to acclimate to the behavior room for one hour before the start
of training or testing. All animals were male littermates between 60-80 days old at the
start of testing. Each experimental group included 6-12 animals, with the exception of
the Latin-square cocaine and place preference Saline groups, which had five animals
per genotype.
Locomotor Sensitization
Procedures for sensitization experiments were adapted from published
methods203. To minimize stress and establish baseline activity, animals were injected
with saline for four days with their locomotor activity monitored. On subsequent days,
animals received cocaine (National Institute of Drug Abuse, Bethesda, MD)
immediately before the 60 min locomotor monitoring. Animals had their locomotor
activity monitored for the first five days of cocaine to ensure the development of
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sensitization and then received two additional injections in their home cages. To test
for the persistence of sensitization, animals were returned to the colony room for one
week before receiving a challenge dose of cocaine.
Conditioned Place Preference
A San Diego Instruments apparatus (San Diego, CA) was modified such that
the two large chambers had different patterns on the walls and different textures on
the floors, making them readily distinguishable. On day one, individual animals were
placed in the central walkway with both doors open and allowed to explore freely for
20 minutes. The least preferred side on this pre-test day became the cocaine or foodpaired side. For four days, animals were conditioned for 15 minutes after a saline
injection in the morning and after a cocaine injection in the afternoon. On the final
day, the animals were again allowed to freely explore all chambers for twenty
minutes. The amount of time spent on the cocaine paired side on the test day
compared to the pretest day was used as the index of preference.
For food preference, the animals were food deprived for 5 days before the
start of training; their weights dropped to ~85% of free-feeding. For conditioning, one
side of the chamber was paired with a petri dish full of grain reward pellets (BioServ,
Frenchtown, NJ) while the other was paired with an empty dish. Animals received 5
fifteen-minute sessions on each side on the same schedule as cocaine conditioning
and were then given a 20 minute test similar to the cocaine animals.

Morphology
Animals for morphology
For study #1, mice (N=4/group) were given eight injections of 20mg/kg
cocaine or saline and were then anesthetized using ketamine and perfusion fixed 30
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minutes after the final dose of cocaine. For study #2, mice (N=3/group) were given 4
daily injections of cocaine (20mg/kg) or saline and perfusion fixed 30 minutes after
the final injection. For both morphology studies, animals were brought into the
behavioral suite and injected in empty rat cages which had been cleaned with a
scented detergent, to allow association of cocaine with a unique context, mimicking
the injection conditions used in the behavioral studies.
Tissue Processing
All mice were perfusion fixed with 4% paraformaldehyde followed by 1 hour of
post-fixation in 4% paraformaldehyde260. Slices (100µm) containing the NAc were
made using a vibratome and were then diolistically labeled using a Gene Gun
[Biorad, Hercules CA]36,270. A side-by side comparison of several different perfusion
and post-fixation conditions (comparing 1.5% and 4% PFA with post-fixation times of
1 to 24 hours) was performed, as an effect of fixation strength on DiI diffusion has
been reported271. In agreement with the majority of the literature, fixation with 4% PFA
followed by post-fixation for 1 hour in 4% PFA yielded the clearest images with the
most readily visible spines36,272-274. Neurons fixed with 1.5% and 4%
paraformaldehyde are compared in Fig. 3-7. After ballistic labeling, the dye (DiI;
Invitrogen, Carlsbad, CA) was allowed to fill the processes for 2 hours before
imaging.

Image Acquisition
Images of medium spiny neurons were taken using a Zeiss LSM 510 Meta
confocal microscope. The NAc core was identified using the anterior commissure as
an anatomical landmark, and medium spiny neurons within the core were identified
by their morphology. Sections of dendrites (50µm) were imaged 75-125µm from the
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soma and after at least one dendritic branch point. Each final image consisted of a zstack of pictures taken at 0.3 µm steps through the dendrite.
Image Analysis & Spine Measurements
Collapsed z-stack images were coded; images were then scored by a blinded
observer. Quantification of spine density, spine length, and spine area was performed
using MetaMorph193,260. Any spines for which the base and tip were not clearly visible
were excluded from length and area measurements, but were included in the spine
density measurements.
Spine length was defined as the length from the base of the spine to the
farthest point, drawn using the straightest line, or pair of lines, possible. To measure
spine area accurately, the methods of Svoboda and coworkers and Yuste and
coworkers were adapted268,275. First, z-stack images were processed using the
nearest neighbor 2D deconvolution function in MetaMorph. Following deconvolution,
the stack was collapsed to a single image using the maximum intensity function. This
collapsed image was opened in ImageJ and the dendritic shaft, partially occluded
spines, and extraneous background signal were carefully removed using the polygon
selection tool. The image was then opened in MetaMorph and an inclusive threshold
was adjusted to outline spines. Lastly, the create regions around objects tool was
used to automatically trace the thresholded regions. A graphical depiction of this
process is shown in Fig. 3-8.
For ANOVA analyses, the average density and length for spines on a single
dendrite was considered to be an N of 1 (range = 27-86 spines per 50 µm image). For
analysis of spine area using the Kolmogorov-Smirnov function, each individual spine
was used as a data point276. This type of analysis allows for equal weight to be given
to each spine and is not biased by dendrites with more or fewer spines.
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Biochemistry
For biochemical quantification of Kal7 in the NAc, animals were treated for 7
days with 20mg/kg cocaine. Twenty-four hours after their final injection the animals
were decapitated and a punch was taken from a coronal section (2 mm thick) that
included the NAc core. For Western blotting, tissue was sonicated in 1% SDS lysis
buffer and analyzed on a 4-20% Tris glycine gel (Invitrogen)260. For qPCR, tissue
samples were homogenized in Trizol (Invitrogen), RNA was prepared following the
manufacturer’s instructions, and cDNA was prepared using random primers (Table 31) and either Superscript II Reverse Transcriptase (Invitrogen) or the iScript Select
cDNA Kit (Bio-Rad). Quantitative polymerase chain reaction (qPCR) was performed
with iQ SYBR Green supermix, using an Eppendorf Mastercycler ep realplex
machine, with the standard program except that elongation time per cycle was 40
sec.

Statistics
Statistical analyses were performed using Microsoft Excel and SPSS
software. Behavioral analyses were performed using one-way, two-way or repeatedmeasures ANOVA as appropriate. Quantification of Western blots and q-PCR was
performed using unpaired t-Tests. Cumulative distribution plots for spine morphology
were analyzed using the Kolmogorov–Smirnov test, all measures of spine density and
morphology were also analyzed using two-way ANOVAs. The qPCR data for each
sample were normalized to GAPDH, with ratios for cocaine treated animals
expressed as a % of ratios for saline treated animals.
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Results
Repeated treatment with cocaine increases Kal7 levels in the NAc
Chronic treatment of laboratory animals with cocaine increases dendritic spine
number in the NAc189,277. Kal7 plays an important role in dendritic spine formation and
maintenance in cultured neurons193 and in the hippocampus of mice260, but is only
one of many Rho-GEFs expressed in the NAc70. To test the hypothesis that Kal7
could be involved in the formation of new dendritic spines following cocaine
administration, we gave Wt mice injections of 20mg/kg cocaine once daily for one
week and examined protein and RNA expression 24 h after the final injection. This
dosing regimen increased levels of Kal7 protein (t21= -2.60, p=0.016) (Fig. 3-1B) and
mRNA (t6= -2.49, p=0.047) (Fig. 3-1C) in the NAc. Adult male rats responded to
chronic cocaine (20 mg/kg for 8 days) with similar increases in Kal7 mRNA and
protein (data not shown).

Kal7 plays an important role in cocaine-induced spine plasticity
The finding that Kal7 levels increased in the NAc after one week of cocaine
injection suggested that Kal7 might be essential for the previously reported increases
in dendritic spine density189,277. To test this hypothesis, we gave Wt and Kal7KO mice
injections of saline or 20mg/kg cocaine once daily for eight days and examined them
30 min after the final injection. We selected this treatment time and post-injection time
to correlate to induction of behavioral sensitization, an approach that has previously
been reported to increase NAc spine density158. In saline treated animals, linear spine
density was indistinguishable in the NAc of Wt and Kal7KO mice (Fig. 3-2A,B,E).
Following eight days of cocaine treatment, Wt animals displayed an increase in
dendritic spine density similar in magnitude to the increases observed with longer
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Figure 3-1. Chronic cocaine induces increased Kal7 expression in the NAc of
Wt mice.
A. The structure of Kal7 is diagramed250 and the locations of the antibody site
(JH2959;194) and the quantitative polymerase chain reaction (qPCR) primers are
indicated. Twenty-four hours following 7 days of cocaine (20mg/kg) or saline
injections, Kal7 protein (B; normalized to βIII tubulin – p=0.016) and mRNA (C;
normalized to GAPDH – p=0.047) were significantly elevated. Primers used are listed
in Table 3-1.
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Figure 3-2. Kal7 modulates morphological effects of cocaine in NAc.
A.-D. Representative DiI labeled dendrites from NAc core after treatment of Wt and
Kal7KO mice with saline or cocaine (20mg/kg) for eight days, as shown below the
images. Scale bars are 5µm. E. Dendritic spine density in the NAc was increased
following cocaine treatment of Wt but not Kal7KO animals. Two-way ANOVA yields
main effects of genotype (p<0.0001) and drug (p<0.0001) as well as a drug x
genotype interaction (p=0.004). F.-H. Quantification of dendritic spine area in Wt and
Kal7KO animals after treatment with cocaine or saline. F. Kolmogorov-Smirnov
analysis of cumulative distribution plots of spine areas shows a main effect of
genotype at baseline, with Kal7KO animals exhibiting larger spines (p<0.005) Similar
analysis shows a main effect of treatment in both genotypes with Wt spines
increasing in size (G. p<0.05) and KO spines decreasing in size (H. p<0.005) [N=235295 spines/group].
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treatment paradigms (Fig. 3-2A,C,E)36,157. In contrast, Kal7KO animals showed no
increase in dendritic spine density following eight days of cocaine treatment (Fig. 32B,D,E). Two-way ANOVA analysis showed main effects of genotype (F1,73=13.537;
p<0.0001) and treatment (F1,73=14.069; p<0.0001) as well as a significant genotype x
treatment interaction (F1,73=8.815; p=0.004). Kal7 is thus one of the few proteins
demonstrated to be essential for cocaine-induced increases in dendritic spine density
in vivo171,173,186.
In addition to linear spine density, we examined dendritic spine length and
area in this group of animals, as these parameters are known to be determinants of
synaptic function103. The effects of cocaine on spine structure in rats are timedependent160; data for animals sacrificed 30 minutes after the final dose have not
been reported. Analysis of dendritic spine length demonstrated a main effect of
genotype (F1,48=23.00; p<0.0001, two-way ANOVA) (Fig. 3-9) but no effect of
treatment (F1,48=2.01; p=0.163) or genotype by treatment interaction (F1,48=0.09;
p=0.760). To examine changes in spine area, data were plotted using KolmogorovSmirnov cumulative distribution plots, as this is the least
biased and most detailed way to examine a large and variable population. In this
approach, each spine is weighted equally, diminishing the influence of dendrites with
more or fewer measurable spines. Interestingly, Kal7KO animals demonstrated
significant increases in spine size at baseline (p<0.005) (Fig. 3-2F) However, the
prolonged cocaine treatment produced opposite effects on spine size between
genotypes. While Wt animals showed an increase in spine size after cocaine
treatment (p<0.05) (Fig. 3-2G), the Kal7KO animals showed a marked decrease in
spine size (p<0.005) (Fig. 3-2H). Recent data have suggested that spine number
and size increase following learning or LTP induction stimuli, and larger spines have
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greater surface area for the expression of receptors and other signaling
molecules103,120,121,278. While the Kal7KO animals do have larger spines at baseline, the
lack of new spine formation and shrinkage of existing spines may be indicative of
disrupted synaptic plasticity in these mice.

Kal7 is essential for behavioral plasticity in response to cocaine
Locomotor Behavior
Given the altered morphological plasticity and lack of increase in spine
number in the Kal7KO animals, we examined what effect this might have on the
behavioral response to cocaine. Initially we examined a range of acute cocaine doses
and measured open field locomotor activity to determine the response of Kal7KO mice
to acute cocaine. Dose-response studies were performed using a randomized Latinsquare cross-over design187. Briefly, after one day of habituation to the locomotor
boxes, the animals were given a single injection of cocaine in a randomized order and
locomotor activity was measured for 45 minutes
after the injection (Fig. 3-3). As expected, there was a strong effect of treatment
(F5,40=566.29; p<0.0001, two-way RM ANOVA). Interestingly however, there was no
effect of genotype (F1,40=1.13; p=0.318) and no genotype x treatment interaction
(F5,40=1.42; p=0.267).
Given that addiction is a chronic condition that develops over time, and that
the majority of the literature on dendritic spine changes following cocaine treatment is
after a prolonged treatment with cocaine, we examined whether the Kal7KO animals
would exhibit abnormal locomotor behavior in response to repeated cocaine injection.
For this locomotor sensitization assay, animals were first given four daily injections of
saline to allow them to habituate to the locomotor apparatus and injections.

101

Figure 3-3. Lack of Kal7 does not affect acute locomotor response to cocaine.
Using a randomized cross-over Latin-square design, Wt and Kal7KO animals were
given the indicated doses of cocaine and examined in the open field. Two-way RM
ANOVA revealed a main effect of treatment (p<0.0001) but no effect of genotype
(p=0.318) or genotype x treatment interaction (p=0.267) [N=5/group].
(F5,40=566.29; p<0.0001, two-way RM ANOVA). Interestingly however, there was no
effect of genotype (F1,40=1.13; p=0.318) and no genotype x treatment interaction
(F5,40=1.42; p=0.267).
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Locomotor activity was monitored for one hour after injection on each day of
the treatment. While there was a main effect of day (F3,20=5.65; p=0.028, two-way RM
ANOVA) there was a stable but insignificant trend towards a genotypic effect during
saline injections (F1,20=3.23, p=0.09) (Fig. 3-4A left). However, when the animals
were given a sensitizing dose of cocaine, the Kal7KO animals began to exhibit a
robust increase in their locomotor activity. Examination of the locomotor response to
cocaine over 5 days yielded main effects of day (F4,20=10.64; p=0.004, two-way RM
ANOVA) and genotype (F1,20=7.72; p=0.01) but no day by genotype interaction
(F1,20=1.45; p=0.24). To examine the differences between genotypes more
thoroughly, we examined the timecourse of the locomotor response during each day
of cocaine as well as the final day of saline (Fig. 3-4B). In this analysis there was a
main effect of time on all days except cocaine day 1 (F5,20=47.45, 18.35, 19.30, 9.94;
all p≤0.005 – in chronological order) and a main effect of genotype on days 2-4 of
cocaine (F1,20=7.77, 7.84, 6.64; all p≤0.018), but not on the final saline day or first day
of cocaine. As a control, we examined levels of stereotypies in these animals, and
found no significant difference between genotypes (Fig. 3-10). Taking these and the
Latin-square data together, it is clear that the Kal7KO animals display an increased
locomotor sensitization response to repeated doses of cocaine, but do not show a
difference at any acute dose.
While the previous experiment tested the development of sensitization, we
next wanted to examine the persistence of sensitization in Kal7KO animals. Given their
altered spine plasticity, it seemed possible that sensitization would not persist. To test
the persistence of sensitization, all animals were returned to their home cages for one
week of abstinence before the test injection. The animals were then returned to the
behavior room and tested for their locomotor response to a single cocaine injection
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Figure 3-4: Kal7 is essential for the normal locomotor sensitization response to
cocaine.
A left. Wt and Kal7KO animals have similar locomotor responses to treatment with
saline (p=0.09), but show a large genotypic difference in their response to repeated
cocaine injections (p=0.01). A right. Animals that had been sensitized to cocaine
were allowed to withdraw for one week before being given a single challenge injection
of cocaine. Kal7KO mice showed elevated responding compared to Wt mice on this
day (p=0.007), and showed similar levels of locomotion to the final days of the
sensitization regimen. B. A breakdown of the ambulatory response time course on
the indicated days shows the increasing separation between Wt and Kal7KO animals
over repeated days of cocaine treatment. Main effect of genotype on days 2-4 of
cocaine (p≤0.018 for each); (*p<0.02, **p≤0.01) [N=10-12/group].
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(20mg/kg) (Fig. 3-4A right). On this day, Kal7KO animals responded at a higher level
than Wt (F1,20=9.09; p=0.007, one-way ANOVA), and displayed levels of locomotor
activity similar to those of the final days of the initial sensitization period. Mice lacking
this single Rho-GEF develop and maintain cocaine locomotor sensitization at a level
higher than their Wt littermates.
Conditioned Place Preference
In addition to locomotor sensitization testing, we also tested the ability of the
animals to form an association between a context and the reinforcing properties of
cocaine, widely considered to be an essential component of addiction173,187,210. Wt
animals showed the expected preference for cocaine (Fig. 3-5 left). Although the
Kal7KO animals showed a preference for cocaine, the magnitude of their preference
was markedly reduced for both 10mg/kg (F1,13=6.58; p=0.025) and 20mg/kg
(F1,15=5.88; p=0.029) cocaine (Fig. 3-5 left). The Kal7KO animals were not hyperactive
on the test day, which could have confounded the finding of decreased preference
(Fig. 3-11). The many other RhoGEFs expressed in the NAc cannot substitute for Kal7 in the pathways involved in
this behavioral response.
Due to the alterations in synaptic architecture displayed in naïve and cocainetreated Kal7KO mice (Fig. 3-2), we considered the possibility that the Kal7KO animals
might simply be incapable of forming an association between reward and context. To
test this possibility, we performed the place preference assay with a different cohort
of mice, using food rather than drug as the unconditioned stimulus. In this task, both
Wt and Kal7KO mice showed a robust and equal preference for the food paired side
(F1,12=0.23; p=0.64) (Fig. 3-5 right). In several other studies, knockout animals have
displayed abnormal drug seeking behavior, yet normal learning for food seeking167,208.
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Figure 3-5: Kal7 is essential for formation of cocaine place preference.
In a conditioned place preference test carried out on the schedule indicated, mice of
both genotypes exhibited a significant preference for the cocaine-paired side, with the
response of Kal7KO mice substantially attenuated compared to littermate controls at
both 10 and 20mg/kg cocaine (Middle; p=0.025 for 10mg/kg; p=0.029 for 20mg/kg).
When food was used as the unconditioned stimulus, both genotypes formed an equal
preference for the food paired chamber (Right; p=0.64) indicating that the difference
between Wt and Kal7KO mice was specific to drug preference. Animals injected with
saline only did not form a preference for either chamber (Left). (*p<0.05; **p<0.01
ANOVA) [N=6-10/group].
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These learning behaviors, which are both dependent on proper striatal function,
clearly utilize distinct pathways.

Cocaine alters spine number within four days
Given that Kal7KO mice and Wt mice exhibited a difference in cocaine place
preference after only four days of exposure to drug, we also examined dendritic spine
density and morphology after four days of cocaine treatment. Examination of spine
density in these neurons revealed a very similar pattern to that seen after eight days
of cocaine treatment (Fig. 3-6A-E). Spine density was significantly increased in Wt
animals whereas Kal7KO animals showed no increase. Statistical analysis revealed a
main effect of genotype (F1,35=9.33; p=0.005) as well as a genotype x treatment
interaction (F1,35=10.67; p=0.003) but no main effect of treatment. Comparison of
these 4 day treated animals (left bars) to the 8 day treated animals (right bars,
repeated from Fig. 3-2) showed that the spine densities did not differ between the two
treatments (Fig. 3-6E). In addition to spine density we also examined spine length
and area. Measurements of length revealed no main effects (Fig. 3-9). KolmogorovSmirnov analyses of spine area showed the same effect of genotype in the saline
treated animals (Fig. 3-6F and 3-2F), but no effect of the shorter cocaine treatment in
either genotype (Fig. 3-6G,H).
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Figure 3-6: NAc spine morphology after 4 days of cocaine
A-D. Representative images are shown; scale bars are 10µm. The treatment
paradigm used is indicated below the images. E. Dendritic spine density was
quantified as described in Fig. 2E. A two-way ANOVA revealed a main effect of
genotype (p=0.005) as well as a genotype x treatment interaction (p=0.003). Spine
density data from Fig.2E (8 day) are replotted for comparison. F. KolmogorovSmirnov cumulative distribution analysis shows the same effect of genotype at
baseline in these animals. G,H. However, the shorter cocaine treatment produced no
main effect of treatment on spine area in either genotype [N=321-442 spines/group].
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Discussion
Morphology
Kal7 expression in the NAc increased following chronic exposure to cocaine
(Fig. 3-1). Since expression of exogenous Kal7 increased spine density in cultured
cortical194 and hippocampal193 neurons, we predicted an essential role for Kal7 in the
morphological response to cocaine. Pyramidal neurons in the CA1 region of the
hippocampus of Kal7KO mice exhibited decreased spine density260. In the NAc, spine
density was indistinguishable in Wt and Kal7KO mice at baseline. While Wt animals
showed the expected increase in spine density in the NAc after 4 or 8 daily injections
of cocaine, spine density was unaltered in Kal7KO mice (Figs. 3-2, 3-6). Taken
together, our data identify Kal7 as an essential mediator of the cocaine-induced
increase in NAc spine density.
In addition to its effects on spine density, Kal7 affects spine
morphology193,232,260. Kal7KO animals displayed larger spines at baseline, a
phenomenon that may reflect compensation by other Rho GEFs at the PSD. It is
noteworthy spine plasticity can change following a single acute injection of cocaine160.
Since our animals were fixed 30 minutes after the final cocaine injection, some of the
observed alterations in spine shape could be due to the acute effects of cocaine.
Most interesting to this study, however, is how the spines of the two genotypes
responded to cocaine. Neither genotype exhibited an increase in spine area after four
days of cocaine. While Wt mice exhibited an increase in spine size after eight days of
cocaine treatment (Fig. 3-2G); spine size was reduced in Kal7KO mice (Fig. 3-2H).
Spines lacking Kal7 displayed an aberrant response to chronic stimulation and were
unable to display the same plasticity exhibited by spines with their full complement of
Kal7. Given the links that have been made between spine size and synapse
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strength103,106,127, this type of disrupted plasticity may play a role in the altered
behaviors seen in the Kal7KO animals.
Increased cycling of the actin cytoskeleton occurs following cocaine
administration155. As a GEF for the small GTPase Rac1, Kal7 is an important
modulator of the actin cytoskeleton and its absence would be expected to alter
cytoskeletal dynamics. Cdk5, which forms a complex with activated Rac and Pak, a
downstream target of Rac, plays an essential role in cocaine-induced morphological
plasticity185-187,205. Cdk5 phosphorylates Kal7, increasing its GEF activity232. Kal7
mutated to block phosphorylation at its only Cdk5 target site still increases spine
formation, but the new spines formed are smaller than normal spines. PSDs
prepared from the cortex of Kal7KO mice contained decreased levels of Cdk5260,
suggesting that the impaired spine morphogenesis observed in the NAc of Kal7KO
mice may reflect both the absence of Kal7 and diminished Cdk5 function.

Behavior
These studies shed new light on the potential behavioral roles of altered
dendritic spine density and morphology following cocaine. It is interesting that animals
such as the Kal7KO mice, which show decreased synaptic plasticity, also show
increased locomotor sensitization to cocaine. In MEF2 over-expressing mice,
increased behavioral sensitization to cocaine was also accompanied by decreased
spine density171. Additionally, intra-NAc infusions of a Cdk5 inhibitor, roscovitine,
reduced cocaine-induced dendritic spine formation186 and potentiated the locomotor
response to cocaine205. These studies all suggest that increased spine density serves
as a homeostatic adaptation tempering the psychomotor activation that follows
repeated cocaine exposure; by removing factors that contribute to homeostatic
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adaptation, the animal may become hypersensitive to repeated doses of cocaine.
One theory is that increased glutamatergic signaling from the PFC following chronic
cocaine treatment imbalances the NAc circuitry6. In response, the NAc may undergo
a type of synaptic redistribution279 as a form of homeostatic plasticity to prevent the
entire neural network from being destabilized. While we are certainly not the first to
suggest this theory171,280, our findings lend strong credence to this idea.
In animal models of drug addiction, increases in locomotor sensitization and
conditioned place preference have long been used to evaluate the effect of factors
that contribute to addiction. One of the most informative results of this study is the
observation that eliminating Kal7 expression has distinctly different effects on these
two behavioral responses to cocaine. While both of these behaviors are heavily
reliant on synaptic transmission in the NAc29,281, both behaviors are also driven by
systems-wide processes. As a direct comparison, we examined the behavior of the
Kal7KO animals in a radial arm maze task and contextual fear conditioning260; both
behaviors rely heavily on normal hippocampal functioning. The Kal7KO animals
showed perfectly normal learning curves in the radial arm maze but showed an
inability to consolidate fully a context-fear memory. Our results with cocaine provide
another example of how behaviors thought to rely on similar structures must be
regulated by distinct pathways within those structures. Future studies of Kal7
interactions and functions at the PSD should clarify some of these mechanisms.
Interestingly, the Kal7KO animals showed a markedly decreased place
preference for cocaine yet normal place preference for food. Thus Kal7-dependent
plasticity is necessary for cocaine, but not food, to have its full reinforcing value.
Intriguingly, animals that learn to self-administer cocaine demonstrate an increase in
spine density in the NAc, while animals performing the same task for food reward
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show no change in spine density168. Since alterations in spine density are widely
considered to underlie normal learning, increased spine density may be essential for
the “learned” drive to seek drugs of abuse28. While we cannot directly demonstrate
that lack of Kal7 leads to a decrease in drug craving, we have shown that its absence
does affect the place preference for cocaine, a behavior thought to be correlated to
drug seeking.
While the alterations in dendritic spines are a striking feature of the Kal7KO
animals, it is important to bear in mind that other adaptations in these mice may
contribute to these behavioral findings. In particular, Kal7KO animals exhibit decreased
PSD levels of Cdk5 and NR2B260. Cdk5 has been shown to have a wide ranging role
in cocaine-mediated behaviors185,261, and decreases in Cdk5 levels or activity lead to
enhanced sensitization and altered place preference behaviors187,205. Additionally,
inhibition of NR2B signaling leads to a sensitized response to amphetamine282, and
disrupts morphine conditioned place preference112. Kal7 is normally intercalated into
the PSD, which is a finely tuned molecular machine. It is likely that Kal7 interacts with
numerous other components of the PSD, and that deletion of Kal7 leads to decreases
or mislocalization of other components that are important for drug-induced behaviors.

Conclusion
Numerous studies have suggested that changes in spine number and size
underlie new learning103 and that drug addiction is simply a corruption of normal
learning mechanisms10. This study identifies Kal7 as an essential modulator of this
pathological plasticity and provides a new model system, the Kal7KO mouse, with
which to explore the diverse roles of the dendritic spines that form anew and change
shape following cocaine treatment.
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Figure 3-7: Comparison of fixation conditions.
Due to literature suggesting that fixation strength may affect ability to visualize spines,
two conditions were compared. A. Representative DiI labeled neurons from the
nucleus accumbens and CA1 region of the hippocampus fixed with 4% or 1.5%
paraformaldehyde. B. Low power images of nucleus accumbens slices fixed under
the two conditions. A similar density of labeled neurons and processes is visible in
both.
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Figure 3-8: Graphical depiction of our method for measuring planar spine area.
To achieve the most accurate measurements of spine area from collapsed z-stack
images (1) we first performed a nearest neighbor deconvolution which sharpened the
edges of the shaft and spines (2). To allow MetaMorph to accurately identify each
spine, the dendritic shaft was manually excised from the image using the ImageJ
program (3). Finally, in MetaMorph, the images were thresholded such that the spines
were filled and traces were automatically drawn around each spine (4).
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Figure 3-9: Spine length analysis.
Following the 8-day cocaine treatment there was a main effect of genotype
(F1,48=23.00; p<0.0001, two-way ANOVA) but no effect of treatment (F1,48=2.01;
p=0.163) or genotype by treatment interaction (F1,48=0.09; p=0.760). Following the
four day treatment there were no main effects. A comparison of the Saline data from
Wt and KO mice in the two experiments shows that there were opposite insignificant
differences between the 8-day and 4-day samples. These trends are the reason for
the genotype effect in the eight day but not four day experiment. Upper Brackets: ###
p <0.001 2-Way ANOVA. Lower Brackets: ***p<0.001 1-Way ANOVA, NS = Not
Significant.
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Figure 3-10. Sterotypy analysis
Analysis of the automated stereotypy counts (fine motor counts) revealed no
difference between Wt and Kal7KO mice either across days (RM ANOVA F(1,19)=
0.472; p=0.4) or on any individual day (all days p>0.245). Video analysis of a subset
of animals corroborated these findings. “Fine motor counts” is a measure employed
by our locomotor analysis software. It is loosely defined as repeated breaks of the
same beam as would be seen with stereotypy, rather than the breaking of
consecutive beams as would be seen with locomotion.
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gene

primer

sequence

nt

(oC)

name
mGAPDH

Tm

mGAPDH-

61

119

TTGTCAGCAATGCATCCTGCACCACC
for
NM_008084.2

mGAPDH-

61
CTGAGTGGCAGTGATGGCATGGAC

rev
mKalirin-7

KalSpec-for

XP_899566.1

KalSpec-

GCCTTTCTCAGCAAACACACTGGGG

61

156

61
ATTCCCCAGTCTGAGCCAGCTGC

rev

Table 3-1. Primers used for qPCR analysis
Primer pairs for Kalirin7 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
were chosen to give 119-156 nt products and primer Tm of 61oC. Maximal rates of
amplification of products for every primer pair were 2.01 + 0.08 per cycle.
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Abstract
The ability of dendritic spines to change size and shape rapidly is critical in
modulating synaptic strength; these morphological changes are dependent upon
rearrangements of the actin cytoskeleton. Kalirin-7 (Kal7), a Rho guanine nucleotide
exchange factor (GEF) localized to the postsynaptic density (PSD), modulates
dendritic spine morphology in vitro and in vivo. Kal7 activates Rac and interacts with
several PSD proteins including PSD-95, DISC-1, AF-6 and Arf6. Mice genetically
lacking Kal7 (Kal7KO) exhibit deficient hippocampal LTP as well as behavioral
abnormalities in models of addiction and learning. Purified PSDs from Kal7KO mice
contain diminished levels of NR2B, an NMDA receptor subunit that plays a critical
role in LTP induction. Here we demonstrate that Kal7KO animals have decreased
levels of NR2B-dependent NMDA receptor currents in cortical pyramidal neurons as
well as a specific deficit in cell-surface expression of NR2B. Additionally, we
demonstrate that the genotypic differences in conditioned place preference and
passive avoidance learning seen in Kal7KO mice are abrogated when animals are
treated with an NR2B-specific antagonist during conditioning. Finally, we identify a
stable interaction between the pleckstrin homology domain of Kal7 and the
juxtamembrane region of NR2B connecting to its cytosolic C-terminal domain.
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Binding of NR2B to a protein that modulates the actin cytoskeleton is important, as
NMDA receptors require actin integrity for synaptic localization and function. These
studies demonstrate a novel and functionally important interaction between the NR2B
subunit of the NMDA receptor and Kalirin, proteins known to be essential for normal
synaptic plasticity.
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Introduction
Kalirin-7 (Kal7), one of approximately a dozen Rho guanine nucleotide
exchange factors (GEFs) localized to the PSD70, is one of many molecules important
for dendritic spine formation and function103,120,234,244,283. Kal7 is critical for spine
formation in cultured hippocampal and cortical neurons192,193 and in vivo260. Kal7
knockout (Kal7KO) mice exhibit decreased hippocampal spine density at baseline260,
with aberrant spine plasticity in the nucleus accumbens after repeated cocaine
injections267. In addition to morphological alterations, Kal7KO mice have decreased
passive avoidance fear conditioning and decreased conditioned place preference for
cocaine260,267. However, Kal7KO mice are normal in object recognition, radial arm
maze acquisition and acute locomotor response to cocaine. Decreased levels of the
NR2B subunit of the NMDA receptor were observed in PSDs from Kal7KO mice260.
These studies indicate that Kal7 has profound, specific effects on normal synaptic
function.
NMDA receptors are ionotropic glutamate receptors critical for many forms of
synaptic plasticity, including long-term potentiation (LTP) and depression (LTD),
considered cellular correlates of learning and memory78,80,81. NMDA receptors are
tetramers primarily composed of obligate NR1 subunits, binding co-agonist glycine,
and NR2 subunits (mainly A and B in adult forebrain), which bind glutamate78. NR2A
subunits support higher peak open probability and faster deactivation kinetics, while
NR2B subunits exhibit prolonged channel open times and greater inward currents84.
Within the PSD, NMDA receptors are embedded in a macromolecular complex,
interacting with multiple proteins284. The juxtamembrane intracellular domains of the
NMDA receptor subunits bind proteins that affect channel function and the
cytoskeleton. Calmodulin binding to the juxtamembrane region of NR1 leads to its
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inactivation285. Spectrin and α-actinin bind to the C-terminal domains of NR1 and
NR2B286,287. Different endocytic motifs in the juxtamembrane regions of NR1 and
NR2B target receptors for recycling and degradation288. The coordinated interactions
of NMDA receptors with these binding partners are critical for proper synaptic
function.
A growing body of evidence suggests that NR2B plays a critical role in many
forms of learning and plasticity. Genetic elimination of NR2B in hippocampal neurons
abolishes NMDA receptor-dependent LTP, reduces dendritic spine density and
decreases the ratio of filamentous to globular actin87. NR2B localized with CamKII in
perisynaptic regions is critical for LTP development in hippocampal slices88,91. In
agreement with electrophysiological experiments, NR2B channel function is important
for conditioned place preference for cocaine and morphine and for normal fear
conditioning111,112,289. Here we demonstrate that Kal7 forms a specific, stable
interaction with the juxtamembrane region of NR2B, and that Kal7KO mice have
decreased NR2B currents and cell surface expression. Furthermore, behavioral
differences between Wt and Kal7KO mice in cocaine place preference and passive
avoidance are abrogated by NR2B blockade.

122

Materials and Methods
Electrophysiology
For electrophysiological recordings, Wt and Kal7KO animals (P28-40) were
decapitated under isoflurane anesthesia and the brains were placed into ice-cold
“cutting and incubating” (CI) solution composed of (in mM): 125 NaCl, 2.5 KCl,1.25
NaH2PO4, 25 NaHCO3, 0.5 CaCl2, 4 MgCl2, 4 MgSO4, 4 lactic acid, 2 pyruvic acid, 20
glucose, and 0.4 ascorbic acid, carboxygenated with 95% O2 - 5% CO2 (pH 7.3, 310 ±
5 mmol·kg-1). Transverse cortical slices (350 µm) were cut using a vibratome and
placed into an incubating chamber containing CI solution at 35°C for 30 minutes
before being transferred to room temperature for at least 30 minutes prior to
recording. During recordings, slices were continuously perfused at 2 ml/min with
artificial cerebrospinal fluid (aCSF) consisting of (in mM) 125 NaCl, 2.5 KCl, 1.25
NaH2PO4, 25 NaHCO3, 2 CaCl2, 2 MgCl2, and 15 glucose (pH 7.3, 310 ± 5 mmol·kg1

); pH was equilibrated by continuous bubbling with 95% O2 - 5% CO2.
Whole cell voltage-clamp recordings (Vhold = -70 mV) were obtained from layer

2/3 cortical pyramidal neurons (PNs). The pipette solution contained (in mM): 117
CH3O3SCs, 8 CsCl, 10 HEPES, 2 EGTA, 0.2 CaCl2, 4 Mg2+-ATP, 0.3 Na+-GTP, and 5
QX-314 (pH 7.3, 295 ±5 mmol·kg-1). Upon breaking into whole-cell configuration, a
brief series of voltage ramps (50 ms, 2 mV/ms) were applied to promote the activitydependent block of the sodium conductance by QX-314. Electrical events were
filtered at 2.9 kHz and digitized at ≥ 6 kHz. Series resistance was compensated 70%
at 10-100 µs lag. Input resistance (Ri) was monitored with 5 mV/50 ms
hyperpolarizing voltage steps. Electrically-evoked excitatory postsynaptic currents
(EPSCs) were elicited with a bipolar tungsten electrode (resistance = 1 MΩ)
positioned 60-120 µm lateral to the patched neuron in layer 2/3. Stimulation consisted
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of a single square-wave current pulse (duration: 50-150 µs, amplitude: 50-200 µA at a
frequency of 0.067 Hz) designed to evoke half maximal responses. Neurons were
discarded from analyses if (i) Rs was >25 MΩ at the time of break-in or >10.5 MΩ
after compensation, (ii) if Ri changed by more than 15% during the course of an
experiment, or (iii) if Ri fell below 100 MΩ. NR2B antagonists (Ifenprodil and Ro 256981; Tocris Bioscience) were dissolved in water.

BS3 Crosslinking
Methods for labeling cortical slices with membrane-impermeable BS3
crosslinker were adapted from published procedures109,290. Age matched Wt and
Kal7KO mice were decapitated and their brains were removed into slush-cold Slicing
ACSF (S-ACSF) composed of (in mM): 26 HEPES [pH 7.4], 250 Sucrose, 2.3 KCl, 2
CaCl2, 2 MgSO4, 1.26 KH2PO4, 10 Glucose. Coronal cortical Vibratome slices
(400µM) were transferred from slush-cold S-ACSF to tubes containing ice-cold
crosslinking ACSF (X-ACSF) composed of (in mM): 26 HEPES [pH 7.4], 125 NaCl,
2.3 KCl, 2 CaCl2, 2 MgSO4, 1.26 KH2PO4, 10 Glucose. To prevent any receptor
trafficking, slices were kept ice-cold for all steps until tissue lysis. Slices were washed
twice with X-ACSF, before addition of X-ACSF containing 2mM BS3
[Bis(Sulfosuccinimidyl) suberate; Pierce, Rockford, IL]. Slices were incubated with
BS3 for 40 minutes with agitation to allow for full labeling of cell surface receptors.
Unreacted BS3 was quenched by adding glycine to 10mM. This solution was
aspirated and replaced with X-ACSF + 5mM glycine. The second wash solution was
aspirated and slices were sonicated into 250µl of SDS lysis buffer (50mM Tris
[pH=8.0], 2% SDS, 5mM EDTA, 50mM NaF, 1mM dithiothreitol, 1mM PMSF, and
protease inhibitor cocktail291. After incubation at 55°C for ten minutes, lysates were
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spun for 20 minutes at 25,000 x g at room temperature. Protein concentrations were
determined by bicinchoninic acid assay (Pierce), and 20µg of protein was mixed with
1X Laemmli buffer and heated to 55°C for five minutes. Proteins separated on a 415% acrylamide gel were transferred to PVDF membranes and Western blotting was
performed as described260. Quantification of discrete intracellular and diffuse surface
bands was performed using GeneGnome software260. Surface receptor included
signal associated with a higher molecular weight than the non-crosslinked receptor;
background signal was subtracted out.

Behavioral experiments
Animals were group housed in the UCHC animal facility on a 12-hour lightdark cycle (lights on 7:00 AM, off 7:00 PM). All experiments were performed in
accordance with UCHC Institutional Animal Care and Use Committee and National
Institutes of Health procedures for animal care. Male Wt and Kal7KO260 littermate mice
2 to 6 months of age were used throughout. These mice have been backcrossed into
the C57BL/6 background for ≥15 generations.
Conditioned place preference
Conditioned place preference methods were adapted from our previously
published experiments267. To determine the role of NR2B-containing receptors in
these behaviors, ifenprodil (2mg/kg in saline) was injected (i.p.) ten minutes before
the injection of saline or cocaine (National Institute on Drug Abuse, Bethesda, MD).
This dose of ifenprodil and timepoint were chosen based on a morphine place
preference study in rats112. On the first day of the experiment, each animal was given
a 20 minute pre-test session in which they were allowed to explore all chambers of
the place preference apparatus freely. The least preferred side became the side
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paired with drug injections. Animals that showed a <30 second difference in baseline
preference were assigned to balance chamber side with treatment and genotype.
During training there were two conditioning sessions each day; in the morning all
animals received saline injections; in the afternoon animals received either ifenprodil
(2mg/kg) or saline ten minutes before cocaine (10mg/kg) or saline. Five minutes after
the cocaine or saline injection, animals were placed into the conditioning chamber for
15 minutes. This conditioning was repeated for four days. Twenty four hours after the
final conditioning session, animals were again placed into the boxes and allowed to
explore all chambers freely. Preference score was calculated as the time spent in the
conditioned chamber on the final day minus the amount spent in the same chamber
on the pretest day.
Locomotor Monitoring
Measurement of the effects of ifenprodil on locomotor activity with and without
cocaine was performed using a Latin square design187,267. After a single day of
habituation to the locomotor chambers, animals were given i.p. injections of saline,
ifenprodil (2mg/kg), cocaine (10mg/kg), or concomitant ifenprodil + cocaine in a
randomized order over four days. Immediately after injection, animals were placed
into the locomotor monitoring chambers (San Diego Instruments, San Diego, CA) and
their activity was recorded for 45 minutes.
Passive Avoidance
Methods were adapted from our previous procedure260. A single injection of
ifenprodil (2mg/kg, i.p.) or saline was administered 15 minutes before passive
avoidance conditioning. For conditioning, animals were placed into one side of a
shuttle box; after five seconds, the house light came on in that chamber only and the
door between chambers was opened. When the animal crossed to the dark
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compartment, the door was closed and the animal received a single 0.3mA x 2sec
scrambled footshock. Previous studies with these mice showed that this stimulus was
sufficient to elicit robust conditioning and that there were no genotypic differences in
shock sensitivity260. After the context-shock pairing, animals were returned to their
home cages. Twenty-four hours after training, animals were returned to the same
boxes and their latency to cross was measured. Increases in latency to cross were
used as an index of the strength of conditioning.

Synaptosomes
For co-immunoprecipitation experiments, synaptosomes were prepared from
adult rat or mouse brain (pooled cortex, striatum and hippocampus). Briefly, brains
were homogenized in 20 volumes Buffer A (20mM Tris-HCl [pH 7.4], 320mM sucrose,
5mM EDTA, 50mM NaF, 2mM sodium orthovanadate, 1mM PMSF and protease
inhibitor cocktail291) and centrifuged at 1000 x g for ten minutes. The supernatant was
then centrifuged at 15,000 x g for 15 minutes, yielding a crude synaptosomal fraction
(P2), which was resuspended in TE buffer (10mM Tris-HCl, pH7.4, 5mM EDTA,
PMSF, protease inhibitor cocktail). Three solubilization protocols were used. In the
first protocol, a mixture of Triton X-100 (TX-100; 1.0%) and SDS (0.1%) was used;
samples were tumbled for one hour at 4°C and then centrifuged for 40 minutes at
20,000 x g. The TX/SDS supernatant was used for analysis. For protocol 2, 10%
deoxycholate (DOC) in 500mM Tris (pH 9.0) was added to a concentration of 1%
DOC, and samples were tumbled for 1 hour at 4°C. Triton X-100 (0.1 volume of 1.0%
TX-100 in 500mM Tris.HCl [pH 9.0]) was added to DOC lysates, where were dialyzed
overnight against binding buffer (50mM Tris.HCl [pH 7.4], 0.1% TX-100)292,293.
Dialyzed DOC lysates were centrifuged for 40 minutes at 40,000 x g and
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supernatants were used for immunoprecipitation. For protocol 3, 10% SDS was
added to a final concentration of 1% and samples were tumbled for 30 minutes at
room temperature; samples were then centrifuged and the supernatant was used for
immunoprecipitation.

Immunoprecipitation
Samples were pre-cleared by incubation with 15µl of Protein A/G beads
(Thermo Scientific, Rockford, IL) for 30-45 minutes. An aliquot of each sample was
saved as input; antibody (3-4 µg) and Protein A/G beads (15 µl) were added to each
sample, which was tumbled at 4°C for 4 hours or overnight. For Kal7
immunoprecipitation, Kal7 monoclonal antibody 20D8260 was enriched by ammonium
sulfate precipitation (45% saturation) of ascites fluid and dialyzed into 10 mM Na
phosphate, pH 7.4, 150 mM NaCl. The ammonium sulfate precipitate (0.4 mg protein)
was linked to 0.2 ml AminoLinkR Plus Coupling Resin using sodium cyanoborohydride
(Thermo Scientific, Rockford, IL). After incubation with antibody plus Protein A/G
beads or Kal7 monoclonal antibody beads, unbound proteins were removed and
beads were washed twice with TMT buffer (0.5 ml 20 mM NaTES, 10 mM mannitol,
pH 7.4, 1.0% Triton X-100) and then twice with TM buffer (0.5 ml 20 mM NaTES, 10
mM mannitol, pH 7.4). Bound proteins were eluted by boiling into 1X Laemmli sample
buffer. For each sample, incubation of equal amounts of protein with pre-immune IgG
was used as a negative control for non-specific binding. IgG was covalently linked to
AminoLinkR Plus Coupling Resin in the same manner as the Kal7 monoclonal
antibody.
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Antibodies
Kalirin antibodies were described previously260 and include rabbit polyclonal
antibodies specific to the terminal 20 amino acids of Kal7 (JH2959) or to spectrin
repeat regions 4 to 7 of Kalirin (JH2582) and mouse monoclonal Kal7 antibody 20D8.
The myc monoclonal antibody (9E10) was described previously294,295. Commercially
available antibodies used included: NR2B (clone 59/20; Neuromab), NR2A (clone
A12W, #04-901; Millipore), NR1 (#556308; BD Biosciences), PSD-95 (clone K28/43;
Neuromab), GluR1 (ab31232; Abcam), GFP (ab290; Abcam), Myc (ab9106; Abcam),
HA (ab9110; Abcam), pan-MAGUK (clone K28/86; Neuromab).

Transfection of non-neuronal cells
pEAK Rapid cells (Edge Biosystems, Gaithersburg, MD) were maintained in
DMEM:F12 medium containing 200 U/ml penicillin G, 20 µg/ml streptomycin sulfate,
25 mM HEPES, and 10% fetal bovine serum. Cells were fed with serum-free medium
for 2 hours before transfection. Vectors encoding rat NMDA receptor subunits and
Kal7 were transfected in a mass ratio of 1 NR1: 3 NR2: 1.5 Kal7. Expression vectors
encoding rat NR1, NR2A and NR2B were generous gifts from Dr. Jon Johnson at the
University of Pittsburgh296,297, and the expression vector encoding ∆NR2B was a
generous gift from Dr. Kelly Foster at Commonwealth Medical College88. The Kal7
expression vectors used were described previously: His-Myc-Kal7, His-Myc-∆Kal7,
His-myc-KGEF17end232, His-myc-I-10197, His-myc-Kal7/ND/AA195, His-mycKal7ΔCT194 and His-myc-KalGEF1298. The Tiam1 GEF vector included tandem Cterminal HA-tags298. PH1-GFP was made by inserting EGFP into the N-terminal
portion of the previously described Kalirin PH vector201. Vectors were mixed with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) in Opti-MEM (Life Technologies) and
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added to cells for 6 hours at 37°C. Cells were then fed with glutamate-free medium
(MEM plus 200U/ml penicillin G, 20 µg/ml streptomycin sulfate, 25 mM HEPES, and
Glutamax [Invitrogen]) to prevent NMDA receptor-induced excitotoxicity. After 24-48
hours, cells were scraped into spent medium, pelleted and solubilized in DOC as
described above. Dialyzed lysates were then subjected to immunoprecipitation as
described above.

Peptide pulldown
Synthetic rNR2B(845-861) preceded by a Gly-Ala spacer
[HGAGAQ845FRHCFMGVCSGKPGMV861NH2] (Biomatik, Wilmington, DE) was
covalently linked to AffiGel-10 beads (Bio-Rad, Hercules, CA); this sequence follows
transmembrane domain 4 and is referred to as NR2B juxtamembrane domain (2BJM). Control AffiGel-10 beads were either blocked with ethanolamine in the absence
of peptide or linked to β-endorphin, a peptide with a positive charge similar to that of
2B-JM. Readily soluble proteins (PH1-GFP, GFP) were solubilized in TE buffer +
0.02% TX-100. For less soluble proteins, samples were solubilized in DOC and
dialyzed as described for immunoprecipitation; solutions were diluted to 0.02% TX100 before binding. Lysates were mixed with 15µl peptide-coated or control beads.
Binding was performed for 4 hours or overnight at 4°C. After binding, beads were
pelleted and washed 4 times with binding buffer. Bound proteins were then eluted by
boiling into Laemmli sample buffer for five minutes.

Statistical Analyses
For behavioral experiments, statistical analysis was performed using
SigmaPlot. Two-way ANOVA tests were used to determine main effects of genotype,
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treatment and any interactions. For experiments in which there was a significant
genotype x treatment interaction, Holm-Sidak post hoc tests were used to parse out
specific effects. For analysis of NR2B currents, an unpaired t-Test was used to
compare the percentage change of evoked currents after ifenprodil or Ro 25-6981
application. Unpaired t-Tests were also used to compare surface/intracellular receptor
ratios for crosslinking experiments.

131

Results
NR2B-mediated currents are reduced in Kal7KO cortical neurons
We recently demonstrated that Kal7KO mice exhibit a decreased NMDA/AMPA
ratio as well as impaired NMDA receptor-mediated hippocampal LTP and LTD
(Lemtiri-Chlieh et al., submitted). Given these findings as well as the decrease in
NR2B expression in purified PSDs from Kal7KO mice260, we used pharmacological
tools to compare NR2B-mediated signaling in Wt and Kal7KO cortical neurons. Using
slices of somatosensory cortex from young adult (P28-40) Wt and Kal7KO mice,
NMDA receptor-mediated activity was isolated using the AMPA/kainate receptor
antagonist 6,7-dinitroquinoxaline-2,3-dione (DNQX; 10 µM); cells were voltage
clamped at +50mV to remove the voltage-dependent blockade of NMDA receptors.
Extracellular stimulation within layer 2/3 evoked NMDA receptor-mediated EPSCs in
slices from both Wt and Kal7KO animals (Fig. 4-1A,B dark traces); these EPSCs
were completely blocked by the NMDA receptor antagonist 3-[(±)-2-carboxypiperazin4-yl]-propyl-1-phosphonic acid (CPP - 3 µM; data not shown). To determine the
NR2B-mediated component of the NMDA receptor current, ifenprodil (3µM)299,300 was
added to the bath solution. In slices from Wt animals, the ifenprodil-sensitive NR2B
component represented 56 ± 4% of the peak current, whereas in slices from Kal7KO
animals, the NR2B-mediated component was only 39 ± 6% of the peak current (Fig.
4-1A-C). A different NR2B-specific antagonist, Ro 25-6981 (0.5 µM)89,301, produced
the same effect. In slices from Wt animals, the Ro 25-6981-sensitive component was
48 ± 2% of the peak current (Fig. 4-1D); in slices from Kal7KO animals, it was only 30
± 4% of the peak current (Fig. 4-1E), significantly less than in Wt tissue (Fig. 4-1F).
These data indicate that the decrease in NR2B levels observed
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Figure 4-1. NR2B-mediated NMDA currents are diminished in Kal7KO neurons
Layer 2/3 pyramidal neurons were voltage clamped at +50mV in the presence of
10µM DNQX to block AMPA receptor-mediated currents. Representative evoked
current traces are shown: black traces were made at baseline (A, D) and grey traces
were made 15 minutes after bath application of an NR2B-specific antagonist,
ifenprodil (3µM; B) or Ro 25-6981 (0.5µM; E). Mean data demonstrate that Wt
animals have a significantly larger portion of their NMDA receptor currents that are
ifenprodil- (C) or Ro 25-6981- (F) sensitive (ifenprodil, **p<0.01; t-Test, n=5
animals/group, 2-3 cells/animal; Ro 25-6981, **p < 0.01; t-Test, n=3-4 animals/group,
2-3 cells/animal).
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in cortical PSDs is associated with a decrease in NR2B functionality in Kal7KO
animals.

Surface localization of NR2B is reduced in Kal7KO animals
To determine whether the decrease in ifenprodil-sensitive currents in the
Kal7KO animals was due to changes in synaptic localization or receptor function, we
used membrane-impermeable BS3 crosslinking to identify surface receptors109,290.
Cortical slices from adult Wt and Kal7KO mice were chilled to 4°C before cross-linking
to prevent receptor trafficking. High molecular weight bands representing crosslinked
NMDA and AMPA receptors were seen only in crosslinked slices (Fig. 4-2A).
Additionally, Western blot analysis of tubulin, an intracellular protein, revealed a
single discrete band of the appropriate molecular weight, demonstrating that BS3 was
unable to enter cells (Fig. 4-2A right). We examined the NR2B and NR2A subunits of
the NMDA receptor as well as the GluR1 subunit of the AMPA receptor (Fig. 4-2B-D).
Quantification of Surface (high molecular weight) to Intracellular ratios for these
receptor subunits revealed a specific decrease in surface expression of the NR2B
subunit in Kal7KO mice (Fig. 4-2E); surface levels of the NR2A subunit and the GluR1
subunit were unaltered.

Differences in Wt and Kal7KO mouse place preference for cocaine are eliminated by
ifenprodil
Given the specific decreases in NR2B localization and function in Kal7KO mice,
we wanted to determine if any of the behavioral differences in Kal7KO mice might be
attributable to a diminished contribution from NR2B-containing receptors. Kal7KO
animals display a substantially reduced conditioned place preference for cocaine
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Figure 4-2. Knockout of Kal7 specifically decreases surface localization of
NR2B
A. Exposure of cortical slices kept at 4°C to BS3 crosslinks surface receptors,
producing high molecular weight bands that are not observed in non-crosslinked
control slices; brackets indicate Surface and Intracellular receptor. As expected, an
intracellular protein, tubulin, was not crosslinked. Representative Western blots of
crosslinked samples from Wt and Kal7KO slices blotted for NR2B (B), NR2A (C) and
GluR1 (D). E. Surface and Intracellular receptor levels were quantified for each
sample and the Surface/Intracellular ratio for Wt slices was normalized to 100%.
Kal7KO animals show a decrease in cell surface expression of NR2B, while surface
levels of NMDA receptor subunit NR2A and AMPA receptor subunit GluR1 were
unchanged. (**p=0.018 as calculated by t-Test; N=9-10 slices/genotype, 3
animals/group).
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despite their normal place preference for food267. Previous studies from other labs
demonstrated that NR2B function is critical for development of cocaine or morphine
place preference111,112. To test our hypothesis, we repeated the place preference
experiment for cocaine, but tried to eliminate the contribution of NR2B signaling by
injecting ifenprodil before cocaine on each conditioning day (Fig. 4-3A). To ensure
specificity for NR2B-containing receptors86, we chose a dose of 2mg/kg, in the lower
end of the range previously reported to have behavioral effects289. A higher dose of
ifenprodil or Ro 25-6981 (10mg/kg for both) was used in previous studies of NR2B in
drug preference111,112.

As expected, animals receiving only saline injections showed no significant
changes from baseline; ifenprodil on its own created no preference or aversion (Fig.
4-3B left) (Genotype, Treatment and Interaction effects: all p>0.75 for Fig. 4-3B left;
two-way ANOVA). In animals receiving cocaine after either saline or ifenprodil, there
were no main effects of genotype (p=0.19) or treatment (p=0.11), but there was a
significant genotype x treatment interaction (F(1,32)=4.32, p=0.047; two-way ANOVA).
In animals receiving saline prior to cocaine, there was a strong effect of genotype
(Fig. 4-3B right) (p=0.02; Holm-Sidak post hoc test); as expected, Kal7KO mice
showed a diminished place preference for cocaine267. When Wt animals were given
ifenprodil before each injection of cocaine, they showed a significant decrease in
preference (effect of ifenprodil within Wt: p=0.01); in contrast, ifenprodil did not alter
the response of Kal7KO animals to cocaine (effect of ifenprodil within Kal7KO: p=0.77).
Pre-treatment with ifenprodil abolished the genotypic difference between Wt and
Kal7KO mice (Fig. 4-3B right; effect of genotype within
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Figure 4-3. Blockade of NR2B receptors eliminates differences in cocaine
conditioned place preference response in Kal7KO and Wt animals
A. Timeline of daily injections. Cocaine injections (10mg/kg) were preceded by
ifenprodil injections (2mg/kg i.p.) to block NR2B-containing NMDA receptors. B left.
Animals that received saline only or ifenprodil before saline showed no genotypic
differences and no significant preference/aversion [n=3-5/group]. B right. In the
groups receiving saline injections prior to cocaine injections, Kal7KO animals showed
a robust decrease in place preference (effect of genotype within saline: *p=0.02;
Holm-Sidak test). In Wt animals, when ifenprodil preceded the cocaine injection there
was a significant decrease in preference compared to saline pretreatment (effect of
treatment within Wt: #p=0.01). The genotypic difference between Wt and Kal7KO
animals was abrogated when animals were pretreated with ifenprodil (effect of
genotype within ifenprodil: p=0.61) [n=7-10/group]. C. Acute locomotor effects of
cocaine (10mg/kg), ifenprodil (2mg/kg) or both administered concomitantly. Ifenprodil
alone produced no effect on locomotor activity. While cocaine produced the expected
increase in locomotor activity, simultaneous injection of ifenprodil did not alter the
response. There were no genotype-dependent effects in these studies. [n=4/group].
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ifenprodil: p=0.61). While blockade of NR2B receptors decreased preference in Wt
mice it did not eliminate it entirely, an effect similar to published results in mice111. Our
data are consistent with the hypothesis that NR2B-containing NMDA receptors play
an important role in cocaine-induced place preference and that the absence of Kal7
diminishes the contribution of NR2B to this behavior.
Kal7KO mice demonstrate a normal locomotor response to a wide range of
acute cocaine doses267. To eliminate a potential confound due to an aberrant
locomotor response to ifenprodil, or to the combination of ifenprodil and cocaine, we
monitored the locomotor response of Wt and Kal7KO mice to an injection of ifenprodil,
cocaine or both using a Latin-square design187,267 (Fig. 4-3C). Animals were given
each of the four treatments in a randomized order over the course of four days. While
the expected significant effect of cocaine was observed (F(1,31)=50.44, p<0.001; 3-way
ANOVA), there were no effects of genotype (p=0.79), ifenprodil (p=0.46) or any
interactions (all p≥0.64). Thus the differences noted in cocaine place preference do
not reflect an altered acute behavioral response of either genotype to ifenprodil.

Differences in Wt and Kal7KO mouse passive avoidance behaviors are abrogated by
ifenprodil
We previously observed a deficit in the passive avoidance form of contextual
fear conditioning in Kal7KO animals260. NR2B is known to play an essential role in fear
memory formation and maintenance289,302. Additionally, transgenic animals
engineered to over-express NR2B showed enhanced fear conditioning and extinction
behavior92. To determine if the Kal7KO animals had an altered response to NR2B
blockade, we injected animals with either saline or ifenprodil (2mg/kg) 15 minutes
before training. There were no significant genotype or treatment differences in latency
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to cross on the training day (data not shown). The avoidance test was administered
24 hours after conditioning (Fig. 4-4). While there were no main effects of genotype
(p=0.11) or treatment (p=0.89) there was a strong genotype x treatment interaction
(F1,35 = 11.30, p=0.002; 2-way ANOVA). Post-hoc tests revealed a strong genotype
effect within the saline (p=0.003, Holm-Sidak test) but not the ifenprodil treated
animals. Interestingly, while the Wt animals showed a significant decrease in
conditioning (effect of ifenprodil within Wt: p=0.01), the Kal7KO animals showed a
significant enhancement of conditioning with ifenprodil pretreatment (effect of
ifenprodil within Kal7KO: p=0.04). Saline treated Kal7KO mice showed a decrease in
conditioning compared to Wt mice that was similar to that reported previously260.
Thus, administration of ifenprodil abolished behavioral differences between Wt and
Kal7KO animals.for both passive avoidance conditioning and cocaine place
preference.

Endogenous Kal7 and NMDA receptor complexes interact
Based on the electrophysiological (Fig. 4-1), biochemical (Fig. 4-2) and
behavioral (Fig. 4-3&4) findings that suggest a specific role for Kal7 in NR2B
localization and function, we investigated the possibility that they interact directly. In
order to explore this possibility, synaptosomes were solubilized using three different
protocols. Given that the PSD is a complex and highly interconnected piece of
machinery, the method used to solubilize PSD proteins is a critical determinant of the
interactions that can be measured. As shown in Fig. 4-5A, the three detergent

139

Figure 4-4. Blockade of NR2B receptors abrogates genotypic differences in
passive avoidance fear conditioning
Left. In animals receiving an injection of saline before passive avoidance
conditioning, Kal7KO animals showed significantly decreased conditioning compared
to Wt mice (**p = 0.003; Holm-Sidak test). Right. In animals treated with ifenprodil
before conditioning, the genotypic differences were eliminated (p=0.18). While Wt
animals showed a significant decrease in conditioning with ifenprodil pretreatment
(effect of treatment within Wt: #p=0.01), Kal7KO animals exhibited a significant
increase in conditioning following NR2B blockade (effect of treatment within Wt:
‡
p=0.04). [n=6-12/group].
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conditions tested solubilized different amounts of NR2B, Kal7, GluR1 and PSD-95. In
the least stringent detergent protocol (1% TX-100/0.1%SDS; TX), very little NR2B or
PSD-95 was solubilized while substantial amounts of Kal7 and GluR1 were recovered
from the supernatant. Deoxycholate (DOC) solubilization increased the recovery of
NR2B and PSD-95 from the soluble fraction, but had relatively little effect on the
recovery of Kal7 or GluR1. Solubilization with 1% SDS (at room temperature), further
increased the solubilization of NR2B and GluR1.
Based on its ability to solubilize NR2B and Kal7 we selected the DOC
protocol, which has been widely used for examining protein-protein interactions in the
PSD74,293,303. Under these conditions, immunoprecipitation of Kal7 led to coprecipitation of a small but significant amount of NR2B, NR2A, and NR1 as well as
PSD-95 (Fig. 4-5B). The AMPA receptor subunit GluR1 was not co-precipitated with
Kal7 (Fig. 4-5B). After solubilization with 1% DOC, Kal7 interacts with endogenous
NMDA receptor complexes, but not with endogenous AMPA receptor complexes.
Using more stringent solubilization conditions (1% SDS), immunoprecipitation of Kal7
still co-precipitated NMDA receptor subunits NR2B and NR2A as well as PSD-95
(Fig. 4-5C). Under these same conditions, immunoprecipitation of NR2B resulted in
robust co-precipitation of NR2A, indicating that NMDA receptor complexes remained
intact (data not shown). Maintenance of the Kal7-NMDAR interaction despite strong
detergent application indicates that the interaction is a stable one. DOC solubilization
was used for subsequent experiments.
To verify the Kal7-NMDAR interaction, we asked whether NR2B antibody coprecipitated Kal7 (Fig. 4-5D); using a pan-Kalirin antibody, co-precipitation of Kal7
was demonstrated. In addition, larger isoforms of Kalirin were detected. Kal7KO mice
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Figure 4-5. Kal7 associates with NMDA receptor complexes in vivo
A. Solubilization of rat forebrain synaptosomal proteins with different detergents
yielded different amounts of soluble NR2B, Kal7, GluR1 and PSD-95. Samples were
loaded as equal percentages of the supernatant after detergent extraction. B. In
samples solubilized with DOC, immunoprecipitation (IP) with the Kal7 mAb coprecipitates a small fraction of the NR2B, NR2A, NR1 and PSD-95, but no detectable
GluR1. IP came from 50-fold more sample than Input (In). C. Solubilization of
synaptosomes with 1% SDS revealed co-precipitation of NMDAR subunits and PSD95 with Kal7. IP came from 100–fold more sample than Input. D. Synaptosomes from
Wt and Kal7KO animals were solubilized with DOC, immunoprecipitated using an
NR2B antibody and blotted for all isoforms of Kalirin. Examination of the Input sample
confirmed the absence of Kal7 and increase in Kal8/9/12 in Kal7KO animals, as
reported260. A fraction of the Kal7 co-immunoprecipitated with NR2B in Wt extracts,
with detectable co-immunoprecipitation of Kal9 and Kal12. In Kal7KO samples, coimmunoprecipitation of Kal9 and 12 was more apparent.
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were engineered to lack Kal7 while still expressing the larger isoforms; as reported
previously, levels of Kal8, Kal9 and Kal12 are increased in Kal7KO animals (Fig. 4-5D,
KO Input)260. NR2B immunoprecipitation from Kal7KO synaptosomes revealed coprecipitation of Kal9 and Kal12 (Fig. 4-5D, IP). Unlike NR2B and Kal7, Kal9 and
Kal12 lack a PDZ binding motif303. Our findings indicate that the Kalirin/NR2B
interaction is not solely dependent on PDZ domain binding.

The PH domain of Kal7 specifically interacts with NR2B
To determine whether Kalirin and NR2B interact directly and to map sites of
interaction, we turned to non-neuronal cells. pEAK Rapid cells, a HEK-293 derivative,
do not express PSD-95 or other MAGUK proteins (Fig. 4-6A). In cells co-transfected
with vectors encoding Kal7, NR1 and either NR2B or NR2A, Kal7 monoclonal
antibody beads co-precipitated NR2B, but not NR2A (Fig. 4-6B). Immunoprecipitation
of NR2B (Fig. 4-6C), but not NR2A (Fig. 4-6D), from these same lysates led to coprecipitation of Kal7. The fact that co-immunoprecipitation of Kal7 and NR2B took
place outside of the meshwork of the PSD and was specific for NR2B, suggests that
Kal7 may interact directly with NR2B.
Kal7 is a large protein; to identify the region responsible for its interaction with
NR2B, vectors encoding fragments of Kalirin were expressed along with NR1 and
NR2B (Fig. 4-6E). A fragment which begins in spectrin repeat 3 and ends in spectrin
repeat 9 (SR3-9) and has been shown to interact with iNOS197 and DISC-1200, did not
co-precipitate with the NR2B subunit. Kal7ΔCT, which lacks the 60 C-terminal
residues of Kal7, including the PDZ binding motif, co-precipitated with NR2B, as did
the GEF1 domain. GEF domains
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Figure 4-6. Kal-PH1 interacts with NR2B
A. pEAK Rapid cell (pE) and mouse brain (Br) lysate (10 or 20 µg protein) were
blotted for PSD-95 and other MAGUK scaffolding proteins. B. In pEAK Rapid cells cotransfected with vectors encoding NR1, NR2A or NR2B and Kal7, Kal7 mAb beads
bound NR2B but not NR2A. Samples B-D loaded as Input (1):IP (90). Similarly,
immunoprecipitation with antibody to the extracellular domain of NR2B coprecipitated a small percentage of the Kal7 (C) but antibody to NR2A did not (D). E.
To map the sites in Kal7 that interact with NR2B, cells were co-transfected with
vectors encoding NR1, NR2B and the indicated fragments of Kal7. Cells were
extracted in DOC and NR2B was immunoprecipitated from the lysates; Kalirin
fragments were then probed for co-precipitation using the appropriate antibody. KalPH1 co-precipitates with NR2B F. pEAK Rapid cells were co-transfected with vectors
encoding NR1, NR2B and a Kal-PH1-GFP fusion protein. GFP immunoprecipitates
were probed for NR2B. Samples F and G loaded as Input(1):IP(90). G. Interaction
specificity was assessed by co-transfecting vectors encoding NR1, NR2B and HAtagged Tiam1-GEF, a different Rac-GEF also localized to the PSD. IP of the GEF
domain of Tiam1 (using HA antibody) did not co-precipitate NR2B.
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consist of a catalytic DH domain followed by a PH domain147. When expressed alone,
a PH1-GFP fusion protein interacted with NR2B (Fig. 4-6E). To verify this, we coexpressed PH1-GFP and NR1/NR2B and used an antibody to GFP to look for an
interaction; immunoprecipitation of PH1-GFP led to co-precipitation of NR2B (Fig. 46F). Interestingly, the PH2 domain of Kalirin, which is only present in the larger
isoforms, also co-precipitated NR2B (data not shown). To determine whether this
interaction were specific to Kalirin, we co-transfected NR1/NR2B and vector encoding
the GEF domain of Tiam1, another Rac GEF localized to the PSD144.
Immunoprecipitation of the Tiam GEF did not result in co-precipitation of the NR2B
subunit (Fig. 4-6G).

Kal7 interacts with a membrane-proximal region of NR2B
We next mapped the region of the NR2B subunit that interacts with Kal-PH1;
both Glu and ifenprodil bind to the large extracellular, N-terminal domain of NR2B
(Fig. 4-7A). Three transmembrane domains and a non-penetrant membrane domain
form the ion channel; the ~80 kDa intracellular C-terminal domain of NR2B interacts
with multiple cytosolic proteins including CaMKII91 and α-actinin78,287 and terminates
with a PDZ-binding motif known to interact with PSD-95304. We first tested ∆NR2B,
which terminates shortly after the final transmembrane domain88. When Kal7, NR1
and ∆NR2B were co-expressed, the Kal7 antibody beads co-precipitated ∆NR2B
(Fig. 4-7B). Immunoprecipitation of ∆NR2B with antibody directed to its extracellular
N-terminal domain co-precipitated Kal7 (Fig. 4-7C). To ensure that this was the same
interaction we were seeing before, we co-transfected PH1-GFP, NR1
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Figure 4-7. Interaction between the PH1 domain of Kalirin and NR2B involves a
membrane proximal intracellular segment of NR2B
A. A diagrammatic representation of the NR2B subunit showing the site of the
truncation for ΔNR2B (∆NR2B; residues 1-861 of NR2B)88 and the antibody binding
epitope. Sites known to interact with specific proteins are indicated. B. pEAK Rapid
cells co-transfected with vectors encoding Kal7 and ΔNR2B were immunoprecipitated
with Kal7 mAb beads; co-precipitated ∆NR2B was visualized using monoclonal
antibody to the extracellular domain. All samples shown in this figure were loaded
Input(1):IP(90). C. Similarly, immunoprecipitation of ∆NR2B co-precipitated Kal7,
which was visualized with Kal7 polyclonal antibody. D. Cells co-transfected with
vectors encoding Kal-PH1-GFP and ΔNR2B were immunoprecipitated with rabbit
polyclonal antibody to GFP; the co-precipitated ∆NR2B was visualized using
monoclonal antibody to the extracellular domain, indicating that this interaction is
specific to the PH domain. D. Cells co-transfected with vectors encoding the GEF
domain of Tiam and ΔNR2B were immunoprecipitated with polyclonal antibody to HA.
The Tiam-GEF domain does not co-precipitate the ∆NR2B receptor.
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and ∆NR2B; co-precipitation of PH1-GFP and ∆NR2B was observed (Fig. 4-7D). As
before, the Tiam GEF domain and ΔNR2B did not co-precipitate (Fig. 4-7E).
The intracellular region of ΔNR2B is limited to three short sequences (Fig. 47A). Since Kal-PH1 interacts with NR2B, but not with NR2A, we compared their
sequences (Fig. 4-8A). Five of the 19 residues in the M1M2 loop differ while none
of the 11 residues in the M2M3 loop differ (Fig. 4-8A; loop diagrams in Fig. 4-7A).
Eight of the 17 residues that follow M4 in ΔNR2B (M4End) differ (Fig. 4-8A). To test
the M4End region, an NR2B juxtamembrane peptide (2B-JM) was synthesized and
linked to AffiGel beads. Lysates of pEAK Rapid cells expressing Kal7, PH1-GFP,
SR3-9, or GFP were incubated with 2B-JM beads or control (no peptide) beads. Kal7
and PH1-GFP bound to 2B-JM beads, but not to control beads (Fig. 4-8B). PH1-GFP
lysates were also incubated with β-endorphin beads; no binding was seen, even with
this positively charged peptide (data not shown). Neither SR3-9 nor GFP bound to the
2B-JM beads. Incubation of 2B-JM beads with lysates from cells expressing Kal-PH2
revealed a similar interaction with Kal-PH2 (not shown). To determine if binding to the
2B-JM beads saturated, we incubated increasing concentrations of PH1 lysate with a
fixed amount of beads. With repeated doubling of the amount of lysate, we saw a
plateau in binding (Fig. 4-8C). Finally to determine whether the juxtamembrane
region of NR2B could interact with endogenous Kal7, we incubated 2B-JM beads with
mouse brain synaptosomes solubilized with TX-100 or DOC. The 2B-JM beads
bound Kal7 solubilized with either detergent (Fig. 4-8D). From these experiments we
can conclude that there is a specific and stable interaction between the PH domains
of Kalirin and the juxtamembrane region of the NR2B C-terminus (Fig. 4-8E).
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Figure 4-8. Interaction of Kalirin PH1 with the juxtamembrane region of NR2B
A. Clustal analysis comparing intracellular regions of NR2B and NR2A. B. Lysates
from cells expressing Kal7 fragments or GFP were incubated with NR2B-JM or
control (no linked peptide) beads. The 2B-JM beads bound Kal7 and PH1-GFP but
did not bind SR3-9 or GFP. None of the constructs bound to control beads. C.
Increasing amounts of PH1-GFP lysate were incubated with a fixed volume of 2B-JM
or control beads; binding began to saturate as the amount of lysate was increased. D.
2B-JM beads were incubated with mouse forebrain synaptosomes solubilized with
1% TX-100 or 1% DOC (dialyzed). Kal7 solubilized in either way bound to 2B-JM
beads. E. A model of the NR2B receptor with the Kal7 PH domain bound to the
juxtamembrane region of the C-terminus.
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Discussion
NR2B function is altered when Kal7 is absent
Purified PSDs from the cortices of Kal7KO animals contain slightly reduced
levels of NR2B260. Here we demonstrate that this decrease results in altered synaptic
physiology, with Kal7KO animals having a decreased portion of their NMDA receptor
currents conducted via NR2B containing receptors (Fig. 4-1). Additionally, we
demonstrate that this decrease in NR2B currents is due to a decrease in cell surface
localization of NR2B (Fig. 4-2). Localization of NR2B to synapses is essential for the
induction of long-term potentiation, and neurons overexpressing NR2B show
enhanced potentiation87,92. More recent studies have shown that NR2B is essential
because of the many proteins recruited to the synapse via their interactions with its
cytosolic C-terminal tail88. The ability of NR2B to localize CamKII and its other binding
partners directly to the source of large calcium currents seems to be critical for LTP
induction91. Decreased synaptic NR2B levels and currents may explain why Kal7KO
animals exhibit significantly impaired NMDA receptor-dependent LTP and decreased
NMDA/AMPA ratios260(Lemtiri-Chlieh et al., submitted).
Smaller spines, and spines where presynaptic input has been blocked, have
greater accumulations of NR2B-containing receptors than larger spines or those
receiving stronger inputs95,96. Additionally, smaller spines are more easily potentiated
and demonstrate more robust and pronounced increases in dendritic head size in
response to stimulation103,122. Numerous studies have suggested that synapses
expressing higher levels of NR2B have a lower threshold for potentiation304. Given
this, it seems likely that localization of NR2B to newly developing synapses is a key to
ensuring synapse stabilization and maturation. Kal7 has been implicated in the
formation and stabilization of new dendritic spines both in vitro and in vivo193,260. As
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we show here, mice lacking Kal7 are deficient in NR2B signaling and surface
localization (Figs. 4-1&2). If NR2B is an important component in stabilizing newly
formed spines, then this may partially explain how Kal7 expression leads to increases
in spine density.

Behavioral differences between Wt and Kal7KO animals are abrogated by ifenprodil
One of the most striking deficits observed in Kal7KO mice is a decrease in
conditioned place preference for cocaine267. The circuitry involved in this response is
complex and includes the striatum, prefrontal cortex and ventral tegmental area, with
roles for dopaminergic, glutamatergic, GABAergic and cholinergic
transmission10,27,28,305. NR2B receptor function is known to be necessary for cocaine
and morphine place conditioning111,112. In Kal7KO animals, loss of the Kal7/NR2B
interaction and subsequent reduction in NR2B-mediated plasticity may underlie this
behavioral deficit. We thus hypothesized that blocking NR2B–containing receptors
would reproduce this deficit in Wt animals, but would have less effect or no effect in
Kal7KO mice. Consistent with this prediction, ifenprodil administration completely
eliminated the difference between Kal7KO and Wt mice, although mice of both
genotypes continued to exhibit a preference for cocaine (Fig. 4-3). This is consistent
with the fact that this behavioral response is not entirely dependent on NR2B.
Similar to the conditioned place preference effect, we had previously seen
decreases in passive avoidance fear conditioning in Kal7KO animals260. When Wt and
Kal7KO animals were given ifenprodil before conditioning, this genotypic difference
was also abolished (Fig. 4-4). NR2B receptor function has been shown to be crucial
for the consolidation of fear conditioning memories92,289. Interestingly, ifenprodil
pretreatment had distinctly different effects in Wt and Kal7KO mice, with reduced fear
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conditioning in Wt mice and increased fear conditioning in Kal7KO mice. Regionspecific responses to the elimination of Kal7 may be a factor; for example, while spine
density is reduced in Kal7KO vs Wt CA1 hippocampal pyramidal neurons under
baseline conditions260, basal spine density is unaltered in the Kal7KO nucleus
accumbens267.
Kal7KO mice may have compensatory developments that allow their function to
rely more heavily on NR2A receptors, which are expressed at normal levels (Fig. 42), or other non-NMDA dependent forms of plasticity. Mice lacking NR2A subunits
have reduced LTP as well, indicating that NMDA receptor mediated LTP is not solely
dependent on NR2B306. Additionally, non-NMDA receptor dependent forms of LTP
have been described307. Interestingly, recent electrophysiological experiments on
Kal7KO mice indicate that they exhibit impaired NMDA-dependent LTP, but normal
non-NMDA receptor mediated LTP (Lemtiri-Chlieh et al., submitted). Increased
reliance on these alternate pathways in Kal7KO mice may explain why inhibition of
NR2B receptors does not further accentuate their behavioral deficits.

Binding of Kal7 to NR2B-containing NMDA receptors is stable and specific
The PSD is an intricate complex of hundreds of interconnected proteins68;
proper pairwise connections amongst specific proteins in this network are critical for
synaptic function. Both Kal7 and NMDA receptors interact directly with multiple PSD
constituents. Their PDZ binding motifs interact with multiple PDZ domain containing
proteins. The C-terminus of Kal7 interacts with PSD-95 in a way that decreases its
catalytic activity194, and with afadin (AF-6) in a way that helps anchor it in the PSD202.
Interactions of the C-terminus of NR2B with PSD-95 and SAP-97 are critical for
stabilizing NMDA receptors in the synapse308,309. It is currently not clear whether Kal7
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and NR2B can bind simultaneously to PSD-95, which has three PDZ domains. We
show here that Kalirin and NR2B interact directly, in a way that is not dependent on
PDZ binding. In addition to NR2B, the PH domain of Kal7 was shown to bind to TrkA,
the high affinity NGF receptor201.
NMDA receptors exist as part of huge macromolecular complexes in the PSD,
reflective of many direct and indirect interactions with receptors, scaffolding proteins
and enzymes284. Interestingly, the interactions of Kalirin with the NR2B receptor
involve its juxtamembrane region (Figs. 4-7&8), placing Kalirin in an excellent
position to either modulate channel function or be directly affected by calcium influx
through the receptor. A number of other proteins interact with the juxtamembrane
regions of specific NMDA receptor subunits. Calmodulin binds the C-terminus of the
NR1 subunit in a calcium dependent manner and causes channel inactivation285. The
interaction of calmodulin with NR1 seems to be directly competitive with the actin
binding protein α-actinin, which may help to crosslink the receptors to the actin
cytoskeleton and stabilize them in the synapse287. Additionally, both NR1 and NR2B
have AP-2 binding sites in their juxtamembrane C-terminal domains, and binding to
these sites leads to dynamin dependent receptor internalization288. The 2B-JM
peptide used to pull down Kal7 and its PH1 domain (Fig. 4-8) contains part of this
AP-2 binding motif and Kalirin may affect surface localization of NR2B-containing
receptors by competing with AP-2.
Kalirin activates Rac1, a GTPase known to mediate actin rearrangement119,190.
Interactions of NMDA receptors with the actin cytoskeleton are known to be essential
for NMDA receptor function and localization139,310. Both spectrin and α-actinin bind to
NMDA receptors, linking them to the actin cytoskeleton286,287. Kal7 is not the only
Rho-GEF known to bind to NMDA receptors. The Rac-GEF Tiam-1 binds to the NR1
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subunit and is critical for NMDA induced spine dynamics in neuronal cultures144.
RasGRF1, a dual Ras and Rac-GEF, binds directly to the NR2B subunit145, and
RasGRF1 knockout mice show decreases in cocaine place preference, as do Kal7KO
mice311. The activity of both Tiam-1 and RasGRF1 is modulated by calcium and/or
calcium-calmodulin dependent kinases144,146,312-314. By being directly coupled to
NMDA receptors, these GEFs are uniquely positioned to directly transduce calcium
dependent signals. We have directly identified multiple CamKII sites in Kal7 (Chapter
5); these sites are distinct from the putative CamKII site previously identified through
indirect means but are consistent with a role for calcium in controlling Kal7 signaling.
Given the rapid (seconds  minutes) time course over which NMDA receptor
dependent changes in spine size occur73, GEF interactions with NMDA receptors may
be critical for morphological plasticity.
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Abstract
Kalirin-7 (Kal7), a multi-functional Rho GDP/GTP exchange factor (GEF) for
Rac1 and RhoG, is embedded in the post-synaptic density at excitatory synapses,
where it participates in the formation and maintenance of dendritic spines. Kal7 has
been implicated in long-term potentiation, fear memories and addiction-like behaviors.
Using liquid chromatography and tandem mass spectroscopy, we identified sites
phosphorylated by six PSD-localized kinases implicated in synaptic plasticity and
behavior, sites phosphorylated when myc-Kal7 was expressed in non-neuronal cells
and sites phosphorylated in mouse brain Kal7. A site in the Sec14p domain
phosphorylated by calcium/calmodulin dependent protein kinase II, protein kinase A
and protein kinase C, was phosphorylated in mouse brain, but not in non-neuronal
cells. Phosphorylation in the spectrin-like repeat region was more extensive in mouse
brain than in non-neuronal cells, with a total of 20 sites identified. Sites in the
pleckstrin homology domain and in the linker region connecting the GEF domain to
the PDZ binding motif were heavily phosphorylated in both non-neuronal cells and in
mouse brain and affected GEF activity. We postulate that the kinase convergence
and divergence observed in Kal7 identify it as a key player in integration of the
multiple inputs that regulate synaptic structure and function.
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Introduction
In the mammalian forebrain, the vast majority of excitatory neurons synapse
onto dendritic spines315. Dendritic spines show rapid plasticity in both their size and
number in response to various stimuli126,127,316, a feature that is dependent on
rearrangement of the actin cytoskeleton which makes up the core of each spine143,268.
Rho-guanine nucleotide exchange factors (RhoGEFs) are critical regulators of the
actin cytoskeleton. In the mouse and human genomes there are ~60 Rho-GEFs and
these proteins are known to play important roles in cell signaling, actin rearrangement
and protein localization147. Dysfunctions in Rho-GEF signaling pathways are
associated with various mental retardation syndromes and schizophrenia149,256,317.
Previous studies have shown that about a dozen Rho-GEFs are localized to the
postsynaptic density70, a subcellular placement that puts these proteins in position to
participate in changes that occur in response to synaptic stimulation.
Kalirin-7 (Kal7) is an190kDa Rho-GEF that is a product of the extensively
spliced Kalrn gene. Linkage studies have identified roles for Kalrn in early onset
coronary artery disease318, schizophrenia152,225, and Alzheimers disease153. While
there are many isoforms of Kalirin, Kal7 accounts for the majority of Kalrn gene
products in the adult mammalian brain. Kal7 is localized almost exclusively to the
PSD and has a C-terminal PDZ-binding motif known to interact with PSD-95191. Over
the past decade a number of studies have demonstrated that Kal7 is essential for
dendritic spine formation and maintenance in cultured primary neurons192,193.
Additionally, Kal7 has been shown to interact with a number of other principal
components of the PSD including the scaffolding molecules DISC-1 and AF-6, as well
as with the enzyme iNOS and the glutamate receptor subunit NR2B74,194,197,200,202.
Mice with a constitutive genetic deletion of the exon unique to the Kal7 isoform show
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a significant decrease in dendritic spine density in the hippocampus, as well as
deficient long-term potentiation (LTP) and focal learning impairments260. When given
repeated doses of cocaine, the Kal7 knockout mice show abnormal dendritic spine
plasticity in the nucleus accumbens and have aberrant locomotor sensitization and
conditioned place preference responses267.
Despite its clear role in multiple signaling pathways, little is known about how
the catalytic activity, protein/protein and protein/lipid interactions of Kal7 are
regulated. As might be expected for a component of the PSD, phosphorylation of
Kal7 affects its function. A single site (Thr1590) in the unstructured region that links the
GEF domain of Kal7 to its PDZ binding motif is phosphorylated by the proline-directed
kinase Cdk5, increasing its catalytic GEF activity; Kal7 that cannot be phosphorylated
at this site (T1590A) produces dendritic spines of altered morphology232. Calcium
influx through NMDA receptors localized to the PSD triggers changes in spine
morphology and function, many of which result from activation of calcium/calmodulin
dependent protein kinase II (CaMKII)319,320. Based on indirect evidence, Xie et al.
suggested that CaMKII-mediated phosphorylation of Thr95 in the Sec14p domain of
Kal7 was essential for Kal7 to exhibit GEF activity254.
The PSD is home to at least 50 protein kinases, and Tiam-1 and β-Pix, other
Rho-GEFs localized to the PSD, are known to be regulated by
phosphorylation70,313,321,322. Advancements in phosphoproteomic and mass
spectroscopic techniques have begun to unearth the depth and breadth of the
phosphorylation events that occur at the PSD323. Hundreds of phosphorylation events
occur within the PSD in response to neurotransmitter stimulation; single proteins can
serve as phosphorylation hubs, being phosphorylated as many as 58 times by 23
different kinases72. We used liquid chromatography and tandem mass spectrometry
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to identify Kal7 as a potential phosphorylation hub. Using recombinant myc-Kal7, we
identified sites phosphorylated by protein kinase A, protein kinase C, CaMKII, casein
kinase II and Fyn.
Analysis of myc-Kal7 expressed in non-neuronal cells and endogenous Kal7
isolated from mouse brain revealed 39 sites of phosphorylation, many conserved in
the single Kalirin/Trio homologues found in D. melanogaster and C. elegans. Based
on direct analysis, Thr95 was neither phosphorylated in vivo nor a CaMKII site in Kal7.
While the functional consequences of the multiple phosphorylation events identified
remain to be determined, it is clear that Kal7 is a heavily phosphorylated target of
numerous PSD kinases.
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Materials and Methods
Cell culture and transfection
pEAK Rapid cells (Edge Biosystems, Gaithersburg, MD) were maintained in
DMEM:F12 medium containing 200 U/ml penicillin G, 20 µg/ml streptomycin sulfate,
25 mM HEPES, and 10% fetal bovine serum. Cells were fed with serum-free medium
for 2 hours before transfection. A vector encoding His6-myc-tagged full-length rat
Kal7195,232 was mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) in OptiMEM (Life Technologies) and added to the cells for 6 hours at 37°C to allow for
transfection. After six hours, cells were returned to growth medium for 24-48 hours.
Cells were stimulated with the cyclic AMP analog 8-Br-cAMP (500µM), the PKC
agonist phorbol myristate acetate (PMA) (1µM) and the calcium ionophore A23187
(10µM) for 30 minutes in the presence of two phosphatase inhibitors, calyculin A
(50nM) and fenvalerate (100nM). Cells were then extracted in lysis buffer containing
1% SDS, 50mM NaF and 2mM Na orthovanadate; after heating at 95°C for five
minutes, samples were centrifuged in a benchtop centrifuge for 15 minutes to remove
insoluble particulates. To prepare Kal7 for phosphorylation by known kinases, cells
were not stimulated and were harvested in SDS lysis buffer without phosphatase
inhibitors (see below).

Preparation of cortical/striatal tissue for immunoprecipitation
Male C57BL/6 mice (2-6 months) were sacrificed and striata and prefrontal
cortices were rapidly dissected and weighed on ice. Samples were then sonicated
into 15 volumes of lysis buffer containing 1% SDS, 50mM Tris [pH 7.4], 130mM
NaCl, 5mM EDTA, 50mM NaF, 1mM PMSF, protease inhibitor cocktail and
phosphatase inhibitor cocktails I & II (Calbiochem). Samples were heated at 95°C for
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five minutes and then centrifuged for 15 minutes in a benchtop centrifuge to remove
insoluble components. Following dilution into buffer containing NP-40 (see below),
samples were used for immunoprecipitation.
For isolating Kal7 from cultured cells or neurons, we used a Kal7 monoclonal
antibody (20D8, specific to the amino terminal portion of the final 20 amino acids of
Kal7)260 crosslinked to agarose beads using the Pierce Direct IP kit (Pierce, Rockford,
IL). Crosslinking was performed according to the manufacturer’s specifications. For
immunoprecipitation from cortex, 4-5mg of total protein (as determined by BCA) was
used for each sample; for cultured cells, protein from two wells of a six well plate was
used. Before immunoprecipitation, SDS lysates were incubated with 0.5 volumes of
15% NP-40 for 20 minutes at 4°C. Samples were then diluted with 5 volumes of TESmannitol (TM) buffer containing 50mM NaF and 2mM Na orthovanadate.
Immunoprecipitations were performed overnight with continuous agitation. In the
morning, beads were centrifuged and washed twice with TM + 1% TX-100 (TMT) and
twice with TM. Samples were then heated at 95C in 40µl of 1X Laemmli sample
buffer and fractionated on polyacrylamide gels.

Gel electrophoresis and staining
For isolation of Kal7, samples were analyzed on 4-15% polyacrylamide gels
(Bio-Rad, Hercules, CA). For samples from transfected cells, gels were stained with
Coomassie Brilliant Blue R-250. For samples immunoprecipitated from brain, proteins
were visualized using the SilverSNAP Kit (Pierce, Rockford, IL). For all samples, the
Kal7 band was excised using a sterile scalpel, placed into a sterile microfuge tube
and frozen on dry ice.
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Protein Digestion and TiO2 Enrichment
Gel bands were washed with 250µl 50% acetonitrile/50% water for 5 minutes
followed by 250µl 50mM ammonium bicarbonate/50% acetonitrile/50% water for 30
minutes, and 10mM ammonium bicarbonate/50% acetonitrile/50% water for 30
minutes. After washing, the gel was dried using a Speedvac and rehydrated with
0.1µg modified porcine trypsin (Promega) in 15 µl 10mM ammonium bicarbonate.
Samples were digested at 37°C for 16 hours.

Gel electrophoresis and staining
The digest was next acidified with 0.5% TFA, 50% acetonitrile. Top Tips
(Glygen Corp.) were prepared by washing with 3 x 40µl 100% acetonitrile, followed by
3 x 40µl 0.2M sodium phosphate pH 7.0, and 3 x 40µl 0.5% TFA, 50% acetonitrile.
Washes were spun through into an eppendorf tube at 2,000 rpm for 1 minute.
Acidified digest supernatants were loaded into Top Tips, spun at 1,000 rpm for 1
minute, and then 3,000 rpm for 2 minutes. Gel pieces were rinsed with 40µl 0.5%
TFA, 50% acetonitrile, with the supernatant transferred to the Top Tip and the spin
repeated. The Top Tip was then washed with 40µl 0.5% TFA, 50% acetonitrile and
the spin repeated. The flow through from these washes were saved and analyzed by
LC-MS/MS as below. Phosphopeptides were eluted from the TopTip with 3 x 30µl
28% ammonium hydroxide. Both the flow through and eluted fractions were dried
using a vacuum centrifuge, and then dried again from 40 µl of water. Samples were
dissolved in 3µl 70% formic acid, vortexed, diluted with 7µl 50mM sodium phosphate,
pH 7.8, spun and transferred to LC-MS/MS vials from which 5µl was injected.
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Liquid chromatography/mass spectrometry analysis (LC-MS/MS)
Was performed on a Thermo Scientific LTQ Orbitrap XL equipped with a
Waters nanoACQUITY UPLC system, a Waters Symmetry® C18 180µm x 20mm trap
column and a 1.7 µm, 75 µm x 250 mm nanoACQUITY™ UPLC™ column (35ºC) for
peptide separation. Trapping was done at 15µl/min, 99% Buffer A (100% water, 0.1%
formic acid) for 1 min. Peptide separation was performed at 300nl/min with Buffer A:
100% water, 0.1% formic acid and Buffer B: 100% CH3CN, 0.075% formic acid. A
linear gradient (51 minutes) was run with 5% buffer B at initial conditions, 50% B at
50 minutes, and 85% B at 51 minutes. MS was acquired in the Orbitrap using 1
microscan, and a maximum inject time of 900 followed by six data dependent MS/MS
acquisitions in the ion trap. Multistage activation was used for neutral losses of 98.0,
49.0, 32.7 and 24.5 amu. External calibration of the mass spectrometer was
performed as per the manufacturer with a solution of caffeine, MRFA and Ultramark
1621.

Identification of phosphorylated peptides
The LC-MS/MS data were searched using the Mascot Distiller and Mascot
search algorithms (Matrix Science, www.matrixscience.com). The Mascot Distiller
program combines sequential MS/MS scans from profile data that have the same
precursor ion. Charge states of +2 and +3 were preferentially located with a signal to
noise ratio of 1.2 or greater and a peak list was generated for database searching
against the NCBInr database, mouse taxonomy and/or the IPI mouse database. The
Mascot significance score match is based on a MOWSE score and relies on multiple
matches to more than one peptide from the same protein. Parameters used for
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searching were a significance threshold of p<0.05, a peptide tolerance of +20ppm,
MS/MS fragment tolerance of +0.6 Da, 1-3 missed cleavage sites and peptide
charges of +2 or +3. Variable modifications included propionamide, methionine
oxidation, phosphoserine, phosphothreonine and phosphotyrosine. Normal and decoy
database searches were run against the mouse Kal7 sequence (NCBI Reference
Sequence: NP_001157740.1).

Generation of Kal7 expression vectors
Point mutations of selected phosphorylation sites in rat His6-myc-Kal7
[Thr95/Ala (T95A); Ser487-Thr495/Ala-Ala (S3-ST/AA); Thr1519-Ser1520/Ala-Ala (PHTS/AA); Thr1519-Ser1520/Glu-Asp (PH-TS/ED); Tyr1653/Phe (Y1653F)] were introduced
into the His6-myc-Kal7 vector using the QuickChange point mutation kit (Stratagene,
La Jolla, CA) as described232. The constructs encoding the inactivated GEF (ND/AA)
and Kal7 lacking the Sec14p domain (∆Sec14p) were created previously195.

Rac activation assays
pEAK Rapid cells were transfected as described above with full length Kal7 or
one of the mutant Kal7 constructs. Twenty-four hours after transfection, cells were
scraped into MLB [25mM HEPES [pH 7.4], 150mM NaCl, 1% NP-40, 10mM MgCl2,
5mM EDTA, 2% glycerol, and protease inhibitor cocktail291] with 10µg/ml of GST-PakCRIB. Samples were briefly sonicated and centrifuged at 1000 x g for 5 minutes at
4°C to remove insoluble particulates. A sample of this supernatant was saved to be
measured as the input fraction and the remainder was incubated with 15µl of
glutathione Sepharose 4B resin for 1 hour at 4°C. Beads were then pelleted and
washed twice with 1X MLB; bound Rac was eluted by heating at 95°C for 5 min in
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30µl of 1X Laemmli buffer. Input and bound samples were analyzed on
polyacrylamide gels; Rac1 was detected with monoclonal antibody from Millipore
(Billerica, MA).

Dephosphorylation of His6-myc-Kal7 and phosphorylation by known kinases
His6-myc-Kal7 expressed in pEAK Rapid cells was left on the antibody beads,
which were exposed to Lambda phosphatase or calf intestinal phosphatase (CIP)
(both from New England Biolabs, Ipswich, MA). These phosphatases were chosen
because they have high specific activities for phosphorylated Ser/Thr and Tyr,
respectively (http://www.neb.com/nebecomm/tech_reference/protein
tools/phosphatases.asp). Samples to be treated with Lambda phosphatase were
washed with PMP buffer (50mM HEPES, 100mM NaCl, 2mM DTT, 0.01% Brij 35 [pH
7.5]) and resuspended in 1X PMP supplemented with 1mM MnCl2 and 2µl of Lambda
phosphatase. Samples to be treated with CIP were washed with NEB Buffer 3 (50mM
Tris-HCl, 100mM NaCl, 10mM MgCl2, 1mM DTT [pH 7.9]) and then resuspended in
NEB Buffer 3 with 2µl of CIP. All samples had 1µM PMSF and protease inhibitor
cocktail added for the phosphatase treatment, which was carried out for 60 minutes at
31°C with constant agitation. EDTA (50mM final concentration) was added to stop the
reaction; after 5 min, the beads were washed twice with TMT and once with TM. One
set of samples was boiled into sample buffer immediately after phosphatase
treatment to identify sites that were not dephosphorylated.
Each sample was then washed once with the appropriate kinase buffer and
resuspended in 100µl of the same buffer (detailed below) plus 200µM ATP,
phosphatase inhibitor cocktails I & II (Tocris Bioscience, Ellisville, MO), 1µM PMSF,
and protease inhibitor cocktail. Incubations were performed for 45 minutes at 31°C
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with agitation. Casein kinase II (CKII; 1000 units/reaction; New England BioLabs,
Ipswich, MA) was used in 20mM Tris-HCl, 50mM KCl, 10mM MgCl2 [pH 7.5] . The
catalytic subunit of protein kinase A (PKA; 5000 units/reaction; New England Biolabs,
Ipswich, MA) was used in 50mM Tris-HCl, 10mM MgCl2 [pH 7.5]. Calcium/calmodulin
dependent protein kinase II (CaMKII; 1000 units/reaction; New England Biolabs,
Ipswich, MA) was pre-activated by incubating 1000 units of enzyme in CaMKII buffer
(50mM Tris-HCl, 10mM MgCl2, 2mM DTT, 0.1mM Na2EDTA [pH 7.5]) containing
200µM ATP, 1.2µM calmodulin and 2mM CaCl2 for 10 minutes at 31°C. The activated
kinase was then added to the immunoprecipitated protein. Protein kinase C (PKCα;
~5000units/ reaction; Sigma-Aldrich, St. Louis, IL) was used in 50mM Tris-HCl,
10mM MgCl2 [pH 7.5]. Fyn (~7000 units/reaction; Sigma-Aldrich, St. Louis, IL) was
used in 50mM Tris-HCl, 10mM MgCl2, 2mM DTT, 0.1mM Na2EDTA [pH 7.5]. After
phosphorylation, the beads were pelleted, washed once with TMT and once with TM
and Kal7 was eluted into 1X Laemmli buffer by heating at 95°C for 5 min.
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Results and Discussion
Purified recombinant Kal7 is phosphorylated by kinases of multiple classes
Kal7 is a complex molecule with multiple functional domains (Fig. 5-1A). At its
N-terminus is a Sec14p domain that is known to interact with phosphatidylinositol-3phosphate and play an essential functional role195. The Sec14p domain is followed by
nine spectrin-like repeat regions that have been shown to interact with a variety of
other proteins including PAM (peptidylglycine α-amidating monooxygenase), Arf6 ,
HAPIP, iNOS and DISC-1196,197,200,324. While the spectrin-repeat region is not
necessary for GEF activity, it plays an essential role in the spine
formation observed when exogenous myc-Kal7 is expressed in neurons. The
spectrin-repeats are followed by tandem DH-PH domains characteristic of RhoGEFs147. At the extreme C-terminus of Kal7 is a PDZ-binding motif which binds to
PSD-95, AF-6 and a number of other PDZ-domain containing proteins194. The final 20
amino acids of Kal7, which are encoded by a separate 3’-terminal exon, are unique to
Kal7 and ΔKal7, an N-terminally truncated isoform. The PDZ-binding motif is
connected to the preceding GEF domain by an unstructured 60 amino acid linker
region.
In the adult rodent brain, Kal7 is highly localized to the PSD, a complex, 1
gigadalton molecular machine67,251. Proteomic analysis has demonstrated that more
than fifty kinases are localized to the PSD74. We selected kinases known to be
intricately involved in synaptic plasticity and evaluated their ability to phosphorylate
purified myc-Kal7 in vitro; Ser/Thr kinases from the basophilic (CaMKII, PKA, PKC),
acidophilic (CKII) and proline-directed (Cdk5) classes were selected, along with one
non-receptor tyrosine kinase (Fyn). Before exposure to these recombinant kinases,
myc-Kal7 was subjected to dephosphorylation by Lambda phosphatase (Ser/Thr
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Figure 5-1. Kinase-specific phosphorylation of Kal7
A. Purified myc-Kal7 is phosphorylated by recombinant protein kinases of different
classes. Myc-Kal7 purified from transiently transfected pEAK Rapid cells was
dephosphorylated. Recombinant kinases were then incubated with myc-Kal7 and
ATP. LC-MS/MS analysis revealed multiple phosphorylation sites for each of the
kinases except Cdk5. Sites that were not dephosphorylated by phosphatase
treatment are indicated by a star; Thr607 and Ser672 are consensus CKII sites
(NetPhos 1.0). B. Immunoprecipitated myc-Kal7 was treated with Lambda
phosphatase or CIP and then visualized with antibody specific for P-Thr or P-Tyr,
respectively. Equal loading of myc-Kal7 was determined by the presence of a single
Coomassie-stained band at the correct molecular weight that was not in an
immunoprecipitate from non-transfected cells (not shown). C. Sites phosphorylated
by each kinase are listed. Red lettering represents sites where multiple kinases
converged on a single residue. It was not possible to distinguish phosphorylation of
Thr1002 from phosphorylation of Ser1003.
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kinases) or calf intestinal alkaline phosphatase (Tyr kinases). Although extensive
dephosphorylation occurred (Fig. 5-1B), mass spectroscopic analysis of tryptic
peptides prepared from dephosphorylated myc-Kal7 revealed continued
phosphorylation of three Ser/Thr (Thr607; Ser672; Thr1519) and two Tyr (Tyr963, Tyr1342)
sites (marked by a star in Fig. 5-1A). Data for all of the tryptic phosphopeptides
identified in in vitro phosphorylated myc-Kal7 are summarized in Table 5-1.
Dephosphorylated myc-Kal7 was phosphorylated by each of the protein
kinases selected. With the exception of Cdk5, a proline-directed kinase studied
previously232, each protein kinase phosphorylated myc-Kal7 at more than one site
(Fig. 5-1A,C). The three basophilic kinases tested each phosphorylated the same two
sites in the Sec14p domain of myc-Kalirin (Thr79, Ser83). Kinase convergence of this
type is observed for many targets of synaptically localized protein kinases72. Casein
kinase II, an acidophilic kinase, phosphorylated one of these same sites in the
Sec14p domain (Ser83). In another case of kinase convergence, casein kinase II
phosphorylated a site in spectrin repeat 8 that was also phosphorylated by CaMKII
(Thr/Ser1002/3) and a site in the PH domain that was also phosphorylated by PKC
(Ser1520). The phenomenon of primed convergence, in which one phosphorylation
event facilitates another, may also occur. Both CKII and PKC phosphorylate Ser1520 in
the PH domain; the preceding residue, Thr1519, was not completely dephosphorylated
by the phosphatase treatment employed. The single tyrosine kinase tested, Fyn,
phosphorylated a site in spectrin repeat 4 along with the penultimate residue of the
PDZ binding motif (Tyr1653).
An essential role for CaMKII activity in the activation of Rac1 in neuronal
cultures was demonstrated using CaMKII inhibitors254. Based on indirect evidence, it
was suggested that CaMKII phosphorylated Kal7 at a single site, Thr95, leading to
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activation of its GEF domain. Using purified Kal7 and purified CaMKII, we observed
phosphorylation of Thr79, Ser83 and Thr/Ser1002/1003, but not of Thr95; the tryptic peptide
containing non-phosphorylated Thr95 was detected repeatedly (Table 5-1).

Identification of myc-Kal7 phosphorylation sites used in non-neuronal cells
Since purified myc-Kal7 was phosphorylated by multiple protein kinases, we
next sought to determine sites in myc-Kal7 that were phosphorylated in cells. For the
initial studies, myc-Kal7 was expressed in pEAK Rapid cells, a derivative of HEK293
cells that adopt a compact, round morphology in response to expression of mycKal7195. In an attempt to maximally phosphorylate myc-Kal7 and identify multiple
phosphorylation sites, we stimulated transfected cells with agonists of the PKA (8BrcAMP) and PKC (phorbol myristate acetate) pathways as well as a calcium ionophore
(A23187) and included cell permeant phosphatase inhibitors (calyculin A and
fenvalerate) in the incubation medium. Analysis of tryptic phosphopeptides of mycKal7 isolated from these cells revealed 20 unique phosphorylation sites (Figs. 5-2
and 5-3). These sites were identified from analysis of over 1700 individual peptides
identified from 8 different cell culture preparations. Data for all of the tryptic
phosphopeptides identified in myc-Kal7 purified from stimulated pEAK Rapid cells are
summarized in Table 5-2, a representative spectrum is shown in Fig. 5-2.
Phosphorylation sites appeared in clusters throughout the protein, with a
concentration of sites near the C-terminus, after the GEF domain and proximal to the
PDZ-binding motif (Fig. 5-3). The catalytic DH domain was notably lacking in
phosphorylation sites. This is of interest since modification of the DH domain might
affect the ability of Kal7 to activate Rac and affect its downstream targets at the
PSD131,325. Although multiple sites in the Sec14p domain were targets for purified
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CaMKII, PKA, PKC and CKII in vitro, no phosphorylation sites were identified in the
Sec14p domain when phosphorylation occurred in these non-neuronal cells. Although
the non-phosphorylated Thr95 peptide was detected more than twenty times (Table 52), the corresponding phosphopeptide was never identified.
Many of the sites phosphorylated by purified CKII and the single site
phosphorylated by purified Cdk5 in vitro were identified in myc-Kal7 phosphorylated
in cells (Fig. 5-3). Phosphorylation at CKII sites was especially common, with four of
the six sites phosphorylated by purified CKII also utilized in non-neuronal cells; two of
these sites are located in the linker region that precedes the PDZ-binding motif, one
in the linker that connects the ninth spectrin repeat to the GEF domain, and one in the
PH domain. The Cdk5 site (Thr1590) utilized in vitro232 also occurs in the region
immediately preceding the PDZ binding motif and was phosphorylated in cells. Seven
additional sites in this linker region were phosphorylated in Kal7 isolated from pEAK
Rapid cells. Given that this C-terminal portion of the protein is known to be critical for
Kal7 to interact with PDZ scaffolding molecules in the PSD, it is likely that some of the
phosphorylation events in this region affect these interactions70,194,326.
In addition to the phosphorylation hot spot detected in the C-terminal linker
region of the protein, small clusters of phosphorylation sites were detected in the third
and fifth spectrin repeat regions of Kal7 (Fig. 5-3). Each spectrin repeat is comprised
of three anti-parallel α-helices connected by loop regions327. In both of these spectrin
repeats, these clusters occur near the end of the second α-helix and in the linker
region that joins it to the third α-helix. The cluster in the third spectrin repeat overlaps
the SH3 binding motif (PLS487P) shown previously to be involved in an intramolecular
interaction with the SH3 domain present in the longer isoforms of Kalirin199. One of
the sites in spectrin repeat five immediately follows Arg722, which is exposed and
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Figure 5-2. Identification of phosphorylated Ser1520 in myc-Kal7 expressed in
pEAK Rapid cells
The spectrum from MS/MS of the doubly charged M+2 1004.46 ion of peptide
K.LLTpSELGVTEHVEGDPCK.F is shown. Based on the y10 and y15-H3PO4 ion,
residue 1520 is phosphoserine. Observed M=2005.8886; calculated M=2005.9068.
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Figure 5-3. Phosphorylation of myc-Kal7 in non-neuronal cells
Experiments on transfected myc-Kal7 were undertaken to determine the extent of
phosphorylation of the protein. Cells were treated with multiple stimulants (8-BrcAMP, PMA, A23187) as well as multiple phosphatase inhibitors (Calyculin A,
Fenvalerate) in order to induce maximal phosphorylation. Sites are indicated on the
Kal7 schematic by a black dot and a bold letter followed by the residue number.
There were two instances in which the phosphorylation site could not be pinpointed to
one of two closely spaced residues; these residues are marked by a hatched dot.
Text boxes indicate sites that were phosphorylated by the purified kinases tested.
Phosphorylation sites in the SH3 binding motif and within the PDZ binding motif are
highlighted, as they may be critical for protein-protein interactions. Tyr963, which was
not dephosphorylated by phosphatase treatment, is indicated by a filled star.
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susceptible to limited tryptic digestion of native Kal7.
In addition to the phosphorylation hot spot detected in the C-terminal linker
region of the protein, small clusters of phosphorylation sites were detected in the third
and fifth spectrin repeat regions of Kal7 (Fig. 5-3). Each spectrin repeat is comprised
of three anti-parallel α-helices connected by loop regions327. In both of these spectrin
repeats, these clusters occur near the end of the second α-helix and in the linker
region that joins it to the third α-helix. The cluster in the third spectrin repeat overlaps
the SH3 binding motif (PLS487P) shown previously to be involved in an intramolecular
interaction with the SH3 domain present in the longer isoforms of Kalirin199. One of
the sites in spectrin repeat five immediately follows Arg722, which is exposed and
susceptible to limited tryptic digestion of native Kal7.

Phosphorylation of cortical and striatal Kal7
We next wanted to determine the phosphorylation status of endogenous Kal7 under
baseline conditions so that we could evaluate factors that regulate its phosphorylation
and dephosphorylation in vivo. We selected mouse prefrontal cortex and striatum for
these experiments because these brain regions are involved in learning, emotion,
decision making and drug addiction6,10,23-27,328,329, behaviors known to be altered in
Kal7KO mice260,267. Given the higher levels of Kal7 in the cortex, we were able to
obtain enough Kal7 from the prefrontal cortices of four mice; on average, six mice
were used to prepare striatal Kal7. In order to solubilize Kal7, lysates were prepared
using boiling SDS; Kal7 was not efficiently solubilized by milder detergents such as
1% TX-100260. Following the addition of NP-40 (to achieve an NP-40/SDS weight ratio
of 7.5/1) and dilution into a buffer lacking detergent, endogenous Kal7 was
immunoisolated using a monoclonal antibody specific for the C-terminus of Kal7 that
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was covalently attached to beads (Fig. 5-4A). All of the Kal7 in a lysate containing 0.5
mg of protein was bound to 20 µl of antibody resin (Fig. 5-4B,C). Kal7 eluted from the
antibody resin was purified by SDS-PAGE; Kal7, which has a predicted mass of 190
kDa, was readily identified by silver staining (Fig. 5-4D). A gel slice containing Kal7
was excised, processed to eliminate detergent and digested with trypsin; following
adsorption to TiO2 tips, LC-MS/MS analysis was carried out as described for mycKal7 isolated from transiently transfected cells. Coverage and data for all of the tryptic
phosphopeptides identified in prefrontal cortex and striatal Kal7 are summarized in
Table 5-3, a representative spectrum is shown in Fig. 5-5. The sites shown were
identified from a total of eight Kal7 preparations and reflect analysis of almost 700
individual peptides.
Kal7 isolated from mouse brain was extensively phosphorylated, with a total of
22 sites identified (Fig. 5-6A and Table 5-3). The only domains not phosphorylated
were spectrin repeat six and the catalytic DH domain. Only nine of the 22 sites were
also phosphorylated in myc-Kal7 expressed in non-neuronal cells (Fig. 5-6A;
indicated by white stars); four of the nine common sites are located in the C-terminal
linker region and two of these sites are CKII sites. Strikingly, only five of these 22
sites were phosphorylated in vitro by purified CaMKII, PKA, PKC or CKII, suggesting
a major role for other protein kinases and for substrate and kinase subcellular
localization and control. Of the 22 unique phosphorylation sites, only one was a
tyrosine residue (Y963), which was not phosphorylated by recombinant Fyn in our in
vitro experiments but was resistant to phosphatase treatment. To ensure that we
were not missing tyrosine phosphorylations due to their relatively low stoichiometry,
we immunoprecipitated Kal7 tryptic peptides using beads coated with a high
concentration of anti-phosphotyrosine antibody. These samples were analyzed by

174

Figure 5-4. Purification of Kal7 from striatum and cortex
A. Flow chart summarizes the steps that were taken in purifying, digesting and
analyzing Kal7 from adult mouse brain. B. The specificity and efficacy of Kal7
monoclonal antibody 20D8 was validated by varying the amount of antibody used to
recover Kal7 from 0.5 mg of cortical protein and comparing the amount recovered to
the input; the beads themselves created no background staining. C. After
immunoprecipitation, an aliquot of the unbound fraction was analyzed (Unbd.); it
contained no detectable Kal7, demonstrating effective recovery of Kal7 from the
lysate. D. A representative silver stained gel of Kal7 immunoprecipitated from cortex
revealed a single 190kDa band, which was excised from the gel and subjected to
analysis.
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LC-MS/MS to look for phosphorylated tyrosines; no additional tyrosine
phosphorylation sites were identified (data not shown).
Unlike myc-Kal7 expressed in pEAK Rapid cells, the Sec14p domain of endogenous
Kal7 was phosphorylated. The only phosphorylation site identified in the Sec14p
domain was Thr79, a site phosphorylated by CaMKII, PKA and PKC in vitro. Once
again, a tryptic peptide containing P-Thr95, the putative CaMKII site reported by Xie et
al.254, was never detected; however, the non-phosphorylated peptide was detected
repeatedly (Table 5-3). The other CaMKII site identified using purified kinase and
purified substrate, Thr/Ser1002/1003, was also phosphorylated in Kal7 isolated from
mouse brain. While our data support the conclusion that Kal7 can be phosphorylated
by CaMKII, the phenomenon of kinase convergence means that additional
experiments will be required to identify the protein kinase responsible for
phosphorylation of these sites under different in vivo conditions.
In contrast to myc-Kal7 isolated from transiently transfected non-neuronal
cells, the spectrin repeat regions in Kal7 purified from prefrontal cortex and striatum
were riddled with phosphorylation sites. These phosphorylation sites were aligned
with the previously predicted secondary structure324 of the spectrin repeats (Fig. 56B). As observed in non-neuronal cells, most of these phosphorylation sites occurred
at the end of helix A or helix B or in the loop that follows; none occur in the linker
regions that connect adjacent spectrin repeat regions. Although spectrin repeat
regions 3 and 5 were multiply phosphorylated when Kal7 was expressed in nonneuronal cells, most of the sites identified in brain Kal7 differed from those identified
in non-neuronal myc-Kal7 (Fig. 5-6B).
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Figure 5-5. Identification of phosphorylated Thr79 from mouse brain Kal7
The spectrum from MS/MS of the doubly charged M+2 930.44 ion of Peptide
K.LVpTYLASVPSEDVCKR.G is shown. Based on the b and y ions, and the tentative
b13-H3PO4, residue 79 is phosphorylated. Observed M=1858.8697; calculated
M=1858.8900.
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Figure 5-6. Phosphorylation of cortical/striatal Kal7
A. Numerous phosphorylation sites were identified in Kal7 immunoisolated from
mouse prefrontal cortex and striatum. Sites are again indicated by a black dot and the
residue number of the phosphorylated site. Sites identified in myc-Kal7 from pEAK
Rapid cells and Kal7 from mouse brain are marked with a white star, sites that were
phosphatase resistant are marked with a filled star. Text boxes again indicate sites
that were phosphorylated by purified kinases and hatched dots indicate where an
exact identification of a phosphorylated residue was not possible. B. Top. Spectrin
repeats are each composed of three antiparallel α-helices (A/B/C) connected by linker
regions327. Bottom. Phosphorylation sites in the spectrin repeats of Kal7 are located
with reference to the predicted secondary structure; filled circles, neuronal Kal7; open
circles, non-neuronal myc-Kal7; gray circles, shared sites. Ambiguous assignments
are shown by a single circle.
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Phosphorylation in the spectrin-like repeats could affect the
alignment/orientation of the helices and alter protein function. The region between
spectrin repeats 4 and 5 is of particular interest since it is responsible for the
interaction of Kal7 with iNOS197. Additionally, spectrin repeat regions 4 and 5 are
involved in the interaction of Kal7 with Arf6, DISC-1 and PAM196,200,324. The proteinprotein interactions of spectrin repeats can be disrupted by small perturbations in
their structure330. For example, phosphorylation of a single site in one of the 22
spectrin repeats of utrophin alters its ability to interact with dystroglycan331.
Additionally, the phosphorylation sites in spectrin repeats 4 and 5 fall at the
junction of the two splice forms of Kalirin, Kal7 and ∆Kal7. ∆Kal7, which begins with
the fifth spectrin repeat of full length Kal7, has the same unique 20 amino acid
sequence as Kal7 at its C-terminus. The properties of ∆Kal7 are very different from
those of Kal7: unlike Kal7, ΔKal7 is soluble; in addition, when expressed in neurons,
ΔKal7 increases dendritic spine size but does not increase dendritic spine number195.
Phosphorylation sites in spectrin repeat 4 may be critical for some of the interactions
that are unique to full length Kal7. Based on this, it seems likely that the six
phosphorylation sites located in spectrin repeats 4 and 5 play an important role in
regulating Kalirin function.
Two consecutive residues in the PH domain of endogenous Kal7 were
phosphorylated (Thr1519, Ser1520). Interestingly, in preparing substrate for the kinase
experiments presented in Fig. 5-1, we found P-Thr1519 resistant to dephosphorylation
by either of the phosphatases utilized. Both recombinant PKC and recombinant CKII
phosphorylated Ser1520 in purified Kal7, which may suggest a primed convergence
mechanism wherein Thr1520 can be phosphorylated only if Thr1519 is also
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phosphorylated. Comparison of the Kal7 PH domain with the crystal structure of the
highly homologous Trio PH domain predicts that Thr1519-Ser1520 are in the loop
between the third and fourth β sheets of the PH domain332. This region is on the
surface of the structure, should be accessible to kinases and might affect the ability of
the PH domain to interact with phospholipids or other proteins333.
As with myc-Kal7 expressed in non-neuronal cells, the 60 amino acid linker
region between the end of the PH domain and the beginning of the region unique to
Kal7 was extensively phosphorylated in mouse brain under baseline conditions; four
phosphorylation sites were identified in this region, all of which were also detected in
myc-Kal7. Tryptic peptides containing Thr1590 or P-Thr1590, a known Cdk5
phosphorylation site, were not detected in digests of endogenous Kal7, perhaps
reflecting the fact that complete tryptic cleavage produces a tetrapeptide (K.TPAK.L),
which is too small for detection by the mass spectrometer. Detection of this
phosphopeptide in myc-Kal7 relied upon missed cleavages by trypsin (Table 5-2).

Effect of phosphorylation on GEF activity
To determine if phosphorylation might have an effect on the GEF activity of Kal7, we
made non-phosphorylatable ThrAla and phosphomimetic ThrGlu/SerAsp point
mutations at selected sites and assessed the effect on Rac activation using pEAK
Rapid cells (Fig. 5-7). We used full length myc-Kal7 as a control, included Kal7 with
its catalytic DH domain mutated (ND/AA: Asn1415-Asp1416/Ala-Ala) as a negative
control and normalized Rac-GTP to expressed Kal7 using the Kal7-specific antibody.
As expected, the ND/AA mutant was much less active than Kal7. Although, it was
never identified as a phosphorylation site in any of our assays, we mutated Thr95 to
Ala since this mutation was reported to eliminate the GEF activity of Kal7254. In our
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hands, this mutation produced a nearly two-fold increase in Rac activation. To ensure
that the construct encoded the desired mutant, it was re-sequenced, confirming that
Thr95 had been mutated to Ala. As a further check on the importance of this region,
we tested a mutant of Kal7 lacking the entire Sec14p domain (∆Sec14p). This
construct displayed Rac activation activity that was indistinguishable from that of
Kal7. These results, coupled with our ability to identify Thr95, but not P-Thr95 in
exogenous and endogenous Kal7 (Tables 5-1 – 5-3), call into question the
conclusion that the ability of Kal7 to activate Rac requires phosphorylation of Thr95 by
CaMKII254.
Since myc-Kal7 is approximately 4-fold less active than its isolated GEF
domain (myc-Kal-GEF1)195, we explored the effect of a spectrin domain mutation on
activity. We mutated two sites in the SH3 binding motif located in the third spectrin
repeat (Ser487-Thr495/Ala-Ala) because this region is known to be involved in
intramolecular interactions199. Rac activation activity was unaltered by this mutation
(Fig. 5-7). Given the proximity of the PH and DH domains, we mutated the two
adjacent phosphorylation sites identified in the PH domain, Thr1519-Ser1520/Ala-Ala and
Thr1519-Ser1520/Glu-Asp. The non-phosphorylatable Ala-Ala mutant was significantly
more active than myc-Kal7; the phosphomimetic Glu-Asp mutant was significantly
less active than the Ala-Ala mutant, but was not significantly less active than the mycKal7. We also mutated Tyr1653, which is located in the 20 amino acid region unique to
Kal7; mutation of this Fyn site, which lies in the PDZ binding motif, had no effect on
Rac activation (Fig. 5-7).
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Figure 5-7. Rac activation activity of Kal7 point mutants
pEAK Rapid cells were transfected with vectors encoding the indicated proteins; Rac
activation was assessed by adding GST-Pak-CRIB to the homogenization buffer and
normalizing the amount of activated Rac (bound to glutathione agarose beads by
GST-Pak-CRIB) to the amount of Kal7 protein in the lysate (assessed using a Kal7specific antibody)260. Data are the mean of at least 4 separate transfections; error
bars represent standard error. (**p<0.01; ***p<0.001; t-Test)
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The catalytic activity of a number of other RhoGEFs localized at the PSD is
altered by phosphorylation; Tiam1334, β-Pix335,336, Ephexin1264, and Arhgef2 (a.k.a.
LFC or GEF-H1) are regulated in this manner337,338. Indeed we have previously shown
that the catalytic activity of Kal7 is increased by phosphorylation of Thr1590 in the
unstructured C-terminal region of the protein232. The fact that the isolated GEF
domain of Kal7 is more active than Kal7 or ∆Kal7195, demonstrates the common
occurrence of N-terminal autoinhibition. Further support for this phenomenon comes
from the ease with which Cdk5 phosphorylates Thr1590 in a protein that extends from
the GEF domain to the end of Kal7 compared to the inaccessibility of this site in
ΔKal7232; the presence of spectrin repeats 5 through 9 clearly inhibits the ability of
Cdk5 to access this site. Given the number of phosphorylation sites identified in the
spectrin repeat regions, determining how their phosphorylation affects the status of
the GEF domain will be a complex undertaking.

Conservation of Phosphorylation Sites
In order to focus on phosphorylation sites of functional importance, we
assessed their conservation in Kalirin and in Trio using Clustal analysis (Fig. 5-8).
Interestingly, all of the phosphorylation sites identified were conserved evolutionarily
from the human to the blowfish (fugu) genome; substitution of a serine for a threonine
was counted as a conserved site. Nineteen of the sites are also conserved in the
orthologous Trio gene. Finally, six of the phosphorylation sites that we identified are
completely evolutionarily conserved from human through Drosophila and C. elegans,
where Kalirin and Trio are encoded by a single gene. These findings suggest two
interesting possibilities. The first is that sites that are fully conserved are of critical

183

importance to controlling GEF activity. If the ability to phosphorylate these sites were
critical to development or function of the nervous system, mutation could not be
tolerated. Since the Kalrn and Trio genes fulfill non-redundant roles, the second
suggestion is that phosphorylation sites unique to Kalirin are of importance to its
unique roles during development, in specific tissues or at specific subcellular
locations.
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Figure 5-8. Evolutionary conservation of 35 identified phosphorylation sites
The sequences of the proteins encoded by Kalrn and Trio from human, mouse,
chicken and fugu, D. melanogaster Trio and C. elegans Unc73 were aligned using
Clustal. Identified Ser/Thr and Tyr phosphorylation sites conserved in both genes in
all species are circled; sites conserved in species with separate Kalrn and Trio genes
are underlined; the remaining sites (bold) are conserved in Kalrn but not in Trio. The
only site unique to the Kal7 isoform is Thr1652.

185

Conclusions
Over the past decade, the importance of Kal7 as a regulator of dendritic spine
morphology and synaptic plasticity has been established70,260,267. While previous
studies have focused on single phosphorylation events232,254,265, it is now clear that
Kal7 could serve as a PSD signaling node and hub for phosphorylation. Comparing
the phosphorylation sites characterized in Kal7 to proteomic analyses of all
phosphorylation events at the PSD identifies Kal7 as one of the most highly
phosphorylated targets in the PSD72. Previous phosphoproteomics surveys identified
only a few sites in Kalirin. One analysis of the PSD proteome identified no sites in
Kalirin72 and the PHOSIDA project339 identified only six (Ser487, Ser491, Ser493, Thr495,
Thr497 and Ser1376); four of these sites were identified in our analyses while two were
not (S497 and S1376).
While many of the kinases that phosphorylate Kal7 remain to be identified, we
have shown that it is phosphorylated by six kinases known to play critical roles in
learning, memory and synaptic plasticity (PKA, PKC, CaMKII, CKII, Cdk5, Fyn).
Future studies will focus on regulated phosphorylation of Kal7 at sites targeted by
these protein kinases. Mice genetically lacking Kal7 have deficient fear conditioning
memory formation and respond aberrantly to repeated administration to drugs of
abuse260,267. We will now begin to look at how these phosphorylation events change in
a quantitative fashion in animals that have been given a footshock or repeated
injections of cocaine. Hopefully, learning about how phosphorylation events affect the
catalytic activity or localization of Kal7 will help us clarify the specific role that this
important protein plays in synaptic plasticity.
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Residue Score Peptide Sequence
CamKII
79
38.67 R.KLVpTYLASVPSEDVCK.R
83
33.22 K.LVTYLApSVPSEDVCKR.G
1002/1003 26.16 K.pTpSEQVCSVLESLEQEYR.R
95-Non
67.48 R.GFTVIID
PKA
79
35.64
83
28.25
PKC
PKC
79
32.12
83
33.49
1520
63.22
CKII
CKII
83
30.44
1002/1003 48.81
1247
35.52
1249
83.59
1520
43.97
1608
91.63
1632
86.22
Fyn
Fyn
591
34.3
1653
56.15
Not dephosphorylated
607
62.72
672
52.77
1519
53.79
963
36.75
1342
61.96

M/Z
916.4415
930.4441
693.9797
534.2798

PKA

R.KLVpTYLASVPSEDVCK.R
K.LVTYLApSVPSEDVCKR.G

916.4418
930.4448

R.KLVpTYLASVPSEDVCK.R
K.LVTYLApSVPSEDVCKR.G
K.LLTpSELGVTEHVEGDPCK.F

916.441
930.4434
1003.952

K.LVTYLASVPSEDVCKR.G
K.pTpSEQVCSVLESLEQEYR.R
K.ALGVNTEDNKDLELDIIPApSLSDR.E
K.DLELDIIPASLpSDR.E
K.LLTpSELGVTEHVEGDPCK.F
R.DGVEDGDpSQGDGSSQPDTISIASR.T
R.TSQNTVEpSDKDGNLVPR.W

930.4428
1040.466
893.4325
818.8926
1003.951
1236.997
970.4376

K.RHDDFEEVAQNTpYTNADK.L
R.WHLGPGDPFSTpYV.

744.9745
778.3316

K.LLEAAEQLAQpTGECDPEEIYK.A
K.EVLEDVCADpSVDAVQELIK.Q
K.LLpTSELGVTEHVEGDPCK.F
K.AEALLQAGHpYDADAIRECAEK.V
K.pYEQLPEDVGHCFVTWADK.F

1215.531
1077.988
1003.952
1177.519
1108.962

Table 5-1: Sites in myc-Kal7 Phosphorylated by Recombinant Kinases
All peptides are numbered using the sequence of rat Kal7 with the N-terminus
encoded by the KalrnA promoter (U88157). Peptides are grouped by the kinase used
for phosphorylation. For each peptide, the sequence is shown, with cleavage sites
indicated by dots and the phosphorylated residue in red. EN/FT indicates whether the
peptide was detected in the TiO2 enriched (EN) or unbound (FT) fraction. M/Z,
mass/charge ratio. Information for the non-phosphorylated Thr95 peptide (95-Non) is
provided along with the data for CamKII.
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Residue Score Peptide Sequence
487
82.08 K.ALLDVLQRPLpSPGNSESLTATANYSK.A
491
59.87 K.ALLDVLQRPLSPGNpSESLTATANYSK.A
493/495
56.12 K.ALLDVLQRPLSPGNSEpSLpTATANYSK.A
710
28.31 R.pSAPPSLGEPTEAR.D
724
47.39 R.SAPPSLGEPTEARDpSAVSNNK.T
963
27.45 K.AEALLQAGHpYDADAIRECAEK.V
1188
22.95 K.LLIQLADpSFVEK.G
1249
22.84 K.DLELDIIPASLpSDR.E
1520
53.17 K.LLTpSELGVTEHVEGDPCK.F
1590
61.94 K.GALKEPIQLPKpTPAK.L
1598
92.54 R.NNpSKRDGVEDGDSQGDGSSQPDTISIASR.T
1608
70.43 K.RDGVEDGDpSQGDGSSQPDTISIASR.T
1613
71.06 K.RDGVEDGDSQGDGpSSQPDTISIASR.T
1614
57.92 R.DGVEDGDSQGDGSpSQPDTISIASR.T
1618
59.31 R.DGVEDGDSQGDGSSQPDpTISIASR.T
1620
65.83 R.DGVEDGDSQGDGSSQPDTIpSIASR.T
1625/1626 63.93 R.pTpSQNTVESDKDGNLVPR.W
1629
54.98 R.TSQNpTVESDKDGNLVPR.W
1632
75.24 R.TSQNTVEpSDKDGNLVPR.W
1652
24.06 R.WHLGPGDPFSpTYV.95-Non

70.54

R.GFTVIIDMR.G

M/Z
942.474
942.475
942.475
696.314
1104.002
1177.522
728.381
818.896
1003.957
835.967
1024.776
877.039
877.039
1334.662
825.007
825.006
970.442
970.443
970.441
778.336
526.284

Table 5-2. Sites in myc-Kal7 Phosphorylated in Non-Neuronal Cells
The peptides used to identify phosphorylation sites in Myc-Kal7 expressed in
stimulated pEAK Rapid cells are identified; formatting for Table 5-2 is the same as
Table 5-1. Closely spaced Ser and Thr residues, where the phosphorylation site could
not be unambiguously assigned, are indicated. Thr95 was not identified as a
phosphorylation site; data for the non-phosphorylated Thr95 peptide (95-Non) are
provided.
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Residue
79
189
379
487
592
607
672
714
943
963
1002/1003
1077
1085
1111
1198
1215
1519
1520
1608
1613
1614
1632

Score
53.91
90.2
51.26
54.54
44.93
27.44
37.24
23.47
36.62
26.16
45.91
33.33
28.75
33.29
24.52
21.59
74.75
63.71
72.76
46.57
54.29
32.83

95-Non

49.3

Peptide Sequence
K.LVpTYLASVPSEDVCKR.G
R.LpSLEEFFNSAVHLLSR.L
R.LpSEAGHYASQQIK.Q
K.ALLDVLQRPLpSPGNSESLTATANYSK.A
K.RHDDFEEVAQNTYpTNADK.L
K.LLEAAEQLAQpTGECDPEEIYK.A
K.EVLEDVCADpSVDAVQELIK.Q
R.SAPPpSLGEPTEAR.D
K.pTHQSALQVQQK.A
K.AEALLQAGHpYDADAIRECAEK.V
K.pTpSEQVCSVLESLEQEYR.R
R.NNVpSMPSVASHTR.G
R.NNVSMPSVASHpTR.G
R.VLHFWpTLK.K
K.GHIHApTEIR.K
R.DFpSLR.M
K.LLpTSELGVTEHVEGDPCK.F
K.LLTpSELGVTEHVEGDPCK.F
K.RDGVEDGDpSQGDGSSQPDTISIASR.T
R.DGVEDGDSQGDGpSSQPDTISIASR.T
R.DGVEDGDSQGDGSpSQPDTISIASR.T
R.TSQNTVEpSDKDGNLVPR.W

M/Z
930.4421
971.4714
756.3428
942.4711
744.9724
1215.534
1077.983
696.311
674.3194
1177.518
1040.438
748.3161
748.314
562.2866
557.2586
717.2919
1003.954
1003.947
877.0382
825.0034
1236.996
647.2962

R.GFTVIIDMR.G

526.283

Table 5-3. Sites in Kal7 Phosphorylated in Mouse Brain.
The peptides used to identify phosphorylation sites in Kal7 immunoisolated from
mouse brain (prefrontal cortex and striatum) are identified; formatting for Table 5-3 is
the same as Table 5-1. Closely spaced Ser and Thr residues, where the
phosphorylation site could not be unambiguously assigned, are indicated. Thr95 was
not identified as a phosphorylation site; data for the non-phosphorylated Thr95 peptide
(95-Non) are provided.
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Chapter 6: Conclusions and Future Directions
These experiments have done much to identify Kal7 as a critical mediator of
synaptic and behavioral plasticity in the mouse brain. Prior to the studies carried out
in Chapter 2, nearly all work examining the functional properties Kal7 had been
performed in vitro192-194,239,324. While these initial studies provided an excellent
foundation for future research, the studies on the Kal7KO animal have allowed more
detailed exploration of Kal7 function at the synapse. From these studies we can now
see that the Kal7KO mice are a potential tool for understanding various pathways
involved in drug addiction (Chapter 3) and potentially numerous other
psychiatric/neurological disorders (Chapter 2&3). In addition to providing a tool to
model disease, initial studies on the Kal7KO mice lead to the series of experiments
revealing a novel Kal7-NR2B interaction. From this, a functional link between these
two proteins has been identified that may serve a critical role in synaptic plasticity
(Chapter 4). Finally, using mass spectrometry analyses we were able to identify Kal7
as a phosphorylation hotspot, and as a target of numerous protein kinases that are
integral to normal synaptic plasticity (Chapter 5). Much like the studies performed in
vitro, these preliminary studies of the Kal7KO animals have laid a foundation that will
hopefully support studies examining Kal7 function with even further depth and
breadth.

Model of Kal7 at the synapse
Based on the results of these studies, I would like to propose a preliminary
model for Kal7 function at the synapse. In a Wt synapse, Kal7 is bound to a portion of
NR2B receptors, stabilizing them at the membrane (Fig. 6-1A). Kal7 has previously
been shown to act as an inhibitor of transferrin endocytosis when expressed in non-
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A. Wt Synapse

B. Kal7KO Synapse

Figure 6-1. Diagrammatic model of Wt and Kal7KO synapses
A. In this theoretical model of a Wt synapse, Kal7 is present and bound to a subset of
NR2B, helping to localize it to the synapse. Additionally, PSD kinases are
phosphorylating Kal7 on multiple residues. This synapse is ripe for potentiation. B. In
the Kal7KO synapse, Kal7 is not present to bind to NR2B. This results in a deficit in
surface NR2B. This synapse has a much higher threshold for the development of
LTP, and may not be able to achieve NMDA-dependent LTP.
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neuronal cells195, so the concept that Kal7 might affect surface stabilization of a
receptor is not without basis. As was demonstrated in Chapter 5, Kal7 interacts
specifically with NR2B and knockout of Kal7 affects surface localization of this
receptor. In the Wt synapse presented in Fig. 6-1A, a fraction of the NR2B is
localized to the synapse, as are its many other intracellular binding partners. A
number of recent studies have suggested that the presence of NR2B and its binding
partners to the synapse is critical in its ability to influence synaptic plasticity88,91. When
these synaptic NR2B receptors are activated, calcium influx activates intracellular
signaling cascades (e.g. CamKII) that are essential for LTP. This synapse is then
able to be potentiated and stabilized, leading to normal learning and memory
processes. A number of studies have suggested that newly formed and immature
spines have higher contents of NR2B, which is required for their potentiation and
stabilization87,94-96,104,107,122,340. Kal7 has also been shown to be important for the
formation and stabilization of dendritic spines192-194. It is possible, that one way Kal7
helps to stabilize newly formed dendritic spines is by helping to localize NR2B to
these nascent synapses.
While the role that phosphorylation at specific sites plays in regulation of Kal7
localization and activity remains unclear, Kal7 is heavily phosphorylated even under
basal conditions (Chapter 5). Importantly, Kal7 is targeted by a number of kinases
that are known to be crucial for multiple aspects of synaptic plasticity such as CamKII,
PKA and Cdk5 (Fig. 6-1A). Phosphorylation of the C-terminus of Kal7 by Cdk5 had
previously been shown to affect both the catalytic and morphogenic properties of
Kal7232. While our recent study revealed that phosphorylation of specific sites altered
the catalytic activity of Kal7, this is far from being the full picture. It seems highly
probable that some of the many phosphorylation sites in Kal7 will be critical for its
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localization and for protein-protein interactions, as well as influencing GEF activity.
These events may be critical in the ability of Kal7 to modulate behavior.
In the Kal7KO synapse, NR2B cannot interact with Kal7, thus decreasing its
surface localization (Fig. 6-1B). This lack of plasma membrane NR2B localization
may contribute to the lack of hippocampal LTP (Chapter 2 and Lemtiri-Chlieh et al.,
Submitted) and the behavioral abnormalities seen in Kal7KO animals (Chapters 2 &
3). Indeed, when NR2B currents are pharmacologically inhibited, Wt mice come to
phenocopy Kal7KO mice in both conditioned place preference and passive avoidance,
while Kal7KO mice remain relatively unaffected (Chapter 4). Additionally, since NR2B
receptors seem to be critical for the formation of new synapses, particularly after
cocaine treatment, this lack of cell surface NR2B may help to explain the
morphological abnormalities in the Kal7KO mice following cocaine (Chapter 3).
While the model proposed in Fig. 6-1 is based on experimental data from the
preceding chapters, it is still speculative and incomplete. However, there are a
number of interesting future directions for this research that will help to clarify this
picture. I would like to take this opportunity to briefly cover some of the possibilities
for future research on the role of Kal7 in behavior and at the synapse.

Future Directions
Kalirin and receptor trafficking
The model proposed in Fig. 6-1 suggests that binding of the Kal7 PH domain
to NR2B helps to stabilize NR2B at the synapse. Given the fact that Kal7KO mice
display decreased surface levels of NR2B (Chapter 4) and that Kal7 inhibits
transferrin endocytosis in non-neuronal cells, this is entirely possible. However, we
cannot yet say definitively that this is the case. A finding of decreased NR2B on the
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surface of Kal7KO neurons may represent decreased surface delivery, increased
endocytosis or altered post-endocytic sorting of NR2B. Additionally, it is important to
take into account that the larger Kalirin isoforms (Kal9 & 12) can bind NR2B through
either of their PH domains (not pictured in Fig. 6-1B). It is entirely possible that the
upregulation of other Kalirin isoforms seen in the Kal7KO animals leads an increase in
NR2B endocytosis via PH domain binding.
The simplest solution for examining these questions is a series of experiments
in pEAK Rapid cells which do not contain endogenous Kalirin or NR2B. By cotransfecting Kal7, Kal PH1 or Kal PH2 and NR1/NR2B and looking at surface
expression of the NR2B receptor by biotinylation or cross-linking, we can determine
how these individual components influence surface levels of the NMDA receptor. As
the next step, agonist-induced internalization and recycling of NR2B containing
receptors can be evaluated341. By inducing receptor internalization and recycling to
the membrane, we will be able to determine if the presence of Kal7 or its PH domain
specifically affects receptor internalization or return to the surface.
In addition to these cell culture experiments, there are some potentially
interesting experiments involving receptor trafficking in Kal7KO neurons in vivo.
Cocaine is widely reported to affect AMPA receptor surface localization in the NAc117
and recent studies have shown changes in surface expression of NR2B receptors
following cocaine treatment107. Given the abnormalities the Kal7KO mice exhibit in their
behavioral response to cocaine, and the baseline difference they exhibit in NR2B
surface distribution, it will be interesting to look at surface receptor levels in the NAc
of Wt and Kal7KO mice after chronic cocaine treatment. These experiments would
likely look at changes in NMDA receptor as well as AMPA receptor localization, and
may help to explain some of the behavioral phenotypes of the Kal7KO mice.
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Kal7 focal knockout
As discussed in Chapters 1&3, the circuitry underlying addiction-like
behaviors is complex. In our initial studies, we used full Kal7KO mice to examine
locomotor sensitization and conditioned place preference (Chapter 3). The same
mice are being evaluated in a self-administration paradigm; preliminary data indicate
that the Kal7KO mice exhibit a robust increase in the amount of cocaine administered
(Foster Olive, unpublished data). These studies reveal a clear role for Kal7 in the
development of addiction-like behaviors; they do not, however, say where in these
complex circuits Kal7 is playing a role (Figure 1-1). In an attempt to pinpoint the brain
areas in which Kal7 plays an important role, our line of conditional Kal7KO mice
(Kal7CKO) will be quite useful. The Kal7CKO mice have loxP sites surrounding the exon
that is deleted in Kal7KO mice. These mice develop expressing normal levels of Kal7
and are functionally wild-type. However, stereotaxic infusion of a virus that drives the
expression of Cre-recombinase, eliminates Kal7 expression in that specific region
(e.g. NAc, PFC, Amygdala). While this approach would likely result in the same
upregulation in expression of other Kalirin isoforms, as was seen with the Kal7KO
mice, it eliminates any developmental concerns and would allow determination of the
role of Kal7 in the circuits regulating locomotor sensitization and CPP. While it is
possible that global knockout of Kal7 is necessary to produce a behavioral
phenotype, these experiments would provide useful data that could guide future
morphological, behavioral and biochemical experiments.
Kal7-shRNA has a profound effect on dendritic spines in cultured
neurons192,193 while the morphological deficits observed in Kal7KO mice are much less
severe (Chapters 2&3). One possible reason for this difference is the compensatory
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upregulation of Kal9 & 12 seen in the Kal7KO mouse. Also as a constitutive knockout,
neurons have had months to make other adaptive changes for the lack of Kal7. It
would be interesting to see how viral infection of NAc neurons with Kal7-shRNA
affected cocaine-related behaviors. Since the mRNA for Kal7 would be targeted for
degradation after synthesis, this should circumvent the compensatory increases Kal9
& 12 brought about by the alternative splicing seen in Kal7KO animals and potentially
in Kal7CKO animals treated with Cre recombinase. Additionally, the relatively shorter
timecourse of these experiments might limit compensatory changes in other genes. If
locomotor sensitization, CPP and self-administration are truly dependent on Kal7 in
the NAc, then these experiments may lead to an even more pronounced behavioral
phenotype. Ideally, these experiments would be paired with morphological analysis
similar to that performed in Chapter 3, as this would allow for comparison of
constitutive Kal7 knockout and Kal7 knockdown with shRNA.

Morphology
As mentioned previously, MSNs in the NAc and striatum are primarily
comprised of two distinct populations: D1-expressing cells and D2-expressing cells.
Dopaminergic transmission has opposite effects on the adenylate cyclase signaling
cascade in these two cell types and it is clear that the two cell types play different
roles in regulating behvior26,33,37,38,161,162. The morphological studies carried out in
Chapter 3 were performed on NAc MSNs without knowing their receptor expression
profiles. A recent study from our lab demonstrated that Kal7 is expressed in both D1
and D2-expressing cells342, however it is not known whether the Kal7 expression
profile is altered in a cell type specific manner by cocaine. For this reason, I would
propose examining NAc spine changes following chronic cocaine in mice expressing
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GFP in their D1-expressing neurons35,342. In so doing, we will be able to ascertain if
the effects of Kal7 knockout on morphology are much more pronounced in one
particular signaling pathway. These data could then be used to guide future
behavioral and biochemical experiments.
In addition to the studies looking at effects of Kal7KO on D1 vs. D2-expressing
neurons, it would also be interesting to look at potential morphological effects of
inhibiting one of the key interactors of Kal7: NR2B. As seen in Chapter 3, injections
of the NR2B antagonist ifenprodil during CPP conditioning result in a marked
decrease in preference in Wt animals. Additional studies have shown that a similar
regimen abrogated locomotor sensitization to cocaine110. A recent morphological
study showed that inhibition of all NMDA receptors by injection of the competitive
pan-NMDA receptor antagonist 3-[(R)-2-carboxypiperazin-4-yl]-prop-2-enyl-1phosphonic acid at the same time as cocaine injections blocked the ability of cocaine
to increase dendritic spine density in the NAc163. It would be interesting to see if
inhibition of NR2B-containing receptors with daily ifenprodil injections would similarly
blunt morphological changes and/or the increase in NAc Kal7 after repeated cocaine
injection. These experiments would provide valuable information on the cellular
pathways that are necessary for the morphological changes that follow cocaine.

Regulation of Kal7 phosphorylation by cocaine
The obvious follow-up to the studies identifying numerous phosphorylation
sites in Kal7 is to look at regulation of phosphorylation of Kal7 by a particularly salient
stimulus (e.g. cocaine or ECS). In collaboration with the Keck Center, we have
recently obtained some quantitative phosphorylation data for Kal7 following an acute
injection of cocaine using mass-spec multiple reaction monitoring techniques. A full

198

study looking at Kal7 phosphorylation after acute or chronic cocaine or saline is
currently underway. Once the sites that are most heavily regulated by cocaine are
identified, point mutations of these sites can be made to either mimic or prevent
phosphorylation. Studies of these point mutants will then reveal how these
phosphorylation events affect the catalytic, morphogenic or protein interaction
properties of Kal7. In the very long term, if one or two sites prove particularly
interesting, a transgenic mouse line can be created that expresses Kal7 mutated at
that specific phosphorylation site343; analysis of these mice will reveal the role that
this specific phosphorylation event plays in behavioral plasticity.

Rac/RhoA/Cdc42 activity after cocaine treatment
As discussed previously, Rho-GTPases and their downstream targets are key
regulators of the actin cytoskeleton131. Following chronic cocaine treatment,
alterations in dendritic spines189 and filamentous actin155 have been reported.
However, no detailed studies of activated Rho proteins have been done following
cocaine treatment. Preliminary studies from our lab have shown that acute cocaine
treatment increases levels of Rac-GTP in the NAc. Determining how activity levels of
Rac and other GTPases change over the course of chronic cocaine treatment would
provide critical information about how the actin cytoskeleton within spines is regulated
by cocaine.

Kal7KO mice as models for other disorders
From the studies presented in Chapter 3 it is clear that knockout of Kal7 alters
cocaine-mediated behaviors in animal models of addiction. Based on this, it would be
interesting to examine the Kal7KO mice in other models of addiction. Chronic
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treatment with amphetamine, morphine or ethanol have all been shown to alter
dendritic spine morphology in the NAc156,344,345. Morphine may serve as an interesting
comparison to cocaine, as morphine treatment is known to decrease dendritic spine
density in the NAc. Ethanol would be another interesting model as the drug has direct
effects on NMDA receptors, and it is the addiction paradigm in which it is the easiest
to model self-administration.
Exploration of the Kal7KO mice as potential models for disease should also not
end with addiction. Schizophrenia, mental retardation, autism and Alzheimer’s
disease are all conditions that are associated with abnormalities in dendritic spine
formation125,149,257,317,346,347. Indeed alterations in Kalirin have already been linked to
both schizophrenia and Alzheimer’s disease in human subjects152,153. Examination of
Kal7KO mice in animal models for these conditions348 would be helpful in verifying the
current human studies and may actually open new avenues of research on Kalirin in
human disease.
A final disease model that may be interesting to examine in the Kal7KO mice is
depression. Depression is one of the largest causes of morbidity in the United States
each year348, and the pathophysiology is still far from understood. From the
experiments in Chapter 2, we know that Kal7KO mice have a decrease in anxiety like
behaviors, anxiety and depression are highly comorbid conditions in human subjects.
Recent findings have demonstrated that injections of NR2B antagonists in rats can
produce antidepressant-like behaviors349. Given that Kal7KO mice have decreased
NR2B signaling at baseline (Chapter 4), it is possible that they would be resistant to
depression-like phenotypes. Examining Kal7KO mice in animal models of
depression348 could place Kal7 as an essential mediator of yet another important
behavioral phenotype.
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Conclusions
While the studies presented in Chapters 2-5 have clearly laid a foundation for
Kal7 playing an essential role in behavior and NMDA dependent synaptic function,
there is clearly more to be learned. The aforementioned studies suggest a number of
potential directions that future research may take. However, each one of the above
sections represents a significant undertaking of time and effort, and each will almost
certainly lead to new experiments off in some new direction. While it is likely that we
will never completely understand the role of Kal7 at the synapse, the fact that it may
play a key role in the pathophysiology of numerous diseases makes these and future
studies important and essential to carry on. If Kal7 and its interactors at the synapse
do play important roles in the pathology underlying these conditions, then it is
possible that modifications of Kal7 could serve as a potential therapeutic target in the
future.
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